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ABSTRACT 
 
 Successful axon regeneration appears to depend on the development of an injury 
response.  Dorsal root ganglion neurons exemplify the necessity of this injury response in a 
unique way.  Peripheral nerve transection leads to development of an injury response and 
successful regeneration whereas central root transection does neither.  The injury response may 
involve extracellular and intracellular pathways.  To investigate the extraneuronal influences, we 
performed nerve transection of either the central or peripheral axon branches and studied the 
expression of GAP-43, a key growth associated protein, and the transcription factors ATF3, c-
Jun, and STAT3.  Our results show that the responses to peripheral versus central nerve 
transection are fundamentally different.  Peripheral but not central nerve transection increases 
GAP-43, ATF3, and c-Jun expression.  STAT3, however, is upregulated as a result of central but 
not peripheral nerve transection.  To investigate potential intracellular signalling pathways, we 
applied FGF-2, an extracellular mitogen, or an analog of cAMP, an intracellular second 
messenger to the cut end of the peripheral axon.  Our results indicate that FGF-2 and cAMP act 
as activators of GAP-43 expression.  On the other hand, FGF-2 and cAMP act to downregulate 
the expression of ATF3.  FGF-2 upregulates c-Jun and the activated form of STAT3.  
Paradoxically, the regulation of GAP-43 expression by cAMP or by FGF-2 in vivo shows 
opposing results from the previously reported in vitro studies.  Our present results suggest that 
the peripheral nerve injury response may be governed by at least three different signalling 
pathways.   
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CHAPTER 1 
1.0 INTRODUCTION 
 
Axonal injury as a result of axotomy, crush, chronic constriction ligation, or 
inflammation induces biochemical and molecular alterations in the neuron collectively 
referred to as the injury response (Stoll and Muller, 1999).  This type of response occurs 
readily in mammalian peripheral nervous system (PNS) neurons (Bosse et al., 2006; 
Bosse et al., 2001), but to a much lesser extent in central nervous system (CNS) neurons 
(Bovolenta et al., 1992; Hagg, 2007). PNS neuronal response to injury is robust and leads 
to successful repair and regeneration (Monaco et al., 1992); whereas the injury response 
that occurs in CNS neurons is weak or absent, a fact that may contribute to the weak or 
absent regenerative capacity of CNS neurons (Fawcett, 1992; Tatagiba et al., 1997; Teng 
and Tang, 2006). A comprehensive understanding of the nature of the PNS injury 
response is yet to be attained.  It is hoped that increased knowledge of the cellular 
mechanisms that mediate the injury response and lead to successful PNS regeneration 
will lead to unlocking the mysteries of poor regenerative response in the CNS. 
 
1.1 Peripheral nerves. 
 The PNS includes all nerves that lie peripheral to and outside the pial covering of 
the CNS.  Peripheral nerves contain motor, sensory and autonomic axons.  Peripheral 
spinal nerves are covered by an outer connective tissue covering called the epineurium.  
Inside the epineurium, the collagenous perineurium covers bundles of individual fibers.  
Axons are covered by an intrafascicular connective tissue called the endoneurium. The 
endoneurium contains fibroblasts, macrophages and mast cells.  Peripheral nerves are 
richly supplied by blood vessels.  The presence of macrophages in the endoneurium and 
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the rich blood supply are indispensable components of the regenerative response to injury 
of the peripheral axon branch (Michael-Titus et al., 2010). 
 Axons within the nerve are intimately associated with Schwann cells along their 
entire length.  These Schwann cells enclose the axons either with a multi-layer myelin 
sheath, or with a simpler ensheathing arrangement.  Schwann cells also produce an 
organized extracellular matrix in the form of a basal lamina (Kandel and Jessel, 2000). 
 
1.1.1 Structure and organization of the dorsal root ganglion. 
Dorsal root ganglia (DRG) are aggregates of sensory neurons located dorsally on 
either side of the spinal cord. These sensory neurons are unique in that they are devoid of 
dendrites typically seen in multipolar neurons, but instead have a single axon that 
bifurcates to form two axon branches at a short distance from the cell body.  The longer 
branch extends into the periphery and forms the sensory endings in the skin, muscle, 
viscera, tendons, and joints and other organs, and the shorter branch enters the spinal cord 
through the dorsal root entry zone (DREZ) to form synapses on CNS neurons (Mescher, 
2009). 
These two axonal branches, though they originate from the same neuronal cell 
body, respond to injury in dramatically different ways. The peripheral branch has an 
intrinsic capacity to regenerate readily following injury, resulting in functional recovery.  
However, the central branch appears to have a lower capacity to regenerate if it is injured. 
This difference in regenerative capacity appears to be largely intrinsic (discussed below), 
but the cellular mechanisms responsible for this difference are poorly understood.    The 
fact that DRG neurons have two axon branches with fundamentally different injury 
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response properties provides a unique opportunity to perform insightful experiments.  
Each axon branch can be manipulated individually, simultaneously, or at a spaced time 
interval.  Likewise, changes in regenerative ability can be examined independently in 
each axon branch (Kandel and Jessel, 2000). 
Early in embryonic development the DRG neurons start out with a bipolar 
morphology.  Later, they undergo a fundamental morphological change, termed pseudo-
unipolarization, to assume their mature pseudounipolar form. Specifically, on the 
fourteenth day of rat gestation, the vast majority of neurons are bipolar and spindle-
shaped.  As development proceeds, the initial portions of the central and peripheral 
neuronal processes gradually approach each other and fuse to form a common initial 
portion. Finally, at about the eighteenth day of gestation, the cytoplasm of this common 
initial portion becomes thinner and elongates to form the stem process of the mature 
pseudounipolar neuron (Matsuda et al., 1996; Matsuda et al., 2000; Matsuda and Uehara, 
1984; Pannese, 1974).  Little is understood about the developmental events that confer 
distinct identities on the common initial segment of the axon, or on the peripheral and 
central axon branches. 
Morphometric analysis reveals that mature DRG neurons are endowed with small 
perikaryal projections that are enveloped by satellite cells (Pannese, 1981) a non-neuronal 
cell type found in ganglia, but not in the nerves.  These projections are more numerous on 
the surface of the mature than on that of premature bipolar neurons and are believed to 
increase in number as the neuronal cell bodies grow larger. The perikaryal projections 
increase the neuronal surface area and neuron-satellite cell interface and improve the 
efficiency of metabolic exchange between these two cell types (Matsuda et al., 2000).  
4 
 
Under the light microscope, DRG neuronal cell bodies, devoid of dendrites, 
appear as large cells with large, centrally located nuclei displaying prominent nucleoli.  
Within a given DRG, there is heterogeneity in the size of the neurons.  In the rat, DRG 
neurons can range between 15 – 100 µ in diameter.  The two main morphological types 
of sensory neurons, large light (LL) and small dark (SD) neurons are intermixed within 
the ganglion (Hanani, 2005; Lawson, 1992; Price, 1985; Zochodne, 2008).  According to 
the presence of Nissl substance (rough endoplasmic reticulum) LL neurons appear to be 
large and have less Nissl substance and thus appear and are classified as light.  On the 
other hand, SD neurons appear to be small with higher concentrations of Nissl substance, 
and thus appear and are classified as dark.  LL/SD neurons can also be subdivided on the 
basis of conduction properties. The axons of SD neurons are classified as C fibers (non-
myelinated, slow conducting), whereas the axons of LL neurons are classified as A types 
(myelinated, fast conducting).  Neurons within the A type are further classified as Aα,  
Aβ, and Aδ (Millan, 1999).  Many of the SD cells are nociceptive and they function 
mainly in thermo- and mechanoreception, whereas LL neurons are low threshold 
mechanoreceptors (Lawson, 1992).   
 
1.1.2 Biochemical markers of DRG neurons. 
The previous LL and SD classification of DRG neurons is based on size and 
morphological appearance.  However, with the advent of molecular biological 
techniques, a more current classification of DRG neurons has been in use based on 
specific markers.  DRG neurons do not receive synapses; they are, however, endowed 
with receptors for numerous neurotransmitters (Devor, 1999; Julius and Basbaum, 2001).  
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Additionally, DRG neurons express a diverse array of peptides, factors and specific 
biochemical markers.  The expression of these factors set the stage for the biochemical 
classification of DRG neurons.  Based on neurochemistry, morphology, trophic 
requirements and sensory modalities, DRG neurons are thus classified into three major 
types: small, medium, and large neurons. 
Small DRG neurons are associated with C and Aδ axons.  These small neurons 
selectively express peptides such as endothelin 1 (ET1), galanin, nociceptin, 
somatostatin, Substance P (SP), pituitary adenylate cyclase activating polypeptide 
(PACAP) , and vasoactive intestinal polypeptide (VIP).  Small DRG neurons also express 
specific receptors such as the α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate  
(AMPA)- and kainate-type glutamate receptors, bradykinin receptor (B2), histamine 
receptor (H1), epidermal growth factor receptor (EGF), fibroblast growth factor 2 (FGF-
2) receptor, neurokinin-1 receptor (NK1), somatostatin receptor (SSTR2a), purigenic 
receptor (P2X3), galanin receptor (GAL2), endothelin A receptor (ETA), and  glial cell 
line-derived neurotrophic factor (GDNF) family receptor (GFRα3).  Small DRG neurons 
express ion channels including bradykinin, calcium-activated potassium channel, L and 
N-type calcium channels, potassium channel (Kv1.4), sodium channel (Nav1.9), Naβ3, 
and members of the transient receptor potential cation channels including TRPA1, 
TRPM8, TRPV1, TRPV4, TRPV3 for a review please see (Zochodne, 2008). 
Medium DRG neurons express calcitonin gene-related peptide (CGRP).  The 
specific receptors expressed by this class of neurons are tropomyosin-related kinase A 
(trkA), p75, GFRα1, GFRα2, and rearranged during transfection receptor (RET).  Other 
receptors are also include a GDNF family coreceptor, µ opioid receptor (MOR), δ opioid 
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receptor (DOR), κ opioid receptor (KOR), and opioid-like receptor 1 (ORL1) and 
P2X2/3.  Small-to-medium neurons also express sodium channel proteins Nav 1.7, 1.8 
reviewed in (Zochodne, 2008).  
Small diameter DRG sensory neurons that are nociceptors can be divided into two 
populations based on neurochmistry: isolectin B4 IB4-positive nonpeptidergic neurons, 
and IB4-negative peptidergic neurons (Stucky and Lewin, 1999).  IB4-positive neurons 
depend on glial-derived neurotrophic factor (GDNF), whereas IB4-negative neurons 
depend on NGF for survival during postnatal development (Molliver et al., 1997). IB4-
positive neurons are characterized by longer-duration action potentials than IB4-negative 
neurons. This difference in electrophysiological properties expressed by IB4-positive and 
IB4-negative small neurons may contribute to their distinct functions especially in 
neuronal response to injury (Fang et al., 2006; Stucky and Lewin, 1999).  
 Most of the neurons in the small and medium size groups are peptidergic and 
respond to nerve growth factor (NGF).  Some of the calcitonin gene related peptide 
(CGRP) positive neurons also respond to GDNF (Nagy and Hunt, 1982). 
Large DRG neurons express TRPV2, cannabanoid 1 receptor (CB1), GAL1, 
GLUR2/3, ganglioside receptor 1 (GM1), purigenic receptor (P2Y1), and trkC.  This 
class of DRG neurons also expresses channels Naβ1, Kv 1.1, Kv β2.1, and 
hyperpolarization-activated cyclic nucleotide-gated potassium channel 1,2 (HCN1,2) 
(Devor, 2009; Kovalsky et al., 2009; Maher et al., 2009; Wickenden et al., 2009). 
Interestingly, between 30-40% of the lumbar DRG neurons are grouped among 
the large and medium diameter neurons, and identified based on the expression of the 
heavy chain neurofilament, NF200. This subpopulation of neurons typically has large 
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myelinated axons and functions as mechanoreceptors and proprioceptors. The neurons 
that express NF200 usually express trkA and trkC, as well as the p75 neurotrophin 
receptor (p75NTR) (Kai-Kai, 1989), and reviewed in (Zochodne, 2008).   
Approximately 70% of the neurons express one or more of the high affinity 
neurotrophin receptors trkA, trkB or trkC (Lindsay, 1996a; McMahon et al., 1994; 
Wright and Snider, 1995).  While the trk family of receptors act +as high affinity 
receptors for the neurotrophins (NGF, BDNF and neurotrophin 3 (NT3)), the GDNF 
family of trophic factors exerts its actions by binding to two different receptors: a high 
affinity receptor GFR-α, and a low affinity RET (Tucker and Mearow, 2008). 
 
1.1.3 Anatomy of the rat sciatic nerve. 
 The peripheral axon branches of sensory neurons in the DRG contribute to the 
formation of peripheral nerves.  The sciatic nerve of the rat originates from the DRG at 
lumbar spinal segments 4 to lumbar segment 6 (L4-L6). The L4 and L5 DRG contribute 
almost all of their peripheral axons, along with a partial contribution from L6.  The 
sciatic nerve in the minor pelvis runs in the deep groove between the dorsal side of the 
ischium and the sacral bone.  It passes on the ventral side of the piriformis muscle after 
leaving the sciatic notch. It courses over the quadratus femoris muscle obliquely to the 
thigh region caudal to the piriformis muscle, where a small branch innervates the biceps 
femoris, semi-tendinosus and semi-membraneous muscles. Then at the knee joint, it 
terminates into its two main branches: posterior tibial and peroneal (fibular) nerves.  The 
tibial portion gives rise to the tibial and the sural nerves, and the peroneal portion gives 
rise to the peroneal nerve and a cutaneous branch that perforates the lateral hamstring 
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muscles to innervate the proximolateral face of the calf (Schmalbruch, 1986; Uysal et al., 
2009).  Anatomical variations exist as to the origin of the rat sciatic nerve.  The rat sciatic 
nerve in the Sprague-Dawley strain originates from L3 to L6.  The major components are 
L4 and L5, since the contribution of both L3 and L6 nerves to the sciatic nerve is small 
(Asato et al., 2000).  The first sacral segment (S1) has also been reported to contribute to 
the sciatic nerve (Uysal et al., 2009).  Despite these anatomical variations, 98 to 99% of 
all sciatic DRG perikarya reside in the L4 and L5 DRG (Swett et al., 1991).  The anatomy 
of the rat sciatic nerve enables the experimenter to easily access the nerve on the dorsal 
aspect of the thigh, allowing for various surgical manipulations that can be perfomed 
peripherally at any point along the course of the nerve.    
 DRG central branches extend through the dorsal roots and into the spinal cord 
through the DREZ.  Fibers either terminate within a short distance or, travel up (the large 
and myelinated fibers) the dorsal columns via the fasicularis gracilis and fasicularis 
cuneatus to project to the dorsal column nuclei in the caudal medulla.  Some sensory 
afferent fibers enter dorsal horn grey matter immediately to synapse with interneurons, 
projection neurons, or motoneurons (Zochodne, 2008).  
 
1.1.4 Satellite cells. 
 Each DRG neuronal perikaryon is enveloped by its own satellite cell sheath 
forming a distinct morphological and functional unit (Hanani, 2005). The distance 
between satellite cells and the neuronal membranes is very small, about 20 nm (Pannese, 
1981).  DRG neurons invaginate microvilli-like structures into the surrounding satellite 
cells allowing for possible cell-cell communication between the two cell types (Pannese, 
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2002).  The number of satellite cells per DRG neuron is size-dependant: the larger the 
neuron the more satellite cells that are present in the perikaryal area (Ledda et al., 2004).   
 Following axotomy (Humbertson et al., 1969; Shinder et al., 1999), or 
inflammation (Lu and Richardson, 1991), satellite cells proliferate, and increase in 
number around the damaged DRG neurons (Hanani et al., 2002; Shinder et al., 1999), 
indicating a possible role for satellite cells in the injury response.  A function of 
phagocytosis of neuronal debris has also been ascribed to satellite cells (Pannese, 1978).  
Activated satellite cells have been found to upregulate expression of a number of growth 
and neurotrophic factors such as transforming growth factor alpha (TGF-α) (Xian and 
Zhou, 1999), FGF-2 (Grothe et al., 1997), and GDNF (Hammarberg et al., 1996), nerve 
growth factor (NGF) (Zhou et al., 1999), and neurotrophin-3 (NT-3) (Zhou et al., 1999), 
providing additional evidence that satellite cells are part of the overall injury response 
mechanism within the DRG. 
 
1.1.5 Schwann cells. 
Schwann cells provide support to both myelinated and unmyelinated axons 
throughout the PNS.  For larger axons, Schwann cells form a multilayered lipid myelin 
sheath around the axons that can be several micrometers in thickness.  The myelin sheath 
is not longitudinally continuous.  The gaps devoid of myelin between adjacent Schwann 
cells are called the nodes of Ranvier. The myelin sheath insulates the axon and decreases 
its membrane capacitance, thereby increasing the conduction velocity of the nerve 
impulse (Berta et al., 2008; Renganathan et al., 2001).  The presence of voltage gated 
sodium channels located preferentially at the nodes of Ranvier facilitates action potential 
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conduction through what is called saltatory conduction.  This is achieved by re-
propagation of the impulse at the nodes of Ranvier, thereby increasing the fidelity and 
velocity of conduction.   
Myelinating Schwann cells form the myelin sheath during late development and 
work by wrapping around and ensheathing the axon.  Schwann cells are also essential for 
the maintenance of healthy axons.  They produce a variety of supporting factors, 
including neurotrophins, and may also provide nutritive support and maintenance of ionic 
balance in the extracellular space (discussed below).  
Schwann cells can also provide support to smaller PNS axons by ensheathing 
them, without forming myelin.  Non-myelinating Schwann cells maintain axons and are 
crucial for neuronal survival. Some non-myelinating Schwann cells surround small C-
fiber axons that are in close proximity and form what is termed as a Remak bundle.  A 
Schwann cell in this bundle keeps the small axons from touching each other by 
interposing its cytoplasm between the axons, thus providing both structural and metabolic 
support (Andres et al., 1985; Griffin and Thompson, 2008; Murinson et al., 2005; 
Pannese et al., 1988a; Pannese et al., 1988b; Pannese et al., 1988c; Peyronnard et al., 
1975).  In addition, non-myelinating perisynaptic Schwann cells (PSCs) have distinct 
roles in the neuromuscular junction.  PSCs cover the neuromuscular synapses and 
activate neurotransmitter receptors (Auld and Robitaille, 2003).  The location of these 
perisynaptic Schwann cells at the synapse supports the idea of a role in the formation and 
maintenance of synaptic connections and transmission. Perisynaptic Schwann cells have 
purinergic and muscarinic receptors that can cause release of internal stores of calcium to 
generate calcium waves upon binding of purines and acetylcholine (Jahromi et al., 1992). 
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A number of neurotrophins have been implicated in maintenance of the neuromuscular 
junction synapse.  For example, BDNF and CNTF may act cooperatively to modulate and 
maintain proper functioning of synapses (Stoop and Poo, 1996a; b).  In addition to CNTF 
and BDNF, NT-3 present at the synapse modulate the Ca++ release and thus differentially 
regulate perisynaptic Schwann cell functions through modulating the purinergic or 
cholinergic signalling pathways (Todd et al., 2007).  Furthermore, PSCs maintain 
synaptic growth, and repair (Griffin and Thompson, 2008). 
During early neurogenesis, Schwann cells do not survive without signals 
originating from the developing axons such as neuregulins and endothelins (Jessen and 
Mirsky, 2002; Mirsky et al., 2002).  Schwann cells may carry out other specialized 
functions in growth, maintenance, and repair of peripheral nerves as well (Clarke and 
Richardson, 1994). Schwann cells play an important role in early peripheral nerve 
formation, and provide tropic and trophic support (Bray et al., 1981; Lundborg et al., 
1994).  Tropic support is provided by extracellular matrix molecules (ECM) that are 
involved both in cell adhesion and migration.  It is well established that the expression of 
laminin, neuronal cell adhesion molecule (NCAM), fibronectin and tenascin are all 
increased on the surface of Schwann cells during peripheral nerve regeneration process 
(Bailey et al., 1993; Martini, 1994).  Trophic support is provided by a number of growth 
factors such as NGF, and the transforming growth factor β family (TGFβ) (Scherer et al., 
1993).  By providing both structural and biochemical support, Schwann cells are 
considered an integral part of the integrity and function of the peripheral nervous system 
in both normal and injured states.  
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1.1.6 Macrophages. 
In the peripheral nervous system, macrophages are present in normal DRG tissues 
(Arvidson, 1977; Hamburger and Levi-Montalcini, 1949; Pannese, 1978; Perry and 
Gordon, 1988; Scaravilli et al., 1991; Stevens et al., 1989).  Macrophages are found 
primarily perineuronally in contact with the neuron/satellite cell complex.  A few exist in 
the perivascular regions, while others exist in interstitial position not in apparent contact 
with either blood vessels or neurons (Lu and Richardson, 1993).   
Peripheral nerve trauma and the ensuing injury-induced inflammation, together 
with the increase in macrophages, play important roles in neuronal survival and axonal 
regeneration after injury (Richardson and Lu, 1994). The number of macrophages in 
DRG increases 2-4 days after sciatic nerve axotomy and remains elevated for four weeks.  
It has been proposed that injury-induced recruitment and/or proliferation of macrophages 
in the injured DRG contribute to the survival or regeneration of axotomized neurons (Lu 
and Richardson, 1993), potentially supplying neurotrophic support to nerve cell bodies 
(Richardson and Lu, 1994).  Macrophage proliferation and recruitment in injured DRG 
also increases expression of certain neuronal mRNAs (Lu and Richardson, 1995).  
Macrophages produce cytokines and may play a role in the generation of neuropathic 
pain (Hu and McLachlan, 2002).  
In injured peripheral nerves, resident and recruited macrophages function in the 
removal of debris of degenerating nerves, and to induce Schwann cell proliferation 
(Beuche and Friede, 1986).  Direct injection of isogenous macrophages into the DRG 
enhances sciatic nerve regeneration in vivo (Lu and Richardson, 1991), and neurite 
growth in vitro by cultured DRG neurons (Hikawa et al., 1993; Luk et al., 2003).   
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Macrophages therefore appear to be key players in the mounting of a successful 
regenerative response in the peripheral nervous system.      
Macrophages and Schwann cells interact during the injury response, particularly 
in Wallerian degeneration.  Wallerian degeneration is part of the neuronal response to 
injury.   In particular, peripheral nerves undergo a process of degeneration of distal 
aspects of a nerve axon following injury to the cell body or proximal portion of the axon. 
The process is also characterized by fragmentation of the axon and its myelin sheath, 
resulting in atrophy and destruction of the axon.  A detailed description of Wallerian 
degeneration process is given below (section 1.2.3).   
When the proximal stump of a transected nerve is separated from the distal stump, 
Schwann cells proliferate.  Proliferating Schwann cells then co-migrate with regrowing 
axons and guide bundles of regrowing axons across interstump gaps (Hall, 1989). 
Processes such as initiation of myelin breakdown, subsequent macrophage 
recruitment, and activation and myelin phagocytosis could not be achieved without the 
proper molecular communication and interaction between the Schwann cells and 
macrophages (Martini et al., 2008).  A Phospholipase A2 signaling cascade appears to 
play a very important role in both cell types, initiating the breakdown of compact myelin, 
and inducing chemokine and cytokine expression.  Cytokines such as monocyte 
chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1α), and 
Interleukin-1 beta (IL-1β) are essential activators of subsequent macrophage recruitment 
and myelin phagocytosis (Martini et al., 2008).  Thus, the interaction between Schwann 
cells and macrophages with the cellular and extracellular components in the PNS may 
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determine the degree of tissue inflammation and repair processes such as remyelination 
associated with neuronal growth and nerve regeneration.  
 
1.1.7 Neurotrophins. 
 Neurotrophins are a family of highly conserved extracellular ligands that affect 
the differentiation, survival and biological function of neuronal cells in vertebrates. The 
family includes NGF, BDNF, NT-3 and neurotrophin-4/5 (NT-4/5) (Gotz and Schartl, 
1994).  Neurotrophins enhance neuronal cell survival and growth during the development 
of DRG neurons.  They influence the proliferation and differentiation of neuron 
progenitor cells and regulate the expression of several differentiated traits of neurons in 
early development and throughout life (Davies, 1994a; b).  In the PNS, a rapid neuronal 
cell body reaction and nuclear responses to distally-derived neurotrophins require 
retrograde transport of ligand-receptor complex (Watson et al., 1999).  The survival of 
the developing neuron is promoted by and depends upon neurotrophins primarily 
synthesized and released by target tissues.  All members of the neurotrophin family bind 
a common p75 receptor with low affinity.  However, there are also high affinity 
tropomyosin-related kinase (trk) receptors which more selectively recognize each of the 
individual neurotrophins.  Thus, NGF binds to trkA, BDNF and NT-4/5 bind to trkB, and 
NT-3 binds to trkC receptors.  NT-3 promiscuously binds to the other trk receptors at a 
lower affinity (Zochodne, 2008).  When neurotrophins bind trk receptors at the nerve 
terminals, the receptor/ligand complexes are endocytosed and trafficked through the axon 
back to the cell body.  Endocytosed neurotrophins/trk receptor complexes activate the 
extracellular signal-related protein kinase 5 (Erk5) pathway, causing nuclear translocation 
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of Erk5, and the phosphorylation of cAMP response element binding protein (CREB).  
Therefore, activation of the Erk5 pathway plays an important role in retrograde signaling, 
leading to enhanced neuronal survival (Watson et al., 2001).  Because of the molecular 
and biological specificity of the mechanisms of action of neurotrophins, especially in 
nerve regeneration, interest into designing derivatives and analogues as potential 
therapeutic agents has been an active area of research in pharmacology (Ibanez, 1995; 
Lindsay, 1996b). 
 The importance of retrograde transport comes from experiments where dynein-
based transport is inhibited.  Under these conditions, neurotrophin stimulation of axon 
terminals will not support survival. This indicates that defects in dynein-based retrograde 
transport obstructs the positive survival effects of target-derived trophic factors, leading 
to degeneration of target-dependent neurons (Heerssen et al., 2004).  Receptor mediated 
retrograde axonal transport of neurotrophic factors is increased after peripheral nerve 
injury (DiStefano and Curtis, 1994).  The neurotrophins NGF, BDNF, and NT-3 display 
distinct patterns of retrograde axonal transport in peripheral neurons (DiStefano et al., 
1992).  In addition to peripheral targets, Schwann cells and macrophages themselves have 
also been identified as potential sources for supplying neurotrophic factors to DRG 
neuronal cell bodies following injury (Richardson and Lu, 1994). 
 Sources of  neurotrophic factors not only can be from the target, but also from 
surrounding glial cells or the neuron itself and mediate their effects via receptor-mediated 
uptake and specific retrograde transport or via an autocrine or paracrine mechanisms 
(Korsching, 1993). 
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1.1.7.1 Nerve growth factor (NGF). 
In contrast to other typical growth factors, NGF is not a mitogen.  NGF is a 
neurotrophic molecule essential for the survival, development and maintenance of 
function of specific populations of peripheral and central neurons (Thoenen et al., 1985).  
NGF was initially discovered as a survival and outgrowth-promoting factor by Levi-
Montalcini (Angeletti et al., 1968; Levi-Montalcini, 1964; 1975; 1976; 1979; 1987; Levi-
Montalcini and Angeletti, 1968; Levi-Montalcini and Calissano, 1979; Varon, 1968).  
NGF selectively stimulates the growth of sympathetic and embryonic spinal sensory 
ganglia.  Target-derived NGF promotes the phenotypic maintenance of DRG nociceptive 
neurons (Delcroix et al., 2003). 
As a result of crush injury to rat sciatic nerve, NGF accumulates at the distal side 
of the crush site, whereas no NGF is detectable proximal to the crush (Korsching and 
Thoenen, 1983).  Two-site enzyme immunoassay for NGF shows that NGF is present in 
the peripheral but not the central axonal projections.  It is thus concluded that NGF 
supply comes exclusively from peripheral and not central axon branches (Korsching and 
Thoenen, 1985).  Following peripheral denervation NGF level in the target increases 
(Korsching and Thoenen, 1985).  This supports the role of target-derived growth factors 
in controlling target organ re-innervation.  Although NGF is required for DRG neuron 
survival during early development, by adulthood, not all DRG sensory neurons require 
NGF for survival (Levi-Montalcini, 1987; Lindsay, 1988). Some subpopulations of 
sensory neurons that do not require NGF for survival, respond instead to other 
neurotrophic factors such as BDNF or NT-3 for prolonged survival (Vogel, 1993).  
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NGF is also produced by cells other than target organs such as Schwann cells, 
macrophages, or the DRG neurons themselves (Ernfors et al., 1990; Schecterson and 
Bothwell, 1992), suggesting an autocrine, and/or paracrine (Lindsay, 1996a) function of 
NGF in adult DRG.   
NGF exerts its effects mainly by interaction with its high affinity specific receptor 
trkA.  This leads to the activation of several intracellular signaling pathways.  One such 
effect is an increase in intracellular calcium levels.  Calcium and calmodulin are both 
necessary for the acute activation of extracellular signal-regulated kinases (ERKs) after 
trkA stimulation (Egea et al., 2000).  Therefore, NGF activation of the ERK pathway is 
facilitated by Ca+2 ions and calmodulin.  
Studies provide evidence for the presence of endosomes within DRG neurons.  
The endosomes contain NGF, activated trkA, and signaling proteins of the Ras-
proximate-1 Rap1/Erk1/2, p38MAPK, and PI3K/Akt pathways, and are retrogradely 
transported in the isolated sciatic nerve in vitro (Delcroix et al., 2003; Grimes et al., 
1996; Tsui-Pierchala et al., 2000; Wu et al., 2001).  NGF injection in the peripheral target 
of DRG neurons increased the retrograde transport of the endosomes.  Conversely, NGF 
antibody injections decreased the retrograde transport of the endosomes, indicating that 
signaling endosomes convey NGF signals from the target of nociceptive neurons to their 
cell bodies (Delcroix et al., 2003).  NGF trophic signaling may also be facilitated by the 
RET coreceptor. Therefore, NGF may promote phosphorylation of a number of signaling 
proteins resulting in augmented growth, metabolism, and gene expression associated with 
sensory neuron function (Tsui-Pierchala et al., 2002). 
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It has been shown that retrograde survival signals can be carried by a mechanism 
activated by NGF at the axon terminal surface and travels to the cell body without the 
transport of NGF endosomes (Campenot and MacInnis, 2004).  This mechanism of 
retrograde signaling adds to the complexity of retrograde signaling mechanisms. 
 
1.1.7.2 Brain-derived neurotrophic factor (BDNF). 
 BDNF was first isolated from pig brain (Barde et al., 1982).  The BDNF gene was 
later cloned and characterized (Leibrock et al., 1989; Thoenen, 1991; Thoenen et al., 
1991) and the deduced amino acid sequence of BDNF revealed a high degree of 
homology to NGF.  BDNF protein is 120 AAs long and shares about 54% homology to 
NGF, particularly in the cysteine residues and in the sequences flanking these residues.  
Moreover, like NGF, BDNF rescues a subset of sensory neurons from naturally occurring 
cell death.  Despite their structural resemblance, there are differences between BDNF and 
NGF in their biological activity and neuronal specificity.  They both are target-derived 
neurotrophic factors that play important roles in the development and maintenance of 
multiple neuronal types of both the CNS and PNS, but especially primary sensory 
neurons (Lindsay, 1996a).  BDNF may also act by an autocrine route in some of these 
sensory neurons (Davies and Wright, 1995). 
 The biological activity of BDNF is mediated by the tyrosine kinase receptors trkB 
and trkC.  Of those two, trkB is the preferred receptor for BDNF (Glass et al., 1991; Ip et 
al., 1991; Lamballe et al., 1991a; b; Squinto et al., 1991).  Trk receptors are 
autophosphorylated upon binding to their ligands.  This leads to phosphorylation of 
downstream intracellular signaling proteins that induce cell growth and differentiation.   
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In cultured neurons and hippocampal slices the transcription factor cyclic AMP 
response element-binding protein (CREB) regulates BDNF-induced gene expression. 
Exposure of neurons to BDNF stimulates CREB phosphorylation and activation via at 
least two signaling pathways: by a calcium/calmodulin-dependent kinase IV (CaMKIV)-
regulated pathway that is activated by the release of intracellular calcium and by a Ras-
dependent pathway. Activation of CREB, therefore, plays a central role in mediating 
BDNF responses in neurons (Finkbeiner et al., 1997).  The mechanism of action for 
BDNF is similar to that of NGF, in activating calcium/calmodulin-dependent kinases, 
important regulatory pathways contributing to survival and regenerative growth. 
BDNF prevents axotomized retinal ganglion cell death through MAPK and PI3K 
signaling pathways.  This BDNF-mediated signaling pathway involves activation of both 
MAPK and Akt on the axotomized adult rat retina, and the collaboration of both MAPK 
and PI3K-Akt pathways seems to be necessary in neuroprotective signaling in 
axotomized retinal ganglion cells (RGCs) (Nakazawa et al., 2002).  This provides 
additional evidence that BDNF and NGF share some common regulatory pathways. 
Indeed, in a peripheral nerve transection injury model, BDNF administration to the ends 
of the cut axons enhances functional recovery (Utley et al., 1996; Yin et al., 1998). 
 
1.1.7.3 Neurotrophin-3 (NT-3). 
 The amino acid sequence of Neurotrophin-3 (NT-3) is 50% homologous to that of 
NGF and BDNF (Barde, 1990; Hohn et al., 1990), and is conserved across different 
species.  NT-3 binds the trkC receptor and is abundant in both central nervous system, 
and peripheral nervous system sensory neurons (Katoh-Semba et al., 1996; Schecterson 
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and Bothwell, 1992).  Specifically, the DRG is a source of NT-3 that may be supplied to 
the spinal cord, and contributes to plasticity in the spinal cord after injury (Wang et al., 
2008).  NT-3 deficient mice show 65% loss of DRG neurons, suggesting an early role of 
NT-3 during neurogenesis (Airaksinen and Meyer, 1996; Maness et al., 1994).  Thus it is 
of interest to determine whether NT-3 can promote peripheral sensory neuron survival 
and regeneration in the adult following injury (Yin et al., 1998). 
 
1.1.7.4 Glial cell line derived neurotrophic factor (GDNF). 
 Glial cell line derived neurotrophic factor (GDNF) was first purified from 
midbrain dopaminergic neurons (Ebadi et al., 1997; Lin et al., 1993).  GDNF is a potent 
survival factor for motoneurons that is present in peripheral nerve and muscle (Henderson 
et al., 1994), and for sympathetic, parasympathetic, proprioceptive, enteroceptive and 
small and large cutaneous sensory neurons (Buj-Bello et al., 1995).  GDNF is found in a 
variety of peripheral organs more than in the neuronal tissues, indicating its function as a 
target-derived neurotrophic factor.  GDNF mRNA is expressed in the sciatic nerve and 
DRG.  Following sciatic nerve axotomy, GDNF mRNA levels increase dramatically in 
the sciatic nerve, implicating GDNF in the overall peripheral nerve resposnse to injury 
(Lapchak et al., 1996; Trupp et al., 1995).  These reports suggest that GDNF is essential 
for the survival of multiple PNS and CNS neurons at different stages of their 
development (Ebadi et al., 1997). 
 GDNF signals through a multicomponent receptor complex consisting of RET 
receptor tyrosine kinase and a member of the GDNF family receptor alpha (GFRα).  This 
complex eventually activates the RAS and PI3-K pathways.  This leads to the activation 
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of CREB and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) 
(Hayashi et al., 2000; Poteryaev et al., 1999; Trupp et al., 1999).  GDNF also activates 
the MAPK pathway (Chen et al., 2001). In early embryogenesis, GDNF-stimulated PI3K 
and Akt activities exert opposing effects on the ERK pathway, protecting 
neuroectodermal cells from apoptosis during their migration in the foregut (Mograbi et 
al., 2001).  These findings show evidence that GDNF activates some pathways in 
common with other neurotrophins.  
  
1.1.7.5 Ciliary neurotrophic factor (CNTF). 
Ciliary neurotrophic factor (CNTF) was initially identified and characterized in 
the intraocular (ciliary) muscles of chick eyes as a target-derived neurotrophic molecule 
that supports the survival of parasympathetic chick ciliary neurons in culture (Adler et al., 
1979; Barbin et al., 1984). The spectrum of CNTF biological activity infuences a much 
broader range of the components of the nervous system, since peripheral and central 
neurons also respond to CNTF (Ip et al., 1991).  It has been shown that CNTF also 
supports the survival of sympathetic, sensory and spinal motoneurons (Thoenen, 1991). 
CNTF is a member of the hematopoietic cytokine family and shares structural and 
functional properties with the members of this family such as LIF and IL6. It is composed 
of a four-helix bundle structure and shares the transmembrane signal transducing 
proteins, glycoprotein-130 (gp130) and leukemia inhibitory factor receptor (LIF-R). 
CNTF binding activates signal transduction cascades mediated by the Janus kinase 
(JAK)/signal transducer and activator of transcription (STAT) and Ras/MAPK signaling 
pathways (Inoue et al., 1996). 
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Evidence indicates that CNTF plays a key role in the injury response in the 
nervous system.  Dramatic changes in the level of expression of CNTF occur following 
neural trauma in the PNS.  Prior to nerve injury, high levels of CNTF mRNA and protein 
were localized within the Schwann cells of the sciatic nerve (Abe et al., 2001; Hu et al., 
2005; Stockli et al., 1991).  However, following peripheral nerve injury, the CNTF 
mRNA and protein levels decrease dramatically in the distal nerve (Rabinovsky et al., 
1992), thus change in CNTF expression is one of the early markers of neural injury.   
CNTF binds to ciliary neurotrophic factor receptor a (CNTFRa) receptor to initiate its 
biological response in neuronal tissues, and shares receptor components with other 
hematopoietic cytokines (Ip and Yancopoulos, 1996).  Interstingly, BDNF and CNTF 
may act cooperatively in modulating the development and functioning of synapses, 
indicating a different level of the complex nature of neurotrophin actions (Stoop and Poo, 
1996b). 
 
1.1.7.6 Leukemia inhibitory factor (LIF) 
Leukemia inhibitory factor (LIF) is a cytokine structurally homologous to CNTF 
(Ip and Yancopoulos, 1996).  Furthermore, the receptors for LIF and CNTF share two 
identical subunit components, which are believed to mediate their overlapping biological 
activity (Ip and Yancopoulos, 1996). However, LIF only requires the receptor 
components gp130 and LIFRβ for signal transduction (Davis et al., 1993). Because of the 
structural and biochemical similarities between the two factors, and because LIF induces 
biological activity on several neuronal classes (Ip and Yancopoulos, 1996), it is 
reasonable to ask whether LIF would also exert trophic activity on neuronal cells. 
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Interestingly and of direct relevance to this project is the fact that the signal of the 
cytoplasmic regions of leukemia inhibitory factor receptor (LIFR) alpha-subunit and 
gp130 involves signal STAT3 activation (Liu et al., 1999). 
LIF expression is induced by injury and is required for the neuronal response to 
injury (Sun et al., 1996; Sun and Zigmond, 1996a; b; Zigmond et al., 1996).  It can act as 
a survival factor for injured peripheral neurons. When applied to peripheral nerves in 
vivo, the cytokine is retrogradely transported and rescues damaged sensory neurons 
(Curtis et al., 1994).   
 
1.1.7.7 Insulin-like growth factors-1 and 2 (IGF-1 and IGF-2). 
Insulin-like growth factors (IGF-1 and IGF-2) are proteins that share a high 
sequence similarity to insulin. They are recogized by their respective receptors IGFR1 
and IGFR2.  IGFs exhibit neurotrophic properties similar to NGF, including the capacity 
to enhance neurite formation and extension (Ishii et al., 1985; Mill et al., 1985).  IGFs 
can act in combination with other growth factors such as fibroblast growth factors (FGFs) 
to elicit their neurotrophic effects (Torres-Aleman et al., 1990a; b). 
IGFs have been demonstrated to both promote and sustain the regenerative 
process in a peripheral nerve injury model (Hansson, 1993; Ishii et al., 1994; Ishii et al., 
1993).  Exogenous administration of IGF-2 increases the rate of peripheral nerve 
regeneration, and endogenous IGFs in nerves are required to maintain a specific rate of 
regeneration (Glazner et al., 1993).  Target-derived and nerve-derived IGFs can regulate 
peripheral nerve regeneration following injury (Ishii et al., 1994).  In particular, sensory 
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neurons respond with enhanced regenerative growth to insulin and IGF-1 (Fernyhough et 
al., 1993). 
IGF-1 has been reported to have an inductive effect on the expression of GAP-43 
expression (Lutz et al., 1999).  Of particular relevance to this project is the finding that in 
primary Schwann cell culture IGF-1 alone was ineffective, but in the presence of 
forskolin or dibutyryl cyclic AMP (dbcAMP), IGF-1 became a potent mitogen, 
stimulating Schwann cell proliferation (Schumacher et al., 1993).  These results suggest a 
regeneration promoting effects of IGF-1 on peripherally transected sciatic nerve. 
 
1.1.7.8 Fibroblast growth factor-2 (FGF-2). 
 Fibroblast growth factors are expressed in dorsal root ganglion neurons.  Acidic 
fibroblast growth factor (aFGF) and its receptors (FGFR-1 and FGFR-2) have been 
reported to be expressed and maintained in postmitotic dorsal root ganglion neurons 
(Oellig et al., 1995).   
Basic fibroblast growth factor (FGF-2) and its receptors have been described as 
important physiological modulators of neurotrophins and in peripheral nervous system 
regeneration (Grothe et al., 2006; Grothe et al., 1997; Grothe and Nikkhah, 2001; Grothe 
and Wewetzer, 1996).  FGF-2 is one of more than 23 members of the FGF family (Ornitz 
and Itoh, 2001).  FGFs can mediate their biological activities through two types of 
binding sites, the low-affinity binding sites represented by heparan sulfate proteoglycans 
(HSPGs) and the high-affinity tyrosine kinase transmembrane receptors (FGFRs) 
(McKeehan et al., 1998).  FGF-2 protein exists in different isoforms representing 
different translation products from a single mRNA (Florkiewicz et al., 1991a; 
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Florkiewicz et al., 1991b; Florkiewicz and Sommer, 1989).  Peripheral nerve lesion 
causes differential increase of the FGF-2 isoforms (Grothe et al., 1997; Meisinger and 
Grothe, 1997).  
FGF-2 and its receptors are expressed in the DRG and the peripheral nerves and 
are upregulated in the DRG and in the proximal and distal nerve stumps following 
peripheral nerve injury. There are two major sources of FGF in the peripheral nerve, 
neurons in the ganglia, and at the lesion site of the nerve, where Schwann cells and 
invading macrophages represent the main sources of FGF-2 and its receptors FGFR1-3 
(Grothe and Nikkhah, 2001).  
FGF-2 is localized in a subpopulation of small and medium neurons in adult DRG 
from all axial levels.  It is colocalized with the somatostatin/bombesin expressing 
subpopulation but not with substance P (Weise et al., 1992).  FGF-2 signaling does not 
appear to regulate CGRP expression in vivo (Jungnickel et al., 2005). 
When applied exogenously, FGF-2 rescues injured sensory neurons and facilitates 
neurite outgrowth of injured peripheral nerves.  FGF-2 exerts a protective effect on the 
maintenance of transected sensory neurons.  Specifically, FGF-2 protects DRG neurons 
from lesion-induced death, possibly via local accumulation of neurotrophic activities at 
the proximal nerve stump that have been elicited by FGF-2 (Otto et al., 1987).  Moreover, 
FGF-2 promotes neurite extension and vascularization of the regenerating nerve fibers 
crossing the gap between the proximal and distal stumps of the transected sciatic nerve 
(Aebischer et al., 1989; Danielsen et al., 1988). 
FGF-2 is also expressed endogenously within both the developing and adult DRG 
neurons.  In the adult rat, FGF-2 is found in subpopulations of sensory neurons within the 
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DRG (Weise et al., 1992). In addition, FGF-2 and FGFR1 immunoreactivity are co-
localized in adult rat DRG neurons (Grothe and Wewetzer, 1996; Meisinger et al., 1996a; 
Meisinger et al., 1996b). Thus FGF-2 and its receptors are constitutively expressed in 
developing and adult DRG neurons.  FGF-2 is also expressed in Schwann cells and 
macrophages, thus it is suggested that FGF-2 can act in concert with other cytokines, 
factors, or neurotrophins (Grothe et al., 2006; Grothe and Nikkhah, 2001). 
In frog retinal ganglion cells, FGF-2 upregulates the synthesis and alters the 
distribution of the axonal growth-associated  protein GAP-43 expression after optic nerve 
injury (Soto et al., 2003), enhancing regenerative axon growth.  It is not known whether a 
similar biological activity may also be involved in regenerative growth in DRG neurons.  
Northern blot analysis of adult rat DRGs reveals the presence of FGF-2 transcript 
(Grothe and Meisinger, 1995). Ligation of the sciatic nerve does not lead to proximal or 
distal accumulation of FGF-2 immunoreactivity (Grothe and Wewetzer, 1996).  
Transection of the sciatic nerve elevates the expression of FGF-2 and FGFR-1 in DRG 
neurons in both postnatal and adult rats (Grothe and Wewetzer, 1996).  This pattern of 
FGF expression is consistent with FGF involvement in the regulation of axon regrowth.  
Intraganglionic expression of FGF-2 may indicate the presence of an autocrine/paracrine 
loop (Murphy et al., 1994). 
Mice lacking FGF-2 showed faster sensory recovery two weeks after peripheral 
nerve injury.  The regenerating fibers of the mutant mice showed both significantly 
increased axon and myelin size, suggesting that loss of FGF-2 could expedite restoration 
of mechanosensory function by accelerating structural recovery, possibly by regulation of 
Schwann cell differentiation (Jungnickel et al., 2004; Jungnickel et al., 2009).  This 
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study, however, was performed on mice that were developmentally deficient in FGF-2.  
The scope of the implications of not having FGF-2 pathway present during normal 
neurogenesis of the sensory neurons could have influenced the outcome of this particular 
experiment; therefore, the results in the absence of FGF-2 should not be taken as the sole 
reason for having potential faster rate of regeneration.   
On the other hand, the same research group reported that mice over-expressing 
FGF-2 had faster nerve regeneration after sciatic nerve injury. The number of regenerated 
axons was shown to be smaller in transgenic mice one week after crush injury, suggesting 
a role of the elevated expression of FGF-2 in early peripheral nerve regeneration by 
regulating Schwann cell proliferation, axonal regrowth, and remyelination (Jungnickel et 
al., 2006).     Despite this reported increased rate of sciatic nerve regeneration, mice 
lacking FGF receptors FGFR-1 and FGFR-2 showed degeneration of sensory axons of 
Remak bundle and impaired thermosensory functions, resulting in c-fiber neuropathy 
(Furusho et al., 2009).    
Different members of the FGF family are expressed following sciatic nerve 
injury.  Using cDNA array, it was reported that FGF 2 and FGF 7 were significantly 
increased in the DRG after 28 days following nerve transection.   Whereas about 60 % of 
the uninjured neurons expressed FGF 13, the percentage dropped to 18% following injury 
(Li et al., 2002).  These data support the notion that FGF-2 plays a key role in the process 
of neuronal inury response mechanism.     
In cultured DRG neurons, FGF-2 was found to repress GAP-43 expression in a 
dose dependent manner.  This repression of GAP-43 by FGF-2 was reversed by 
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MEK/ERK inhibition, suggesting that the repressive action of FGF-2 occurs, at least in 
part, through the MEK pathway (Schreyer, 2004).   
In contrast to this study, it was recently shown that Sprouty2, a negative feedback 
loop modulator that limits the intensity and duration of tyrosine kinase activation is 
expressed in adult sensory neurons (Hausott et al., 2009).  Down-regulation of Sprouty2 
enhances regenerative axon growth by adult sensory neurons, associated with enhanced 
FGF-2-induced activation of the ERK and Ras signalling pathway. In contrast, Sprouty2 
overexpression inhibited axon growth (Hausott et al., 2009).  It appears, therefore, that 
Sprouty2 may inhibit the influence of FGF-2 via Ras/Raf/ERK pathway.   Because of the 
potential importance of FGF-2 in peripheral nerve regeneration and maintenance of 
sensory neurons, FGF-2 was selected in the current project as one of the main potential 
exogenous modulators of injury-induced biochemical markers.    
 
1.2 Peripheral nerve injury-response. 
As a consequence of peripheral nerve axotomy, between 10-40% DRG neurons 
die within a week of axotomy (Aldskogius and Risling, 1981; Arvidsson et al., 1986; 
Himes and Tessler, 1989; Liss et al., 1994; McKay Hart et al., 2002; Rich et al., 1989; 
Schmalbruch, 1987).  Factors such as proximity of axotomy to the DRG (Ygge, 1989), 
the age of the animal (Bahadori et al., 2001; Kerezoudi et al., 1995), and the species used 
(Kline et al., 1964a; b) have been shown to influence the regenerative capacity and the 
outcome of neuronal death in response to injury.  The closer the axotomy to the DRG 
ganglion perikarya, the more drastic is the rate of DRG neuronal loss (Ygge, 1989). The 
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process of cell death described here is likely to be apoptotic, due to the immediate loss of 
target derived neurotrophins and supporting factors.  
The DRG neurons that survive following peripheral nerve transection undergo a 
morphological change termed chromatolysis, in which the injured neurons swell.  Their 
nuclei move to an eccentric position, concomitant with increases in RNA synthesis.  
Morphological changes may be induced in injured DRG neurons as a result of 
restructuring of cytoskeletal elements such as neurofilaments (Oblinger et al., 1989).   
Biochemical changes that ensue following injury to DRG neurons include, but are 
not limited to, changes in gene transcription, changes in translation, stability, or 
subcellular localization of translated proteins, and post-translational modification of 
proteins (Bhave and Gereau, 2004; Caroni, 1998).  Most of these biochemical changes 
are restored to normal levels upon successful reinnervation of the target tissues.  Other 
biochemical changes may arise at a distance from the neuronal cell body, namely at the 
injured axon tip.  Local translation of axonal mRNA coding for proteins with nuclear 
localization signals (NLS), and of critical carrier proteins (including vimentin) that link 
diverse signaling molecules to the dynein retrograde motor at the injury site have been 
reported.  These proteins are retrogradely transported to the cell body as part of the injury 
response (Hanz and Fainzilber, 2006; Hanz et al., 2003).  Additionally, local translation 
of other cytoskeletal elements such as β-actin, α-tubulin, low molecular weight 
neurofilament, Tau, actin-depolymerizing factor (ADF), EphA2, and importins have also 
been reported at the site of injury (Willis et al., 2005).   
DRG neuronal somata are electrically excitable, and some are able to generate 
action potentials repetitively on sustained depolarization.  It has thus been hypothesized 
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that electrical properties of the soma may be required to insure reliable propagation of 
impulses past the DREZ and into the spinal cord (Devor, 1999).  The disruption of this 
normalized electrical activity by axotomy is one of the earliest events in DRG neuronal 
response to injury (Liu et al., 2000).  One of the major electro-physiological effects of 
peripheral nerve transection is to trigger an ectopic afferent action potential barrage 
carried by DRG neurons afferents into the spinal cord (Liu et al., 2000).  
Axonal injury can alter the electrophysiological properties of DRG neurons 
(Abdulla and Smith, 2001a; b; Bishop, 1982; Ma et al., 2003).  Peripheral nerve injury 
can change the receptor phenotype of both small and large neurons and may, as a result, 
have differential effects on the membrane electrical properties of these neuron types (Xu 
et al., 1997).   Peripheral nerve injury can also lead to an abnormal afferent barrage 
generated in the cut end of the nerve (Wall et al., 1979).  This abnormal discharge can 
amplify and or distort naturally generated signals (Wall and Gutnick, 1974a; b; Wall et 
al., 1974).  The changes in electrical properties of the injured peripheral nerve have been 
linked to increased sensitivity and hyperalgesia associated with the injury (Wall, 1984).  
Following crush lesion, continuous conduction has been found in the regenerating 
processes of myelinated dorsal root fibers in the rat 12-20 days after injury (Feasby et al., 
1981).  The initial discharge of electrical activity may be one of the very earliest events 
that take place in response to injury, prior to any other visible morphological signs.     
Ion channels present in the DRG neurons show changes as a result of neuronal 
injury.  At least six different sodium channels are known to be expressed in DRG 
neurons, including several sensory-neuron-specific sodium channels that are not present 
in other parts of the nervous system (Waxman et al., 1999). Following injury to their 
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peripheral axons, DRG neurons down regulate some sodium channel genes and 
upregulate others. As a result, different groups of sodium channels are inserted into the 
DRG neuron cell membrane following injury (Goldin et al., 2000; Waxman et al., 2000).  
Axotomy reduces the action potential threshold by significantly increasing the expression 
of tetrodotoxin (TTX)-sensitive sodium currents (Zhang et al., 1997). Injured neurons 
also increase the expression of voltage-gated sodium channels Nav1.3 (Berta et al., 2008). 
These changes are accompanied by alterations in physiological properties that contribute 
to hyperexcitability in these cells, and altered depolarization firing rates.   
At least seven different families of voltage-gated potassium channels are normally 
involved in regulating and modifying the integration and transmission of electrical 
signals in the nervous system (Ishikawa et al., 1999).  Cultured DRG neurons from 
axotomized adult rats show remarkable decreases in a number of potassium channels 
(Ishikawa et al., 1999).  Similar decreases in potassium channels in the DRG neurons 
have been seen as a result of sciatic nerve chronic constriction injury (Kim et al., 2002), 
and axon axotomy (Park et al., 2003) .  The decreases in some voltage gated potassium 
channels as a result of injury, along with simultaneous increases in some sodium 
channels, may lead to changes in electrical excitability of the DRG neurons (Ishikawa et 
al., 1999), and may, thus, be additional contributors to the overall injury response 
mechanism.   
Calcium channels are present in DRG neurons (Fedulova et al., 1981; Morad et 
al., 1988).  Calcineurin, a compound that regulates the activity of calcium channels, also 
exists in the DRG neurons (Lukyanetz, 1997).  Increases in the pore forming part of  
calcium channels α2δ in DRG neurons of injured peripheral nerves have been reported 
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(Kim et al., 2001b; Luo et al., 2001; Newton et al., 2001). A concurrent increase in 
ectopic spontaneous discharges has been related to increased calcium channel activity 
(Xing and Hu, 1999).  These drastic changes have been associated with injury-induced 
allodynia (Luo et al., 2001). 
Application of brief or extended electrical stimulation (1 hour to 2 weeks of 20 Hz 
continuous electrical stimulation) to the proximal cut end of peripherally axotomized 
femoral nerve has been found to accelerate axonal regrowth (Al-Majed et al., 2000).  
Continuous 20 Hz electrical stimulation applied proximal to injury site for 1 h lead to a 
significant increase in DRG neurons regenerating into cutaneous and muscle branches, 
and increased the numbers of neurons that regenerated axons.  This enhanced 
regenerative capacity is correlated with increased GAP-43 mRNA in the regenerating 
neurons, and with elevated expression of brain-derived neurotrophic factor (BDNF) 
(Geremia et al., 2007).  The results of this experiment provided evidenc that linked 
electrical stimulation to increased  expression of a neurotrophic factor, BDNF.  This, in 
turn, leads to an increased expression of GAP-43 message.  It would be of interest to 
study the potential correlation between this brief stimulation with other known neutrophic 
factors.     
  
1.2.1 Response to peripheral axon injury. 
Lesions or trauma of the peripheral axon branch induce a number of 
morphological, metabolic, and molecular alterations in the DRG neuronal cell body that 
may ultimately contribute to the initiation and maintenance of the axonal regeneration.  
There may be an additional role for non-neuronal cells to take an active part in the DRG 
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collective response to injury.  For example, macrophages actively remove myelin debris, 
and Schwann cells proliferate and migrate. Non-neuronal cells may also be sources of 
biochemical factors that might influence axon regrowth.   
The neuropeptide expression of DRG neurons appears to be sensitive to axon 
injury. Following peripheral nerve injury the population of DRG neurons shows a marked 
decrease in those that express SP (Barbut et al., 1981; Bisby and Keen, 1986; Jessell et 
al., 1979; Tessler et al., 1985), PPT (Kashiba et al., 1992; Noguchi et al., 1989), CGRP 
(Inaishi et al., 1992), and galanin (Kashiba et al., 1992).  On the other hand, there is a 
robust increase in the number of DRG neurons that express other neuropeptides, such as 
VIP (Kashiba et al., 1992; Noguchi et al., 1989) and NPY (Frisen et al., 1992).  Little is 
known about what role altered neuropeptide expression (and release) may play in axonal 
regeneration. 
Peripheral axon injury also causes increased expression of intracellular proteins 
that are known to relay extracellular signals and control cytoskeletal dynamics such as 
cortical cytoskeleton-associated and calmodulin binding protein (CAP-23), neuron-
specific growth associated protein/stathmen homolog (SCG10), and GAP-43 (Hoffman, 
1989; Mason et al., 2002).  Also, chaperonins such as HSP27 (Costigan et al., 1998), are 
robustly enhanced in peripherally axotomized sciatic nerve.  These proteins are 
collectively called growth associated proteins, the expression of which is associated with 
the regenerative process.   
Transcription factors such as c-Jun (Jenkins et al., 1993), STAT3 (Qiu et al., 
2005), and ATF3 (Seijffers et al., 2006), also undergo changes following peripheral axon 
injury in DRG neurons.  As a result of injury, MAPK signaling pathway is activated.  
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Consequently, phosphorylation and nuclear localization of a number of transcription 
factors including c-Jun, ATF3, and STAT3 may contribute to the alteration in gene 
expression of the injured neuron.   Many of these transcription factors control the 
expression of neuropeptides, ion channel expression, and their own expression.  
These collective phenotypic changes suggest that when DRG neurons suffer 
peripheral axon injury, there is a switch from the normal action potential transmitting 
phenotype to a phenotype more suitable for the initiation and support of axonal 
regeneration. The process of regeneration is dependent upon, and may be governed by 
intrinsic and extrinsic factors to neurons (Fawcett, 1992; Fu and Gordon, 1997), 
including trophic factors (Navarro et al., 2007).   
Intrinsic factors refer to the biochemical factors that exist within the confinement 
of the neuron proper.  In contrast, the term extrinsic factors refers to those factors that are 
present in the immediate surroundings of the neuron, and the neuron is subject to their 
potential biological actions. 
 
1.2.2 Response to central axon injury. 
The central axons of the DRG extend through the dorsal root, then into the spinal 
cord at the dorsal root entry zone. Central DRG axon branches synapse with dorsal horn 
interneurons to relay sensory information to the CNS.  For many larger DRG neurons, 
collateral of the central axon branch may also ascend through the dorsal columns to 
ultimately synapse in the brainstem.   
A lesion of the central axons of the DRG neurons, by itself, largely fails to induce 
the full range of morphological, physiological and biochemical changes that are normally 
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seen following lesions to the peripheral axons.  For example, no cell death is observed 
among L5 DRG neurons after dorsal transection (Himes and Tessler, 1989).  
Chromatolysis is also not seen in DRG neurons following central axon injury (Cragg, 
1970).  Injury of the central branch axon, by itself, is followed by poor regeneration of 
the central branch (Oblinger and Lasek, 1984).   
Expression levels of neuropeptide markers such as VIP and PPT (Noguchi et al., 
1989), and NPY  do not change following dorsal root transection.  Expression of 
transcription factors such as c-Jun (Broude et al., 1997; Jenkins et al., 1993; Kenney and 
Kocsis, 1997a), and ATF3 (Seijffers et al., 2006) also does not change dramatically as a 
result of dorsal transection. On the other hand, levels of neuropeptide CGRP (Inaishi et 
al., 1992) increase following dorsal root transection, whereas, neurofilament protein 
NF200 is one of the few proteins that show a marked reduction following a lesion to the 
central axon branch (Guseva and Chelyshev, 2006).  
Molecules that interact with membrane signal-transduction mechanisms and 
control cytoskeletal dynamics such as CAP-23, SCG10, and GAP-43 remain unchanged 
after injury of the DRG central axon branch (Schreyer and Skene 1993) (Mason et al., 
2002) even though they are robustly enhanced in peripherally axotomized sciatic nerve.   
Ion channels such as sodium channel type III (Black et al., 1999; Sleeper et al., 2000) and 
α2δ 1 pore forming part of calcium channels (Li et al., 2004; Luo et al., 2001) remain 
unchanged as a result of dorsal transection, contrary to these channels’ enhanced 
expression following peripheral axotomy.  There are other proteins that do not change 
following dorsal root transection, but increase as a result of peripheral axotomy such as 
Neuropilin-1 (NP-1) (Gavazzi et al., 2000). 
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1.2.3 Distal nerve stump injury-response (Wallerian Degeneration): 
Following peripheral branch nerve injury, axons distal to the lesion are 
disconnected from the cell body and undergo a process termed 'Wallerian degeneration' 
(Koeppen, 2004; Pearce, 2000; Waller, 1850) reviewed in (Fawcett and Keynes, 1990; 
Hall, 2005; Navarro et al., 2007; Zochodne, 2008).   Damage to the axonal membrane, or 
axolemma, induces calcium-mediated proteolytic activity that will break down the axon, 
causing myelin to break down, and recruits resident and circulating macrophages to the 
damaged site (Akassoglou et al., 2000; Coleman and Perry, 2002; George and Griffin, 
1994; Kiryu-Seo et al., 2000).  This infiltration of macrophages into the area of injury 
accomplishes two important processes: first, it allows for interactions between 
macrophages and Schwann cells; secondly, it clears the myelin and axonal debris by 
phagocytosis (Martini et al., 2008).   
 Eliminating myelin debris is an important step to successful regeneration, because 
myelin associated proteins are known to impede and inhibit successful regeneration.  The 
inhibitors include myelin-associated glycoprotein (MAG) (Chen et al., 2006), 
oligodendrocyte-myelin glycoprotein (OMgp) (Xie and Zheng, 2008) and Nogo (Schwab, 
2004), all three of which appear to act via the Nogo receptor (NgR) despite the fact that 
they have little structural similarity (Mandemakers and Barres, 2005).  It is believed that 
the microenvironment of the intact peripheral nerve does not support axons that had been 
cut and undergoing regrowth (Hall, 1993).  It is only upon injury and initiation of the 
regenerative response that Schwann cell proliferation and axonal sprouting and 
elongation are permitted to take place (Alvarez et al., 2000; Tapia et al., 1995).  These 
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processes are normally inhibited in intact nerves by signals that originate from Schwann 
cells (Hall, 2005).         
The basement membrane that surrounds the axon and Schwann cell remains intact 
and serves as a pathway or a tract for Schwann cells to line up, elongate and form bands 
of Büngner or Schwann tubes (Stoll and Muller, 1999). Schwann cells then begin to 
synthesize growth and neurotrophic factors that act as tropic (guidance cues), and trophic 
(maintenance) factors for the newly forming axonal sprouts from the proximal end of the 
injured nerve (Campana, 2007; Cheng et al., 1996; Pellitteri et al., 2006).  After providing 
the proper extracellular environment that supports axonal growth, Schwann cells adopt a 
different phenotype and begin to remyelinate the newly regenerated axons (Stoll and 
Muller, 1999).   
After nerve injury and successful repair, the newly regenerated peripheral nerve is 
thinner with shorter internodes than it had prior to injury (Hall, 2005; Navarro et al., 
2007).  The axons have smaller diameters, and suboptimal conduction velocities and 
excitability (Fields and Ellisman, 1986a; b).  Regenerated Schwann cell myelin is also 
thinner. 
1.2.4 Proximal nerve stump injury-response.   
Peripheral nerve injury leaves the surviving proximal nerve axon stumps 
potentially available to respond to exogenous substances available in the immediate 
extracellular microenvironment (Yoo et al., 2003).  Some of these substances may 
initiate, or act as, "positive" signals that are retrogradely conveyed back to the DRG 
neuron cell bodies to initiate a regenerative response.  Immediately following axotomy, 
the membranes at the severed proximal end of the axons begin to seal off (Kristensson 
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and Olsson, 1981).  Before membrane sealing is complete, calcium ions may enter 
damaged axonal elements and activate calcium-dependent proteases (LoPachin and 
Lehning, 1997). 
Simultaneously, axotomy deprives the DRG neuron cell bodies of any target-
derived molecules that are normally retrogradely transported from peripheral target 
tissues.  Deprivation of a normally tonically available signal is often described as a 
"negative” signal.  Examples of such retrogradely-acting tonic signaling molecules 
include FGF-1 that counteracts the injury induced expression of NPY (Ji et al., 1996). 
These proteins and their role in the injury response will be described in more detail 
below.  The presence of new, retrogradely transported molecules (positive signals) from 
the microenvironment of the injury site, or the absence of normally available target-
derived molecules (negative signals) could each presumably play a role in initiating a 
metabolic response to injury in DRG neurons.   
DRG neurons that survive peripheral axotomy will initiate the injury response, 
leading to regenerative growth, ultimately culminating in functional reinnervation.  
Within the first few hours following axotomy, a small area of the axon's proximal 
segment adjacent to the injury undergoes Wallerian degeneration back to the first node of 
Ranvier (Terenghi, 1999).  The axon may initially form several regenerative sprouts 
(Desouches et al., 2005; Wong and Mattox, 1991).  These sprouts start to migrate 
distally, likely supported by Schwann cells, and in active search for a suitable growth 
supporting pathway (Bixby et al., 1988).  The regenerating axonal sprouts respond to 
guidance (tropic) and survival (trophic) factors supplied by dedifferentiating Schwann 
cells and peripheral targets. Despite these early signs of regenerative response, it may be 
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several days before any axonal outgrowth extends beyond the proximal nerve stump (Al-
Majed et al., 2000).   
If the gap between the distal and proximal nerve stumps is not more than a few 
millimeters, axon growth into the distal stump may be successful. The regenerating axon 
can then take advantge of the local permissive environment of the Wallerian degenerating 
distal nerve stump and axons successfully navigate toward their original targets.  
However, if the gap between the proximal and the distal stumps is wide, growing axons 
may not reach the distal stump, and no functional recovery takes place.  
 
1.2.5 Conditioning lesion. 
A conditioning axon lesion is defined as an earlier, suitably timed injury that may 
alter regenerative success in response to a later 'test' injury of the same axons (Forman et 
al., 1980).  Indeed, an earlier conditioning lesion in the same peripheral nerve has been 
found to enhance the regenerative response to a subsequent, more proximal test lesion of 
the same nerve (McQuarrie, 1978; McQuarrie et al., 1977).  The improvement in 
regeneration caused by a prior conditioning lesion appears to involve faster initiation of 
regeneration, faster growth during regeneration, and a larger number of regenerating 
axons.  
The conditioning lesion effect is dependent upon the type of the initial conditional 
lesion itself.  The more severe the initial lesion, the longer the effect lasts (Bondoux-
Jahan and Sebille, 1986).  The increase in the number of axons that ultimately regenerate 
as a result of the conditioning lesion effect also depends on the time interval between the 
initial and test lesions (Arntz et al., 1989; Jenq et al., 1988).  In some cases, more than 
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one conditioning lesion at the same site, separated by a week, resulted in an increased 
rate of regeneration (Bisby, 1985; Bisby and Pollock, 1983).  In addition, a conditioning 
lesion in a rat sciatic nerve not only accelerated regeneration of the same nerve when 
subsequently tested, but also lead to enhanced regeneration of previously unconditioned 
nerves on the contralateral side.  This was accompanied by enhanced expression of 
cytokines in the contralateral DRG neurons (Ryoke et al., 2000).  It is not clear how a 
conditioning lesion on one side might influence regenerative ability in contralateral 
neurons that did not receive the conditioning lesion.  The influence could presumably be 
carried either through systemic circulation or through neuronal connectivity across the 
midline. 
The unique axonal morphology of the DRG neuron has allowed the test of 
whether conditioning lesions of one axon branch (i.e. the DRG peripheral axon branch) 
can influence the regenerative ability of a second, non-conditioned axon branch from the 
same neuron (i.e. the central axon branch).  The central axon branches of DRG neurons 
regenerate very poorly if subjected to an unpaired 'test' lesion, but regenerate much more 
readily if their corresponding peripheral axon branches are also given a 'conditioning' 
lesion either beforehand, or simultaneously (Richardson and Issa, 1984; Richardson and 
Verge, 1986; 1987) .  Regeneration of the central axons can also be enhanced by 
peripheral exposure to inflammatory challenge (Lu and Richardson, 1991).  If an injury 
occurs in the central branch after peripheral branch lesion, the central branch can 
regenerate beyond the injury site and into a (Wallerian degenerating) peripheral nerve 
graft, or even into the inhibitory environment of the spinal cord itself (Neumann and 
Woolf, 1999; Richardson and Issa, 1984). Peripheral conditioning injury of the sciatic 
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nerve resulted in an increase in the number of myelinated axons at the corresponding 
dorsal root entry zones and on the surface of the spinal cord (Chong et al., 1999). 
The effects of a conditioning lesion may result from early initiation of the cell 
body response to injury, including altered gene expression and increased protein 
synthesis to meet the demand of regenerating axons.  Changes in non-neuronal cells 
(Schwann cells and satellite cells) may also be involved (Sjoberg and Kanje, 1990; 
Torigoe et al., 1999). Neurons cultured from DRGs that have undergone a sciatic nerve 
conditioning injury one week earlier show enhanced growth of neurites in vitro.  The 
effect seems to involve earlier initiation of neurites, more rapid growth, and altered 
sensitivity to tropic factors (Smith and Skene, 1997).   The experiments demonstrating 
that a conditioning lesion of DRG peripheral axons can contribute to increasing the 
growth capacity of injured DRG central axons implies that the effect works through a 
signaling mechanism in the cell bodies of the injured neurons. 
 
1.2.6 Evidence for a negative signal inducing the injury response. 
 Microtubules are the cytoskeletal substrate for fast anterograde (away from cell 
body) axonal transport driven by kinesin proteins and for retrograde (toward cell body) 
axonal transport driven by dynein proteins (Cyr and Brady, 1992; Hirokawa, 1997).  The 
existence of a retrograde axonal transport mechanism and its importance in sensory 
neuron survival is well documented (Dumas et al., 1979; Fink et al., 1985; Max et al., 
1978; Schwab and Thoenen, 1977; Streit, 1980; Streit et al., 1980).   
Distinct subpopulations of DRG neurons are selective in terms of their retrograde 
transport of trophic factors (DiStefano et al., 1992).  For example, small diameter, 
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nociceptive sensory neurons, respond mainly to and transport NGF (Lindsay, 1996a).  
Additionally, small to medium diameter neurons preferentially transport BDNF (Zhou 
and Rush, 1996), while large, proprioceptive neurons tend to be responsive to and 
transport NT-3 (DiStefano et al., 1992).  Although GDNF is transported by all sensory 
neurons, the small RET-positive, IB4-positive, non-TrkA-expressing neurons show a 
preferential ability to transport GDNF (Leitner et al., 1999; Matheson et al., 1997). A 
similar subpopulation of small, CGRP positive, TrkA expressing sensory neurons 
favorably transport LIF (Thompson et al., 1997).  
Pharmacological blockade of retrograde axoplasmic transport using microtubule 
disrupting agents, such as vinblastine or colchicine, initiates a number of neuronal cell 
body reactions similar to the response seen following peripheral axotomy (Aldskogius 
and Svensson, 1988; Woolf et al., 1990).  If  dynein-based retrograde transport is 
specifically inhibited, trophic stimulation of axon terminals will not support neuronal 
survival (Heerssen et al., 2004).  Disrupting anterograde transport, on the other hand, 
does not initiate a peripheral nerve injury response (Csillik et al., 1982).   
It has been hypothesized that there are repressive factors originating from the 
peripheral target tissues, and through retrograde transport, these repressive factors 
maintain low expression of growth-associated proteins and other injury-induced features 
(Andersen et al., 2000; Liabotis and Schreyer, 1995; Schreyer and Skene, 1993).  Support 
for this retrograde repressor hypothesis comes from a number of experimental findings. 
The magnitude of GAP-43 expression following peripheral axotomy does not depend on 
the distance of the site of lesion from the DRG perikarya.  This is consistent with a 
mechanism involving loss of a tonic retrograde repressive signal derived from the 
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periphery (Liabotis and Schreyer, 1995).  The observations from a number of studies 
suggest that unknown substrates from the periphery, or peripheral target tissue, might 
regulate GAP-43 expression.  In corticospinal neurons, GAP-43 expression is elevated 
during the perinatal period. This increase gradually declines as target tissues are 
innervated in normal development. When colchicine, a compound that disrupts retrograde 
neuronal transport, is applied to those target approaching axons, GAP-43 expression 
remains elevated (Karimi-Abdolrezaee and Schreyer, 2002; Karimi-Abdolrezaee et al., 
2002; Margolis et al., 1991).  
Peripheral axotomy of the sciatic nerve upregulates GAP-43 expression in the 
DRG neurons, whereas, central axotomy does not (Schreyer and Skene, 1993).  A similar 
pattern of reaction to peripheral, but not central axotomy is seen with c-Jun (Kenney and 
Kocsis, 1998),  STAT3 (Schwaiger et al., 2000), NPY, and VIP (Sterne et al., 1998). 
Such results suggest that retrograde repressive signals (or negative regulators) are derived 
only from peripheral target tissue because central axotomy apparently does not interrupt 
them.   
GAP-43 expression in developing cultured DRG neurons appears to be decreased 
when the DRG neurons are cultured in the presence of peripheral target tissues (Baizer 
and Fishman, 1987).  However, the biochemical nature of such “repressive” signals is yet 
to be determined.  Neurotrophins can retrogradely influence expression of neuropeptides 
such as SP (Mulderry, 1994), and NPY (Sterne et al., 1998), but do not appear to directly 
repress GAP-43 expression in cultured DRG neurons (Schreyer et al., 1997). Experiments 
using skeletal muscle extracts (Kimura and Schreyer, unpublished) indicate that a target-
derived GAP-43 repressive signal can be in soluble or membrane-bound form.   
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Considerable evidence exists in the literature implicating FGFs as potential 
modulators of injury-induced expression of neuropeptides and growth associated 
proteins.  FGF-1 has been shown to counteract injury-induced expression of galanin and 
NPY (Ji et al., 1996). In CNS, FGF-2 stimulates the proliferation of GAP-43 positive O-
2A precursor cells (common precursor for oligodendrocytes and type-2 astrocytes) as 
well as increase the level of GAP-43 mRNA in these cells (Deloulme et al., 1993).  
Additionally, FGF-2 has also been shown to stimulate GAP-43 phosphorylation at serine 
41 (ser41), thereby modifying its intracellular localization in cultured hippocampal 
neurons (Tejero-Diez et al., 2000).  In injured frog retinal ganglion cells, FGF-2 
modulates expression and distribution of GAP-43 after optic nerve injury (Soto et al., 
2003).  
Recently, bone marrow stromal cells are have been shown to differentiate into 
various neuronal cells both in vivo and in vitro (Egusa et al., 2005).  An important and 
relevant finding shows that FGF-2 effectively induces neuronal differentiation from 
stromal cells, as evidenced by elevated levels of GAP-43.  This effect of FGF-2 requires 
FGFR-1, MAPK/ERK, and an activator protein 1 (AP-1) recognition site (Yang et al., 
2008).  The AP-1 site is also part of the GAP-43 gene. 
 
1.2.7 Evidence for a positive signal inducing the injury response. 
 
Positive retrograde injury signals have also been postulated to exist at the injury 
site.  Proteins may be activated at the injury site by undergoing post-translational 
modification, and then traveling retrogradely to the cell body.  The post-translational 
modification, activated by injury, could include phosphorylation, or proteolysis (Perlson 
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et al., 2004). One example is the phosphorylation of MAP kinases Erk1 and Erk2 at the 
injury site, and their subsequent retrograde transport to the cell body (Agthong et al., 
2006; Perlson et al., 2005). 
Some transcription factors, such as STAT3, ATF3, and c-Jun have also been 
identified in peripheral axons and may participate in positive retrograde signaling 
(Agthong et al., 2006; Lee et al., 2004; Lindwall and Kanje, 2005).  Recent works 
suggest that this positive retrograde transport requires the presence of carrier proteins, 
including importins that interact with the retrograde transport motor dynein (Hanz et al., 
2003).    
Formation and maintenance of the regrowing axon seems to involve protein 
synthesis within the distal axon (Willis et al., 2005).  It is therefore plausible that newly 
synthesized proteins could be retrogradely transported from the site of axotomy and act 
as a positive signal to initiate the injury response.  As part of the neuronal response to 
injury, adult sensory neurons that are conditioned by axonal crush can rapidly extend 
processes in vitro by regulating the translation of existing mRNAs that encode ribosomal 
proteins essential in neurite regeneration and growth (Twiss et al., 2000). Blocking 
protein synthesis in these regenerating axons causes a rapid retraction of their growth 
cones (Twiss and van Minnen, 2006; Zheng et al., 2001).  Axons of adult mammalian 
sensory neurons can synthesize proteins independent of transcriptional control, leading to 
synaptic plasticity and/or pathfinding and injury responses (Wang et al., 2007).  
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1.2.8 Proteins of the injury response. 
 Peripheral nerve regenerative propensity is reflected by the expression and 
upregulation of a number of genes referred to variously as 'growth-associated proteins' 
(GAPs) (Benowitz and Routtenberg, 1997; Benowitz and Schmidt, 1987; Skene, 1984; 
1989; 1990; Skene and Willard, 1981) or as 'regeneration associated genes' (RAGs) (Al-
Majed et al., 2004; McPhail et al., 2004; Schmitt et al., 2003). These genes and their 
encoded protein products include transcription factors, growth stimulating substances, 
intracellular signaling enzymes, cytoskeletal proteins and cytoskeleton interacting 
proteins (McLean et al., 1995; Schreyer and Skene, 1993; Skene, 1984).  For many of 
these proteins, there is evidence suggesting that their presence leads to successful nerve 
regeneration.  
 
1.2.8.1 Growth-associated protein-43 (GAP-43). 
One of the first well characterized examples of a protein that is upregulated in 
association with developmental and regenerative axon growth is GAP-43, also known as 
B-50, F-1, pp-46, and neuromodulin (Benowitz and Routtenberg, 1997; Meiri et al., 
1986; Skene, 1989).  GAP-43 is a 24 kDa neuronal-specific phosphoprotein that is 
expressed in virtually all developing neurons at high levels as they initiate axon growth. 
Although the actual size of rat GAP-43 protein is 24 kDa, it migrates with an apparent 
size of 40-60 kDa on sodium dodecyl sulfate (SDS) polyacrylamide gels due to its 
unusual amino acid composition (rich in acidic amino acids and alanine, but with few 
hydrophobic residues) and aberrant SDS binding properties (Skene, 1989).  As 
development proceeds and axons reach their target tissues, the level of GAP-43 
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expression declines (Chong et al., 1992), but does not disappear altogether in some 
neurons.   
In adult DRG neurons and in other neurons of the PNS, GAP-43 is markedly 
upregulated following (peripheral) axotomy (Chong et al., 1994; Mason et al., 2002; 
Schreyer and Skene, 1993).  Once synthesis is increased, GAP-43 is transported to both 
the peripheral and the central DRG axon branches (Schreyer and Skene, 1991; Woolf et 
al., 1990). 
GAP-43 appears to be involved in transducing intra- and extracellular signals to 
regulate cytoskeletal organization in the axon (Benowitz and Routtenberg, 1997; Frey et 
al., 2000; Laux et al., 2000; Meiri et al., 1996).  The amino acid sequence of GAP-43, 
highly conserved among mammals, has a unique calmodulin binding domain (Alexander 
et al., 1988; Skene, 1989).  GAP-43 has a high affinity to bind calmodulin in the absence 
of free Ca+2 (Masure et al., 1986).   It is proposed that GAP-43 binds and localizes 
calmodulin at specific sites within the cell and that free calmodulin is released locally in 
response to phosphorylation of GAP-43 by protein kinase C and/or to increases in 
intracellular free Ca+2 (Alexander et al., 1987; Alexander et al., 1988). Phosphrylated 
GAP-43 may be a substrate for calcineurin and both calcineurin and protein kinase C may 
regulate the levels of free calmodulin available in neurons (Liu and Storm, 1989).  
Biochemical properties that are central to the biological effects of the GAP-43 are its  
membrane- and calmodulin-binding properties, which could allow it to sequester a large 
fraction of calmodulin to the submembranous regions, and to release free calmodulin in 
response to protein kinase C activation (Skene, 1990).  In addition, such calmodulin 
binding properties could be useful in modulating the responses of membrane and 
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cytoskeletal assembly events to calcium signals in the growth cones of regenerating 
axons (Skene, 1990). The calmodulin pathway also appears to link elevated intracellular 
calcium to gene induction (Morgan and Curran, 1988). 
GAP-43 interacts with the GTP binding protein Go, a member of the G protein 
family that links receptors and second messengers (Strittmatter and Fishman, 1991; 
Strittmatter et al., 1991).  Because of its ability to associate with the neuronal membrane, 
to interact with calmodulin, and to associate with cytoskeletal elements, GAP-43 is 
important in coordinating activity between the neuronal membrane and the arrangements 
of cytoskeletal elements, as well as coordinating the effects of both extracellular signals 
and intracellular growth proteins. 
The GAP-43 gene contains three exons.  The first exon codes for the first 10 
amino acids of the protein that contain two reversible palmitolylation sites.  
Palmitoylation allows for strong association with membranes, and is essential for 
targeting the protein to the growing axonal terminal (Benowitz and Routtenberg, 1997; 
Skene and Virag, 1989).  The second exon contains most of the coding region, including 
serine-41, the site phosphorylated by protein kinase C (Benowitz and Routtenberg, 1997; 
Dent and Meiri, 1992).  Phosphorylation at serine-41 inhibits calmodulin binding to 
GAP-43 (Liu and Storm, 1990).  The third exon codes for the carboxy terminus and 
contains regions with structural similarity to intermediate filaments giving it a unique 
ability to interact with actin and actin associated proteins (Meiri and Gordon-Weeks, 
1990).  
GAP-43 has been associated with axon growth cone pathfinding (Strittmatter et 
al., 1995), consistent with a possible role in axon guidance. High concentrations of GAP-
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43 in a growth cone alter the way an axon terminal responds to environmental stimuli 
acting through calcium and calmodulin (Lankford et al., 1990; Skene, 1990).  Thus, 
GAP-43 was suggested to modulate complex cellular properties such as growth cone 
guidance and motility, synaptic plasticity and neurotransmitter release (Coggins and 
Zwiers, 1991).   
Null mutation of the GAP-43 gene disrupts axonal pathfinding and is generally 
lethal shortly after birth (Benowitz and Routtenberg, 1997). During development, GAP-
43-deficient retinal axons remain stalled in the optic chiasm, unable to navigate past this 
midline decision point.  However, cultured neurons of GAP-43-deficient mice extend 
neurites and growth cones in a very similar fashion to wild type. Thus, it is suggested 
that, while GAP-43 protein may not be essential for axonal growth, is required to guide 
the growing axon at certain decision points, such as the optic chiasm (Strittmatter et al., 
1995). This is compatible with the hypothesis that GAP-43 serves to transduce 
extracellular pathfinding signals at the growth cone (Strittmatter et al., 1995).  
We know little about how axon injury leads to increased expression of GAP-43.  
Clues as to the nature of the mechanism(s) that control GAP-43 expression have come 
from analysis of its gene structure.  The GAP-43 gene, located on chromosome 3 in 
humans and chromosome 16 in mice, spans at least 50 kb (Benowitz and Routtenberg, 
1997; Denny, 2006; Grabczyk et al., 1990). The 5'-flanking sequence lacks CAAT or 
TATA elements.  This sequence however does have the ability to initiate RNA 
transcription from several sites, depending on the neuronal type.  The 1.5 kb mRNA is 
spliced from three widely separated exons: the first includes a 5' untranslated region 
(5'UTR) of variable length and the first ten codons; the second contains most of the 
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coding region, while the third includes the last few codons and a long 3'UTR (Grabczyk 
et al., 1990).  The rat GAP-43 promoter region has seven E-boxes, but only one of them 
(E1) was found to control GAP-43 promoter activity (Chiaramello et al., 1996).  Basic 
helix-loop-helix (bHLH) transcription factors may regulate the expression of the GAP-43 
gene (Chiaramello et al., 1996).  The E1 box can be a positive or a negative regulator of 
the GAP-43 promoter, depending on which bHLH transcription factor binds to it (Denny, 
2006). 
The GAP-43 gene promoter contains AP-1 site that contributes to gene activity in 
neurons. The fact that GAP-43 expression is minimally detected in mature neurons after 
growth is complete, suggests that repressive elements play an important role in allowing 
AP-1 signaling pathways to control the activity of the GAP-43 gene in neurons (Weber 
and Skene, 1998). In injured CNS neurons, c-Jun, a transcription factor that binds AP-1 
sites, has been implicated in the upregulation of GAP-43 expression (Haas et al., 2000).    
 
1.2.8.2 Tα1 tubulin. 
 Tubulin is a globular, cytoskeletal protein that exists as a dimer.  The tubulin 
dimer has one α and one β subunit.  Tubulin dimmers are the building blocks of 
microtubules that support cellular structural integrity and play a central role in the 
trafficking and movement of intracellular components.  The regulation of Tα1 tubulin 
expression after injury differs according to the neuronal cell type and the distance of 
axotomy from the cell body (Bisby and Tetzlaff, 1992).  In the PNS an upregulation of 
Tα1 tubulin mRNA (Miller et al., 1989) and protein (Mohiuddin and Tomlinson, 1997) is 
observed in all neurons after peripheral nerve injury concomitant with elevated GAP-43 
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expression (Al-Majed et al., 2004; Geremia et al., 2007).  This suggests that expression of 
Tα1 tubulin and GAP-43 may be regulated together as part of the overall injury response. 
In addition to Tα1 tubulin, other members of the tubulin proteins are upregulated in 
axotomized DRG neurons.  These include βII, βIII tubulins.  Other tubulin family 
members such as βIV, however, do not show any changes in injured neurons (Hoffman 
and Cleveland, 1988; Miller et al., 1989; Moskowitz et al., 1993; Wong and Oblinger, 
1990). 
Tα1 tubulin and GAP-43 expression are coregulated in response to neurotrophins.  
A study using BDNF and NT-4/5 showed that both neurotrophins stimulate GAP-43 and 
Tα1 tubulin mRNA expression, and promote axonal regeneration (Kobayashi et al., 
1997).  Moreover, expression of these growth associated proteins increases as a result of 
brief electrical stimulation in the regenerating femoral nerve (Al-Majed et al., 2004).  In 
the CNS, CCAAT enhancer binding protein-beta (C/EBPbeta), a transcription factor 
implicated in cellular injury and regeneration has been shown to be essential for the 
neuronal injury response.  Of particular relevance to the current project, C/EBPbeta acts 
to transcriptionally activate both GAP-43 and Tα1 tubulin gene expression (Nadeau et al., 
2005).  Beta3-tubulin (βIII tubulin) gene expression is induced by vinorelbine through an 
AP-1 site (Saussede-Aim et al., 2009), a site that is also shared with GAP-43 promoter.  
 
1.2.8.3 Heat shock protein 27 (Hsp-27). 
 Heat shock proteins (HSPs) are molecular chaperones that function in proper 
folding and trafficking of proteins (Kampinga, 2006).  They can also play an important 
role in mediating the assembly of proteins into oligomeric structures.  Primarily, they act 
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to prevent the formation of incorrect structures which may result from the transient 
exposure of charged or hydrophobic surfaces normally involved in interactions between 
or within polypeptide chains (Ellis et al., 1989). Hsp-27 is a member of this family of 
molecular chaperone proteins and is induced in cells that have been exposed, not only to 
sub lethal heat shock treatment, but also to oxidative stress or various other 
environmental stresses (Arrigo, 2007).  Hsp-27 possesses anti-apoptotic properties and is 
upregulated following peripheral nerve injury in a very similar fashion to GAP-43. 
 In the PNS, Hsp-27 is expressed at low levels in medium sized DRG neurons and 
upregulated following chronic constriction injury (Kim et al., 2001a).  There is up to a 
nine fold increase following peripheral nerve transection (Costigan et al., 1998).  Hsp-27 
expression is induced by transcription factors ATF3 and c-Jun (Nakagomi et al., 2003). 
Because of this correlation with GAP-43 expression, its potential protective role in 
neuronal cell survival (Klettner, 2004; Latchman, 2005) and its contribution to 
rearrangement of cytoskeletal elements (Gerthoffer and Gunst, 2001), Hsp-27 is 
classified among the growth associated proteins that are upregulated in the neuronal 
response to injury.  
 
1.2.8.4 Neuropeptides. 
 NPY is a 36 amino acid peptide widely distributed within neurons of the CNS and 
PNS (Gray and Morley, 1986).  NPY is upregulated in medium to large DRG neurons 
following peripheral axotomy (Hokfelt et al., 1994; Landry et al., 2000; Verge et al., 
1995; Wakisaka et al., 1991; Zhang et al., 1993).  The role of the upregulated NPY in 
DRG neurons as a result of injury is not fully understood, although antinociceptive 
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effects have been attributed to NPY (Xu et al., 1994).  A strong correlation between 
GAP-43 expression and that of NPY in response to NT-3 (Ohara et al., 1995) suggests 
that NPY upregulation may also be a part of the DRG neuronal response program to 
peripheral injury.  
SP and CGRP are transmitters for a proportion of DRG neurons and are 
implicated in the nociceptive transmission of the primary sensory system. Substance P 
protects neurons from apoptosis via PKC-Ca2+-MAPK/ERK pathways (Lallemend et al., 
2003). 
The newly identified small proline-rich repeat protein 1A (SPRR1A) is 
upregulated by the main subpopulations of DRG neurons following an injury to their 
peripheral, but not central, axon branches (Bonilla et al., 2002; Starkey et al., 2009).  This  
follows the pattern of GAP-43 and many other elements of the injury response. 
 
1.2.9 Transcription factors. 
 There are several transcription factors whose synthesis and activation are 
modified as part of the injury response (Raivich and Makwana, 2007).  Examples of such 
factors are ATF3, cJun, and STAT3.  They may therefore be involved as higher-order 
regulators of other aspects of the neuronal injury response.  These three transcription 
factors will be the major focus of the experimental work described in this thesis. 
 
1.2.9.1 Activating transcription factor 3 (ATF3). 
ATF3 is a member of activating transcription factor/cyclic AMP response element 
binding protein (ATF/CREB) family of transcription factors that share a common motif 
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of bZip DNA binding domain which binds to the consensus site 'TGACGTCA' (Hai and 
Hartman, 2001; Hai et al., 1999).  ATF was first described as a protein that activates 
transcription of multiple E1A-inducible adenovirus early promoters (Lee et al., 1987). 
cAMP response element binding protein (CREB) was described as protein product that 
binds to cAMP responsive element (CRE) (Montminy, 1997).  ATF/CREB transcription 
factors can heterodimerize with the transcription factor AP-1, utilizing a common 
dimerization motif.  This suggests that there may be cross-talk between the two types of 
transcription factors (Karin et al., 1997).  Genomic AP-1 consensus sequences have also 
been found to interact with c-Jun and other transcription factors.    
ATF3 was first isolated from a library derived from HeLa cells (Hai et al., 1989). 
It is an immediate-early gene induced by a number of stimuli such as carbon 
tetrachloride, ischemia, radiation, and anticancer drugs such as tetradecanoylphorbol 
acetate (TPA).  It is also rapidly and highly expressed in regenerating liver (Hsu et al., 
1991) and has thus been called liver regenerating factor-1 (LRF-1).  Other names that 
refer to ATF3 are LRG-21, CRG-5, and TI-241 (Hai and Hartman, 2001). The ATF3 gene 
is activated in a variety of organs as a result of chemical or surgical insults.  For example, 
the ATF3 gene is activated in ischemic heart (Yin et al., 1997), in hepatectomized or 
carbon tetrachloride treated liver (Chen et al., 1996), as well as in epileptic brain (Chen et 
al., 1996), and in transected peripheral nerves (Tsujino et al., 2000).  ATF3 is an unusual 
transcription factor in that it can both repress and activate transcription.  The ATF3 
homodimer is a transcriptional repressor.  However, heterodimeric complexes of ATF3 
with c-Jun function as transcriptional activators (Hai and Hartman, 2001).  
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ATF3 expression and nuclear localization increase robustly in DRG neurons 
following peripheral nerve injury (Tsujino et al., 2000), indicating that the induction of 
ATF3 is part of the overall neuronal response to injury.  It is also upregulated following 
chorda tympani nerve injury, concomitant with increases in GAP-43 (Tsuzuki et al., 
2002).  In the DRG neurons, ATF3 mRNA is detected by 12 hours, peaks at 1 day, and 
remains high 2 weeks following axotomy (Tsujino et al., 2000). Thereafter, ATF3 
gradually decreases but is expressed at a low level beyond 10 weeks after axotomy.  
The ATF3 gene is considered to be one of the immediate early genes whose 
activation regulates other, downstream genes, initiating a network of transcriptional 
regulation.  Thus, regulation of ATF3 gene expression has been an area of recent active 
research.  Treatment of cultured HeLa cells with anisomycin leads to activation of the 
p38 pathway by mitogen-activated protein kinase kinase 6 (MAPK 6), a kinase upstream 
of p38.  This activation is sufficient to induce the expression of the ATF3 gene.  This 
induction is possibly carried out through phosphorylation of CREB by p38, and does not 
seem to involve extracellular regulated kinase (ERK) nor c-Jun-N-terminal kinase/stress-
activated protein kinase (JNK/SAPK) pathways (Lu et al., 2007). However, in a 
peripheral nerve injury model the ATF3 appears to be induced through retrograde 
signaling involving JNK.  Retrograde axonal transport of JNK signaling components 
contribute to the injury induced activation of the ATF3 gene (Lindwall and Kanje, 2005). 
Because of the variation in range of factors (stressful and nonstressful) and conditions 
that control ATF3 expression, ATF3 has been described as an adaptive response gene that 
initiates cellular processes that adapt to various cellular stress signals (Lu et al., 2007).    
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Transfection of cells with siRNAs that block the expression of SOX11, a gene 
that encodes a member of the SOX family of transcription factors caused a transcriptional 
and translational level reduction in ATF3 expression in vitro and in vivo (Jankowski et 
al., 2009).  Growth arrest and DNA damaging/ C/EBP-homologous protein 10 
(gadd153/Chop10), another bZip protein, heterodimerizes with ATF3 and inhibits its 
expression (Chen et al., 1996).  Inversely, ATF3 represses the expression of 
gadd153/Chop10 (Wolfgang et al., 1997), making gadd153/Chop10 a potential target 
gene of the repressor activity of ATF3.  Interestingly, ATF3 can repress its own 
promoter, providing a potential mechanism of homeostatic autoregulation (Wolfgang et 
al., 2000).  Thus, ATF3 induction in DRG neurons may be a part of a protective response 
to injury, in addition to any direct role in promoting axon growth. 
1.2.9.2 c-Jun. 
c-Jun was first identified and isolated from transformed cultured chick embryo 
fibroblasts (Bos et al., 1986). c-Jun dimerizes with other transcription factors (such  as 
Fos) through the leucine zipper domains, and the Jun/Fos heterodimers bind to DNA and 
regulate transcription of numerous other genes (Ransone and Verma, 1989; Vogt and 
Bos, 1989; Vogt and Morgan, 1990). Jun protein is a major component of the 
transcription factor complex AP-1, which regulates the expression of multiple genes 
essential for cell proliferation, differentiation and apoptosis (Hartl et al., 2003).  c-Jun is 
also induced in cancer cells (Whitmarsh and Davis, 2007).  Phosphorylation of c-Jun by 
JNK (jun N-terminal kinase) leads to c-Jun nuclear translocation, whereby it can affect 
transcription.  c-Jun has a number of binding domains such as DNA binding domain, a 
leucine zipper region, a transcription-activating or transactivating module, and binding 
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domains for the mitogen-activated protein kinases.  c-Jun forms homodimers and 
heterodimers with Fos and other transcription factors such as ATF3. c-Jun homo-and 
heterodimers bind the AP-1 promotor complex, thus initiating transcriptional regulation 
of genes that are involved in cell growth and differentiation.  
c-Jun is upregulated in rat lumbar DRG neurons following sciatic nerve axotomy 
(Herdegen et al., 1992; Jenkins and Hunt, 1991; Kenney and Kocsis, 1997b).  The timing 
of c-Jun induction is dependent upon how far the lesion is from the lumbar ganglion 
(Kenney and Kocsis, 1997b). The trigger signal for c-Jun upregulation following 
axotomy has been extensively examined and appears to be a negative signal, such as 
interruption of the retrograde flow of unidentified molecule(s). This is supported by 
observations that blockade of retrograde transport alone, without concurrent nerve injury, 
leads to c-Jun elevation in DRG neurons (Leah, Herdegen et al. 1991; Jenkins, McMahon 
et al. 1993).  
Although c-Jun is upregulated substantially following a peripheral nerve 
transection, it is not upregulated following a central root transection (Broude et al., 1997).  
This substantiates the idea that target-derived factor(s) from peripheral target tissue 
contribute to the suppression of transcription factors that are a part of the injury response, 
in a pattern similar to GAP-43.  It is certainly of interest to investigate the possible 
molecular regulatory pathways that may connect c-Jun expression to that of GAP-43.  
Immunohistochemistry of ATF3 protein in the axotomized DRG does not reflect 
complete colocalization with c-Jun.  More DRG neurons were labeled for ATF3 than for 
those labeled for c-Jun (Tsujino et al., 2000).  This indicates that the factor(s) that may 
regulate the expression of ATF3 may not be the same as those that regulate c-Jun, 
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although in PC12 and Neuro-2a neuron-like cell lines, co-transfection of c-jun and ATF3 
genes doubled the number of cells producing neurites, compared with expression of c-Jun 
alone (Pearson et al., 2003). 
 
1.2.9.3 STAT3.  
Signal transducers and activators of transcription (STATs) are a family of 
transcription factors that mediate a wide variety of biological functions in the PNS and 
CNS.  STATs are phosphorylated by janus kinases (JAKs) in response to cytokine or 
growth factor activation of a cell surface receptor. Following phosphorylation by receptor 
tyrosine kinases, STATs then form homo- or heterodimers that translocate to the cell 
nucleus where they act as transcription activators. Activation of STAT3 protein through 
phosphorylation of the Tyr705 residue initiates the expression of a variety of genes in 
response to cell stimuli, and thus plays a key role in many cellular processes such as cell 
growth and apoptosis.   
STAT3 promotes neuronal survival by inducing neuroprotective genes (Dziennis 
and Alkayed, 2008).  In the nervous system, STAT3 is activated in acute spinal cord 
injury (Tsai, Yang et al. 2007), and in peripheral nerve inflammation (Tamura et al., 
2005).  Sciatic nerve axotomy results in phosphorylation and activation of the STAT3 
transcription factor in DRG neurons.  Perineural infusion of the JAK2 inhibitor AG490 at 
the proximal nerve stump blocks STAT3 phosphorylation following sciatic nerve 
transection and results in reduced GAP-43 upregulation.  It significantly attenuates 
central branch regeneration in the spinal cord after a preconditioning sciatic nerve 
axotomy (Qiu, Cafferty et al. 2005).  STAT3 activation is thus necessary for increased 
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DRG neuronal growth and improved axonal regeneration within the spinal cord after a 
conditioning injury (Qiu, Cafferty et al. 2005). 
STAT3 by itself can be a potential retrograde signaling transcription factor.  
Peripheral nerve lesion leads to a rapid activation of STAT3 in axons at the lesion site. 
This activation extends from the lesion site to the DRG neurons and motor neurons in the 
spinal cord. This indicates the possibility that axonal STAT3, activated at the injury site, 
may act as a retrograde signaling transcription factor, thus promoting the survival and 
regeneration of both sensory and motor neurons (Lee, Neitzel et al. 2004).  
 
1.3 Modulation of axonal regeneration. 
 
1.3.1 Exogenous growth factor/neurotrophin supplementation. 
 A number of methods to deliver growth factors, neurotrophins, and other factors 
of therapeutic interest in vivo have been reported and reviewed (McDonald and 
Zochodne, 2003).  The methods include direct near-nerve local injection (Finkelstein et 
al., 1996; Ro et al., 1998), delivery by osmotic pump with catheter to the repair site (Ishii 
et al., 1993; Leong et al., 1999; Mohiuddin et al., 1999; Newman et al., 1996; Utley et al., 
1996), infection with neurotrophic factor-transducing recombinant adenoviruses (Gravel 
et al., 1997; Isenmann et al., 1998),  and subcutaneuous and intraperitoneal injections and 
intrathecal delivery.   
Molecular delivery of exogenous growth factors or neurotrophins has also been 
attempted in vitro through introduction of an adenoviral vector to cultured neurons.  A 
single infection with an adenoviral vector coding for NT-3 maintains active production of 
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NT-3 for at least 20 days in culture, as evidenced by continued neurite extension assay 
(Dijkhuizen et al., 1997). 
Manipulation of the extacellualr matrix material proteins, mixed with 
neurotrophins in the vicinity of injury, has also been attempted.  For example, grafting 
NT-3 impregnated fibronectin mats into the site of injured sciatic nerve attenuated the 
upregulation of NPY expression, a neuropeptide protein that is associated with injury 
(Sterne et al., 1998). 
Exogenous delivery of BDNF antibody or antisense oligodeoxynucleotide into 
injured DRGs reduced the sprouting of sympathetic axons witin both ipsi- and contra-
lateral DRGs.  Delivery of exogenous BDNF into an intact L5 DRG resulted in a 4.2 fold 
increase this sympathetic sprouting (Deng et al., 2000).  These findings indicate that 
BDNF that is endogenously synthesized and secreted from the DRG proper is involved in 
the sympathetic axonal sprouting that follows the peripheral nerve injury.  In another 
study, exogenously and peripherally delivered BDNF to an already condition lesioned 
sciatic nerve enhanced regeneration of ascending sensory neurons in the spinal cord 
(Song et al., 2008).  Endogenous infusion of BDNF antibodies intrathecally via a mini-
osmotic pump for 3 days at the level of the fifth lumbar dorsal root ganglion, immediately 
following unilateral spinal nerve injury decreased expression of the injury/regeneration-
associated genes GAP-43 and Tα1 tubulin in the injured sensory neurons. Similar results 
were observed following intrathecal delivery of or siRNA targeting BDNF 3 days prior to 
injury (Geremia et al., 2009). These results substantiate the importance of endogenous 
BDNF in the initial induction of the cell body response in injured sensory neurons.    
61 
 
 Intrathecal delivery of NGF but not GDNF induced extensive sprouting of 
sympathetic neurons within lumbar DRGs (Jones et al., 1999).  A similar method of NGF 
delivery dramatically upregulated pituitary adenylate cyclase-activating polypeptide 
(PACAP) expression in intact and injured L4-L6 DRG neurons (Jongsma Wallin et al., 
2001).  Moreover, NGF infusion increased BDNF expression in both intact and injured 
trkA-positive neurons, accompanied by reduced trkB expression (Karchewski et al., 
2002), suggesting that NGF could regulate BDNF expression.  Exogenous infusion of 
NT-3 and NGF also differentially modulated PACAP expression in DRG neurons 
(Jongsma Wallin et al., 2001), suggesting a dynamic role in injury response and 
inflammation. 
 Intrathecal infusion of NT-3 on intact, uninjured adult rat dorsal root ganglion 
neurons was investigated. NT-3 did not appear to alter trkC expression, but reduced trkA, 
high-affinity NGF binding sites and SP levels (Gratto and Verge, 2003).  
Osmotic minipump infusion of GDNF to injured DRG prevented a number of 
injury induced manifestations.  These included the loss of binding of IB4, downregulation 
of the purinergic receptor P2X(3), upregulation of galanin and  NPY immunoreactivity in 
large diameter DRG cells, and expression of the transcription factor ATF3. The findings 
confirm that exogenous GDNF has a broad neuroprotective role in injured primary 
afferents (Wang et al., 2003).  
Materials that can be exogenously applied include a variety of other growth 
factors.  For example, exogenous injection of transforming growth factor-beta 1 (TGFβ1) 
to the proximal crushed end of the sciatic nerve increased the expression of FGF-2 in the 
anterior horn motoneurons of a regenerating spinal cord.  Distal to the crush injury, 
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TGFβ1 increased both the number and diameter of regenerating myelinated axons. These 
results indicate that TGFβ1 promotes peripheral nerve regeneration, and up-regulates the 
FGF-2 expression in the anterior horn motoneurons of spinal cord during the peripheral 
nerve regenerative process (Pei et al., 2005).   
Other proteins not characterized as growth factors have also been introduced to 
injured nerves.  An osmotic pump delivering oxidized galectin-1, a carbohydrate binding 
protein with an affinity for ß-galactosides, peripherally to the site of sciatic nerve injury 
restored and significantly improved functional recovery of the injured nerve.  There was 
also an increase to the number and size of regenerating myelinated fibers (Kadoya et al., 
2005).  Another example of a protein that does not belong to growth factors is the tissue 
plasminogen activator (tPA), an essential component of the proteolytic cascade that lyses 
blood clots.   Following sciatic nerve injury in the mouse, concomitant application of 
exogenous tPA promoted axonal regeneration, remyelination, and functional recovery.  A 
significant increase in the total number of axons and myelinated axons was observed, as 
manifested by enhanced expression of neurofilament preotein.  In addition, tPA markedly 
reduced the deposition of fibrin and fibrinogen after nerve injury, increased the number 
of macrophages and induced matrix metaloprotease-9 expression at the injury site.  
Moreover, exogenous tPA application reduced collagen scar formation and accelerated 
clearance of myelin and lipid debris after treatment.  Mice lacking tPA, or plasminogen 
genes showed delayed functional recovery after sciatic nerve crush (Siconolfi and Seeds, 
2001). These findings support the notion that tPA promotes axonal regeneration and 
remyelination, making it a potential candidate for the treatment of peripheral nerve injury 
(Zou et al., 2006). 
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1.3.2 cAMP. 
Cyclic 3’,5’-adenosine monophosphate (cAMP) is a second messenger for various 
extracellular signals.  When external stimuli, such as hormones and activating or growth 
factors bind certain receptors on the effector cell membrane, receptor occupation triggers 
dissociation and activation of heterotrimeric G proteins and the membrane-bound 
adenylate cyclase is activated.  This enzyme catalyses the intracellular production of 
cAMP. The substrate for the catalytic action of adenylate cyclase is the complex Mg-
ATP.  cAMP exerts its regulatory action via the activation of protein kinase A (PKA) and 
can phosphorylate a number of key proteins.  The substrate proteins for PKA can be 
enzymes, structural proteins (cytoskeletal elements, ribosomes, and synaptic membranes), 
nuclear proteins (histones), and growth associated proteins. The attachment of a 
phosphate to either a serine (in most cases) or a by PKA to a substrate protein may result 
in activation or inhibition of catalytic or binding properties. Phosphorylation of proteins 
is reversed by the activity of a special class of enzymes, the phosphoprotein 
phosphatases.  
Degradation of intracellular cAMP is controlled by phosphodiesterases which 
convert the active cAMP into the inactive 5’- AMP. The intracellular levels of cAMP, 
and thus the kinases that cAMP regulates, are continuously governed by the balance of 
activities of adenylate cyclase and phosphodiesterase (Wiegant, 1978).  A number of 
diverse families of adenylate cyclases and phosphodiesterases have now been identified, 
allowing for complex and diverse mechanisms to modulate the levels of intracellular 
cAMP (McKnight, 1991). 
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Cyclic AMP can exert its effects on gene expression through PKA mediated 
phosphorylation of transcription factors tht bind to enhancers located in the regions of 
DNA upstream of the transcription start sites to the genes. Examples of the two best 
characterized enhancer elements are the CRE (5'-TGACGTCA-3') and the AP-2 site (5'-
CCCCAGGC-3'). The activity of the CRE is regulated by CRE binding proteins 
(CREBs). These proteins contain leucine zipper regions that allow for either homo- or 
hetero dimerization (Walton and Rehfuss, 1990). CREB-containing dimers, once 
phosphorylated, bind to the CRE and stimulate transcription of cAMP-responsive genes 
(Montminy et al., 1990b). Phosphorylation of CREB is reversible and is regulated by 
cytoplasmic PKA (Montminy et al., 1990a). Another nuclear factor that regulates CRE is, 
cAMP-responsive element modulator (CREM) (Delmas and Sassone-Corsi, 1994; 
Habener et al., 1995).  
In the brain, damaged hippocampal dentate granule cells secrete neuroprotective 
molecules that activate CREB by phosphorylation of Ser133 and through the Akt 
signaling pathway (Walton and Dragunow, 2000). It would be important to investigate 
the role of CREB and the downstream survival genes that are activated by CREB in 
mediating the neuroprotective actions. 
In the nervous system, cyclic nucleotides can regulate growth cone movement and 
directionality.  Chemorepulsion induced in cultured Xenopus spinal neurons can be 
reversed by activation of the guanosine 3',5'-monophosphate (cGMP) or adenosine 3',5'-
monophosphate (cAMP) signaling pathways.  These findings suggest that it may be 
possible to counteract the inhibition of nerve regeneration by repulsive factors in the CNS 
(Song et al., 1998).  The cellular machinery that regulates actin- and tubulin in the growth 
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cone, integrates stimulatory and inhibitory signals from the local environment and 
translates them into axon growth or growth cone collapse (Snider et al., 2002).  
Neurotransmitters, neurotrophic factors, prostaglandins, and other extracellular 
signaling molecules can activate adenylate cyclase in neurons leading to increased 
production of cAMP. Evidence from this lab and others shows that cAMP signalling 
promotes neuronal survival and axonal elongation in neuronal cells.  Dibutyryl cAMP 
(dbcAMP), a membrane permeable cAMP analogue, and forskolin, an adenylyl cyclase 
activator, stimulate neurite outgrowth in cultured DRG neurons (Anderson et al., 2000).  
These findings indicate that increased levels of cAMP in neurons may have an important 
role in axonal elongation. 
Treatment with dbcAMP in vivo or addition of forskolin in vitro markedly 
increases axon growth, supporting the notion that cAMP triggers the intrinsic growth 
program of mature DRG neurons (Qiu et al., 2002b).  However, in other neuronal 
cultures, cAMP addition alone does not support growth, nor does PKA inhibition prevent 
conditioning lesion-induced axon growth on a favorable substrate (Qiu et al., 2002b). 
This work suggests that elevation of cAMP levels alone may not be sufficient to mediate 
the enhanced growth state activated by peripheral axotomy, but may regulate the 
response to inhibitory cues (Snider et al., 2002). 
Studies on the effect of introducing cAMP to injured sciatic nerve have been 
carried out.  In one such study, clamping the sciatic nerve for 2 seconds, and injecting 
dbcAMP (50 mg/kg) intramuscularly for 7 days enhanced the return of sensorimotor 
functions, as demonstrated by foot-flick response (Pichichero et al., 1973).  However, 
another study showed that a daily intramuscular injection of dbcAMP had no effect on 
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crushed sciatic nerve (McQuarrie et al., 1977).  Although the latter study reported no 
effect of dbcAMP, the duration of the clamping of the sciatic nerve was longer than in the 
former study.  It is documented that increasing cAMP levels in neuronal cell bodies 
elicits a partial regenerative response, altering expression of tubulin isotypes but not 
expression of other growth-associated genes or the rate of axonal transport (Han, Shukla 
et al. 2004). This approach suggests that control of the regenerative response may be 
complex and that multiple regulatory mechanisms may be involved (Liu and Brady, 
2004).   
In this lab, peliminary studies have shown that FGF-2 partially represses 
expression of GAP-43 in cultured adult DRG neurons.  This effect occurs, at least in part, 
through a MEK pathway.  Interestingly, combined application of both dbcAMP and FGF-
2 completely represses GAP-43 expression in these cultures, indicating a combinatorial 
role for FGF-2 with cAMP in maintaining the mature, uninjured state (Schreyer, 2004).  
Additional experiments indicated that selective inhibition of FGF-2 increases GAP-43 
levels of expression. 
Microinjection of dbcAMP into lumbar DRG markedly increases the regeneration 
of central axon branches injured within the spinal cord. Regenerating central axons reach 
well into the spinal cord lesion, often passing the original injury site. Thus, cAMP 
signaling appears to mimick the effect of a conditioning peripheral nerve lesion through 
increasing the intrinsic growth capacity of injured sensory axons by overcoming the 
central nervous system myelin inhibitory effects (Han et al., 2004; Neumann et al., 2002). 
Intraganglionic injection of dbcAMP also increases the expression of growth-associated 
tubulin isotypes. However, it does not increase the average axonal transport rates of 
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tubulin delivered to the tips of growing axons. Injection of dbcAMP therefore induces 
some, but not all of the changes that may be necessary to increase intrinsic axon growth 
capacity (Han et al., 2004). 
 
1.3.3 Mechanisms of Signaling 
The well-understood consequence of adenyl cyclase activation is that cAMP 
signaling leads to the activation of protein kinase A (PKA), phosphorylation of both the 
mitogen-associated protein kinase (MAPK) and cAMP-response element-binding protein 
(CREB), and subsequent transcription of growth-associated genes.  Convergent signalling 
through Ca2+ elevation can also lead to MAPK activation via the Ras pathway (Waltereit 
and Weller, 2003).   
The guanine nucleotide exchange protein activated by cAMP (Epac), which 
belongs to the cAMP-binding protein family, represents an alternative pathway through 
which adenyl cyclase can have diverse effects on cellular functions including 
hormone/transmitter secretion, cell adhesion, and intracellular Ca2+ mobilization. Epac 
mediates the PKA-independent effects of cAMP on cellular activities.  Thus, cAMP 
regulates cellular activities by coordinating both PKA-dependent and PKA-independent 
pathways, possibly within different domains of the cell (Seino and Shibasaki, 2005).  A 
finding that supports the possible influence of cAMP through a PKA independent 
pathway is that in cultured DRG neurons, signaling from cAMP to PKCε, (epsilon 
isoform of protein kinase C) is not mediated by PKA, but by Epac.  Epac, in turn, is 
upstream of PLC and PLD, both of which are necessary for translocation and activation 
of PKCε.  In DRG neurons, this signaling pathway was specific to IB4-positive 
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nociceptors. Thus, cAMP signaling through Epac may involve both the MAPK pathway 
and PKC in parallel (Hucho et al., 2005). 
Little is known about the signals that control how adult neurons switch from a 
normally transmitting, differentiated state to a regeneration state, although BDNF appears 
to be a critical part of this process (Geremia et al., 2009).  There is no clear indication as 
to whether expression of the various components of the injury response are directed by a 
common regulatory mechanism or whether each GAP gene, or protein is controlled by 
individual inducing or silencing factors that act in parallel.   
It is well established that deprivation of target-derived trophic factors (Lee et al., 
1998; Raivich et al., 1991) and the arrival of activating signals (chemokines and 
cytokines) from the injured axon tip and from the surrounding non-neuronal cells, can 
initiate the regenerative signaling cascades. In the few days after injury, macrophages and 
reactive Schwann cells infiltrate the degenerating nerve and release cytokines and 
neurotrophic factors, the effects of which may reach the injured neuronal cell body 
through retrograde axonal transport to switch on, promote, and sustain the regenerative 
program of the neuron.  
A variety of mechanisms in response to signals are responsible for the initiation 
and maintenance of the regenerative neuronal response.  Some signals that are common 
with cAMP signaling pathway have been reported. For example, the high frequency burst 
of action potentials generated at the lesion site results in the rapid influx of Ca+2 ions 
immediately following injury.  This can activate several protein kinase pathways, 
including CMAK2, protein kinases PKA, PKC, and MAPK (Ghosh and Greenberg, 
1995).  The activation of PKC and calmodulin dependent kinases can influence GAP-43 
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expression and other growth associated proteins.  Additionally, the intense burst of 
excitation causes transmitters, such as glutamate, neuropeptides and BDNF to be released 
at the spinal cord. These can also activate PKA, PKC and MAPK postsynaptically 
(Navarro et al., 2007). 
Other signaling pathways that may be common with the cAMP signaling pathway 
in response to nerve injury are activated in DRG neuronal cell bodies. Among these 
pathways are kinases such as the MAPKs Erk1 and Erk2, JNK and p38 kinase (Navarro 
et al., 2007). Following axotomy, Erk activation has been observed in axotomized sciatic 
nerve and DRG (Agthong et al., 2006; Katsura et al., 2007; Obata et al., 2007; Obata et 
al., 2004a; b; Obata et al., 2003). This activation of Erk is influenced by neurotrophic 
factors such as NGF and GDNF (Wiklund et al., 2002).  JNK is rapidly activated after 
nerve injury and remains elevated for weeks until either neuronal death or axonal 
regeneration occurs (Kenney and Kocsis, 1998; Waetzig et al., 2006).   Similarly, p38 is 
transiently activated following peripheral axotomy in small diameter DRG neurons (Ji et 
al., 2002; Murashov et al., 2001) as well as in small-to-medium DRG neurons after 
chronic constriction injury (Obata, Yamanaka et al. 2004). 
Activation of these kinases as a result of axotomy influences downstream events 
that include upregulation or activation of a number of transcription factors. Activated 
JNK increases the expression and phosphorylation of c-Jun, JunD and Fos, and their 
translocation into the nucleus.  This leads to the formation of AP-1 complexes that 
activate many downstream genes (Kenney and Kocsis, 1998; Raivich and Behrens, 2006; 
Raivich and Makwana, 2007).  Activation of AP-1 sites can influence the expression of 
GAP-43 and Tα1 tubulins and perhaps other growth associated proteins.  The presence of 
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basal levels of transcription factors characterized as immediate early genes in DRG 
neurons has been reported (Sheng et al., 1995), but many of these are increased following 
axotomy or lesion of the sciatic nerve (Herdegen et al., 1992; Kajander et al., 1996; 
Kenney and Kocsis, 1998; Wang et al., 2002).   
In the CNS, c-Jun deficient neurons do not express CD44, galanin, and α7β1 
integrin, genes that normally participate in the injury response (Raivich et al., 2004).  
Several protein kinase pathways activate transcription factor CREB in the early stages 
after injury, some through the Erk pathway.  ATF3 expression is upregulated in all DRG 
neurons after peripheral, but not central axotomy (Tsujino, Kondo et al. 2000). ATF3 
expression in subpopulations of DRG cells can be modulated by exogenous trophic 
factors, such as NGF and GDNF (Averill et al., 2004). Activated STAT3 is required in 
the regeneration process of DRG neurons and the central axonal growth in the spinal cord 
after a conditioning injury (Qiu, Cafferty et al. 2005). The PI3K-Akt pathway seems to 
also be involved in DRG neuronal response to injury (Leinninger et al., 2004).   
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CHAPTER 2 
2.0 RATIONALE OF THE CURRENT PROJECT 
 
We have insufficient knowledge about the mechanisms by which positive or 
negative signals associated with peripheral axon injury may lead to the injury response 
and enhancement of intrinsic regenerative ability in DRG neurons. Evidence from this lab 
and others show that the activation of cAMP-signalling promotes neuronal survival and 
axonal elongation in cultured DRG neurons and stimulates peripheral nerve regeneration 
in vivo.  These findings indicate that increased levels of cAMP in neurons have an 
important role in axonal elongation.  Paradoxically, this lab has found that cAMP 
signaling suppresses expression of the prominent growth-associated protein GAP-43 in 
cultured adult DRG neurons (Andersen et al., 2000). 
FGF-2 acts specifically on central and peripheral neurons during development and 
regeneration (Unsicker, 1993).  FGF-2 is expressed by the Schwann cells of the 
peripheral nerves and by the satellite cells of the DRG, and is important in wound repair 
and regenerative events in the injured peripheral nerves (Duobles et al., 2008). 
In this lab, recent unpublished studies have shown that exogenous FGF-2 also 
suppresses GAP-43 expression in cultured adult DRG neurons.  FGF-2 was shown to 
repress GAP-43 at least in part through a MEK pathway.  Combined application of both 
cAMP and FGF-2 completely represses GAP-43, indicating a complimentary role for 
FGF-2 with cAMP in maintaining the repressed state of GAP-43.  Additional 
experiments indicated that selective inhibition of FGF-2 signaling increases GAP-43 
level of expression in the brain.  
The survey of the literature and the preliminary results from tissue culture 
experiments leads to a reasonable assumption that cAMP and/or FGF-2 may act as 
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retrograde signaling molecules to maintain the basal metabolic state in uninjured neurons, 
(for example suppressing GAP-43 expression), and whose absence contributes to the 
generation of the injury response. 
The current project endeavors to answer two key questions: 1) Is the expression of 
transcription factors ATF3, c-Jun, and STAT3 by DRG neurons similar to that of GAP-
43? 2) If so, could these transcription factors be regulated by signaling mechanisms that 
aslo regulate GAP-43? 
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CHAPTER 3 
3.0 HYPOTHESES 
 
1) FGF-2 regulates expression of GAP-43 in DRG neurons in vivo, through modulation 
of transcription factors ATF3, c-Jun and/or STAT3. 
2) cAMP regulates expression of GAP-43 in DRG neurons in vivo, through modulation of 
transcription factors ATF3, c-Jun and/or STAT3. 
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CHAPTER 4 
4.0 SPECIFIC AIMS 
 
1. Establish through Western blot analysis, immunohistochemistry and image 
analysis whether expression patterns of ATF3 and GAP-43 are similar in their 
response to peripheral sciatic nerve transection or dorsal root transection of DRG 
neurons. 
2. Establish through Western blot analysis, immunohistochemistry and image 
analysis whether expression patterns of c-Jun and GAP-43 are similar in their 
response to peripheral sciatic nerve transection or dorsal root transection of DRG 
neurons. 
3. Establish through Western blot analysis, immunohistochemistry and image 
analysis whether expression patterns of STAT3 and GAP-43 are similar in their 
response to peripheral sciatic nerve transection or dorsal root transection of DRG 
neurons. 
4. Develop, design and test an improved in vivo method using mini osmotic pumps 
to study the possible modulatory role of FGF-2 and cAMP on GAP-43 
expression, when applied to the site of injured sciatic nerve. 
5. Develop, design and test an improved in vivo method using mini osmotic pumps 
to study the possible modulatory role of FGF-2 and cAMP on expression of 
ATF3, c-Jun and STAT3 transcription factor, when applied to the site of injured 
sciatic nerve. 
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CHAPTER 5 
5.0 SIGNIFICANCE 
 
The elucidation of the nature of signal(s) that lead to the reexpression of the GAPs 
in response to injury could help to understand the requirements for peripheral neuronal 
growth and might suggest ways to improve regeneration in the CNS.  From a cell 
biological point of view, it will be important to relate renewed expression of GAPss 
following injury to the expression and activation of transcription factors.  These studies 
of FGF-2 and cAMP application could help identify extrinsic influences (positive or 
negative) which are crucial to the modulation of the injury response in a model system in 
which axon regeneration readily occurs.  Moreover, detailed knowledge of the role of 
transcription factors in mediating the response to injury could be utilized to design new 
therapeutic strategies for PNS and CNS trauma to complement the current clinically 
available techniques.  
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CHAPTER 6 
6.0 MATERIALS AND METHODS 
 
 
6.1 Animals. 
All animals used in this project were cared for and used in accordance with the 
guidelines of the Canadian Council on Animal Care, and the regulations of the University 
of Saskatchewan Committee on Animal Care and Supply. 
Female Sprague Dawley rats (Charles River, Wilmington, MA, USA) weighing 
between 250 - 300 g were maintained in our animal facilities with 12 hour light/dark 
cycle at 25ºC, and fed rat chow ad libitum.   
 
6.2 Peripheral sciatic nerve transection. 
Animals were anesthetized using halothane (Halocarbon Laboratories, River 
Edge, NJ, USA) or isoflurane (Baxter Corporation, Toronto ON, Canada) delivered by 
inhalation using an anesthetic vaporizer (Medishield Products Ltd. Rexdale, ON, 
Canada).  The vaporizer was connected to an oxygen cylinder (100% O2).  The oxygen 
and the anesthetic at a concentration of 1.5-2% were delivered in a closed circuit at a 
flow rate of 1 L/min to a nose cone attached to the rat’s snout.  Deep anesthesia was 
confirmed by pinching the hind paw with forceps and noting the absence of a withdrawal 
reflex.  Anesthesia administration and the entire surgical procedure were done under 
aseptic conditions and.  Body temperature was maintained using an electrically heated 
pad.  Care was taken to continuously monitor the breathing signs of the rat, as well as the 
color of the paws during the entire surgery.  The skin over the left (ipsilateral) thigh 
region was shaved, cleansed with 70% alcohol, and a 0.5 cm incision was made in the 
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skin using size 21 stainless steel Paragon sterile surgical blades at the mid-thigh level.  
The biceps femoris muscle was then teased with small curved tip scissors to allow access 
to the common sciatic nerve, which is located immediately beneath this muscle. The 
nerve was then carefully transected using 6 mm blade spring scissors from separating the 
proximal from the distal stumps.  The damaged muscle was sutured using 6.0 ophthalmic 
silk sutures.  The external incision in the skin was then sutured using 4.0 silk sutures 
(Ethicon Inc., Johnson and Johnson, NJ, USA).  The right sciatic nerve (contralateral) 
was left intact to serve as an internal control.  At the end of surgery, the nose cone was 
removed from the rat and recovery was monitored.  The rat was then transferred back to 
the cage, and placed in the recovery room for 1 (or 2) wk.   
Transcardial perfusion was done after an intraperitoneal injection of sodium 
pentobarbital (Somnitol; 30 mg/kg or Euthanyl (65 mg/kg)) to achieve terminal 
anesthesia.  Deep anesthesia was confirmed and a ventral midline incision was made 
from mid-thoracic to the most caudal part of the abdominal region.  The diaphragm was 
immediately cut transversely and the thoracic cage was reflected to expose the heart.  
Immediately the right ventricle was nicked and a perfusion needle was inserted through 
the left ventricle, reaching the transparent aorta.  The needle was stabilized using a small 
pair of suturing forceps, and the animal was flushed with ice cold phosphate bufferd 
saline (PBS) at pH 7.4, at a flow rate of 50 ml/min.  After a total volume of 200 ml of 
PBS was used, an equal volume of 4% ice cold paraformaldehayde in 0.1M phosphate 
buffer was delivered.  Both ipsilateral and contralateral fourth lumbar (L4) and fifth 
lumbar (L5) DRG  (N = 4 animals) were then carefully removed, post-fixed in 4% 
paraformaldehyde for 2 hours, and cryoprotected with 20 % sucrose (in PBS) overnight at 
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4°C. The tissues were then coated with Tissue-Tek OCT compound in disposable vinyl 
cryomolds and kept frozen at -800C until cryosectioning and immunohistochemical 
analysis was performed (detailed below in section 6.6). 
 
6.3 Dorsal root transection. 
 The animals were deeply anesthetized using isoflurane as described above to 
shave the entire back, and the skin was sterilized using 70 % alcohol.  A dorsal midline 
incision was made from twelfth thoracic vertebra (T12) to the sixth lumbar vertebra (L6). 
The paraspinal muscles were separated from the spinal processes on the both sides of the 
vertebral column spanning the L3-L5 region. The transverse processes of L3 and L5 were 
exposed by scraping off attached ligaments using rongeurs, and the spinous processes of 
L3, L4, and L5 were all removed.  Hemilaminectomy was performed on the left side at 
L3 and L4 to expose the L4 and L5 dorsal roots.  The dura was carefully opened using 
the tip of a 27.5 gauge needle to expose the dorsal spinal roots within the vertebral canal.  
The occasional bleeding that took place during surgery was blotted using small pieces of 
sterilized filter paper or Gelfoam to clot and minimize the bleeding.  Both the left L4 and 
left L5 dorsal roots were identified under a dissecting microscope and cut using 6 mm 
blade spring scissors.  The separated paraspinal muscles were sutured together using 6.0 
silk ophthalmic sutures.  A piece of Gelfoam comparable to the size of the incision was 
placed in areas where muscles had been removed.  The external skin incision was sutured 
using 4.0 silk sutures.   The right dorsal roots of both L4 and L5 were left as internal 
controls.  Postoperative pain was controlled by 0.05 mg/kg subcutaneous injections of 
buprenorphine hydrochloride (Buprenex) every eight hours during the first three days of 
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the postoperative period.  Seven days after surgery, rats were perfused with 4% 
praformaldehyde in 0.1M phosphate buffer (as described above) and both ipsilateral and 
contralateral DRG (N = 4 animals) were collected and processed for cryosectioning as 
described above.   
 
6.4 Mini-osmotic pump preparation. 
 Altzet® mini-osmotic pumps Model 2001 (Durect Corporation, Cupertino, CA, 
USA) were used in order to ensure the delivery of controlled and constant amount of 
FGF-2, and/or dbcAMP to the cut end of the proximal nerve stump for seven consecutive 
days (Figure 6-1).  Each mini-osmotic pump is designed by the manufacturer to hold up 
to 200 µl of material in the reservoir and can be surgically implanted subcutaneously with 
ease anywhere in the body.  As a result of osmotic pressure from bodily fluids, the pumps 
deliver at a flow rate of 1 µl/hr.  This pumping rate is ideal for our experimental 
procedures, since we leave the animals for seven days postoperatively.   
For our experiment, control pumps were filled with vehicle (1 mg/ml rat serum 
albumin plus 10 µl/ml penicillin-streptomycin mixture in 0.1M PBS).  The experimental 
pumps are filled with either FGF-2 in vehicle at a final concentration of 50 ng/ml, or 
dbcAMP in vehicle at a final concentration of 0.5 mM.   
 
6.4.1 Mini-osmotic pump and chamber surgical implantation. 
Under aseptic conditions, surgical implantation of the mini-osmotic pumps was carried 
out after animals were deeply anesthetized using isoflurane, as described above.  An 
incision (2 cm) was made on the dorsal aspect of the rat, between the thoracic and lumbar 
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region.  The skin was then separated using the blunt tip of large scissors in order to create 
the necessary space for the pump implantation.  The pump was implanted on the 
 
Figure 6-1. Implantable mini-osmotic pump nerve chamber model.  Surgical 
implantation of osmotic mini-pumps for fluid delivery to the cut sciatic nerve. The 
connection between the pump and the site of injury is done using silastic tubing.  At the 
site of injury an appropriate size chamber is made using silastic tubing of a larger size.  
This chamber ensures that the material that is coming from the pump is confined to the 
proximal end of the nerve, and minimizes the effects of any reterograde signal that might 
emminate from the immediate surrounding environment.  
 
6.4.1 Mini-osmotic pump and chamber surgical implantation. 
Under aseptic conditions, surgical implantation of the mini-osmotic pumps was 
carried out after animals were deeply anesthetized using isoflurane, as described above.  
An incision (2 cm) was made on the dorsal aspect of the rat, between the thoracic and 
Osmotic mini-pump 
Proximal sciatic nerve stump
Distal sciatic nerve stump
Silastic tubing
Silastic tubing chamber
Silastic medical adhesive
To CNS through DRG
From PNS 
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lumbar region.  The skin was then separated using the blunt tip of large scissors in order 
to create the necessary space for the pump implantation.  The pump was implanted on the 
dorsal thoraco-lumbar region, and secured by 6.0 ophthalmic sutures to ensure stability.  
The pump was connected by 5 cm long small diameter silastic tubing the dimensions of 
which are: 0.025 in. ID (0.64 mm) x 0.047 in. OD (1.19 mm).  This length was chosen to 
ensure that the contents of the mini-osmotic pump reached specifically the proximal cut 
end of the sciatic nerve in the mid-thigh region.  Another incision was made at the mid-
thigh level and a peripheral sciatic nerve transection was carried out just as described 
above.  A large diameter silastic tubing (0.5 cm long) the dimensions of which are:  0.14 
in. ID (2.64 mm) x 0.192 in. OD (4.88 mm) was sealed from one end by silastic medical 
adhesive silicone.  The open end served as a chamber in which the small diameter silastic 
tubing connected to the pump was inserted.  The proximal cut end of the nerve was also 
inserted in the same chamber.  The chamber was then carefully placed in the mid-thigh 
region, where it was secured by additional 6.0 sutures to the muscles in the area.  This set 
up was ideal since it took advantage of the anatomical confinements and utilized them to 
secure foreign objects for a period of time. The animals tolerated the chamber and the 
implanted mini-osmotic pump well. The incision wound from the implantation of the 
mini-osmotic pump was adequately healed one day following surgery.  At the end of the 
experimental period (7 d), animals were either perfused as described above for DRG 
tissue immunohistochemical processing (Vehicle: N = 4 animals, FGF-2: N = 4 animals, 
dbcAMP: N = 4 animals), or killed with carbon dioxide asphyxiation for Western blot 
analysis (Vehicle: N = 4 animals, FGF-2: N = 4 animals, dbcAMP: N = 4 animals).  
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6.5 Western blot analysis. 
 L4 and L5 DRG tissues ipsilateral and contralateral to the sciatic nerve injury 
were immediately removed from each of the four animals in each experimental group and 
pooled in ice cold PBS solution.  Attached nerve and roots were carefully removed under 
the dissecting microscope, and the epineurium cut to expose the neurons.  The tissues 
were then placed in lysis buffer (20 mM HEPES (pH 7.5), 50 mM KCl, 10% glycerol, 0.5 
mM EDTA, 0.5 mM EGTA, 1 mM DTT, Sigma anti-protease cocktail, and 1% NP-40).  
Tissues were then homogenized at high speed using Tissue Tearer (Biospec Products, 
Inc, OK, USA) to break down connective tissue components.  The homogenate was 
further subjected to pulse sonication (three times for 5 sec with 1 min interval on ice).  
The sonicated homogenate was centrifuged at 14,000 rpm at 4ºC for 30 minutes.  The 
supernatant was then collected and its protein content was assayed using the Bradford 
method (Bradford, 1976), or Lowry’s method (Lowry et al., 1951).   
 Electrophoresis was done using a BioRad Mini-Protean Tetra Cell system.  
Proteins (20 µg per lane) were loaded and separated using polyacrylamide gel 
electrophoresis (2 h at room temperature, 120V).  10 % acrylamide gels were used for 
higher molecular weight detection and 12% acrylamide gels were used for smaller 
molecular weight detection.  The proteins were transferred and blotted on Pall BioTrace 
NT nitrocellulose membranes, (Pensacola, FL USA) using standard transfer buffer (12.08 
g Tris base, 56.6 g glycine, 800 ml methanol, added to water in a total volume of 4 liters).  
Transfer time was 2 hours at 4ºC.   Membranes were initially soaked in PBS for 10 
minutes prior to blocking.  Non-specific binding was blocked overnight on a shaker 
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(Fisher Scientific clinical rotator) using blocking solution containing 5% (w/v) non-fat 
milk (Biorad, Hercules, CA, USA) in PBS + 0.1% Tween 20.   
The following primary antibodies were diluted in blocking solution: mouse anti-
GAP-43 monoclonal antibody 9-1E12 (Schreyer and Skene, 1991) (1:5000), rabbit anti-c-
Jun (Santa Cruz, 1:300), rabbit anti-ATF3 (Santa Cruz, 1:200), rabbit anti-STAT3 (Santa 
Cruz, 1:300), rabbit anti-pSTAT3 (Cell Signaling, 1:500), and mouse anti-c-Jun (Cell 
Signaling, 1:200).  All incubations of membranes in primary antibodies in blocking 
solution were done overnight.  After several washes with PBS, two types of detection 
methods were used: chemiluminescent and fluorescent.  For enhanced 
chemiluminescence (ECL) detection, membranes were incubated in mouse or rabbit 
horseradish peroxidase (HRP)-conjugated secondary antibodies for 1 h at room 
temperature. The chemiluminescence was detected using enhanced ECL luminol 
substrate of the peroxidase captured on Kodak film.  For fluorescent detection, 
membranes were incubated in donkey anti-mouse conjugated to IRDye 800 (green), or 
with goat anti-rabbit conjugated to IRDye 680 (red) fluorescent secondary antibodies 
(Licor Biosciences). Fluorescence detection was carried out using an Odyssey Infrared 
Imaging System (Licor Biosciences, NE, USA).  This system is uniquely equipped with 
two infrared channels (800 nm and 680 nm) for direct fluorescence detection on 
membranes. 
 
6.6 Immunohistochemistry (IHC). 
A separate set of experiments under identical conditions set forth in the Western 
blot analysis were performed and employed for IHC analysis.  For peripheral transection 
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immunohistochemistry, DRG from ipsilateral (cut) and contralateral (uncut) L4 and L5 
DRG from the four animals were embedded  in the same mold and placed on the same 
slide to ensure that all sections underwent similar processing conditions for primary and 
secondary antibodies, and for further fluorescence image analyses.  L4 and L5 DRG 
collected from dorsal transection experiments underwent similar tissue processing 
procedures (Figure 6-2).   Spararte slides were prepared for each antibody (i.e. ATF3, c-
Jun, STAT3, and pSTAT3), from the same group of experiments.  Since these antibodies 
were raised in rabbit, and since GAP-43 was raised in mouse, we double labeled all the 
slides with GAP-43.  This procedure was repeated for reproducibility.    
  
 
  
Figure 6-2. Arrangement of DRG sections from peripheral nerve or dorsal root 
transection experiments.  Contralateral (blue ovals) and ipsilateral (red ovals) DRG 
tissues from animals that have andergone peripheral sciatic nerve transection, or dorsal 
root transection.  Tissues were arranged so that tissues from four similar animals are 
placed on the same slide for immunohistochmical analysis.  1-4 denotes the animal 
number. 
 
For mini-pump experiments, ipsilateral and contralateral L4 or L5 DRG sections 
from four animals from each of the three experimental treatment groups were arranged on 
gelatin coated slides and processed on the same slides under identical experimental 
conditions (Figure 6-3).  This arrangement avoids bias resulting from variance in 
 Ipsi 
 Contra 
         L4 
1     2     3   4 
         L5 
1     2     3   4 
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immunofluorescence intensities from slide to slide.  Representative slides that contained 
roughly similar number of neurons in each DRG section were chosen for further 
quantitative analysis.  L4 and L5 DRG tissues were segregated onto different slides. 
 
                  Set 1        Set 2       Set 3   Set 4 
Figure 6-3. Arrangement of DRG sections from mini-pump experiments.  
Contralateral (blue ovals) and ipsilateral (red ovals) L4 DRG tissues from animals 
surgically implanted with mini-pumps containing: vehicle (V), dbcAMP (C), or FGF-2 
(F) were arranged so that each set of experiments are placed on the same slide for 
immunohistochmical analysis.  
 
 
 Briefly, DRG tissues were cryo-sectioned at 6 µm and placed on gelatin coated 
slides.  Sections were blocked (2% horse serum, 2% goat serum, 1% BSA, 0.1% Triton 
X-100 in PBS) for 1hr at room temperature.  Sections were double labeled and incubated 
overnight at 4°C with the primary antibodies mouse anti-GAP-43 (1:5000) and rabbit 
anti-ATF3 (Santa Cruz, 1:1000) in blocking solution.  Sections were washed (3 x 5 
minutes) with PBS and then incubated with fluorescently labeled secondary antibodies 
that included Cy2-and Cy3-conjugates of goat-anti-rabbit IgG (Jackson ImmunoResearch 
Laboratories, West Grove, PA) both at a dilution of 1:300 in blocking solution for 1 hr at 
room temperature.  Sections were washed (3 x 5 min) with PBS.  For nuclear labeling, all 
slides were incubated for 5 min in 4',6-diamidino-2-phenylindole (DAPI) at a 
concentration of 1:20,000.  Sections were coverslipped with Citifluor and viewed using a 
Zeiss Axioskop fluorescence microscope (Zeiss Canada). 
V   C F V   C FV   C F V   C F
 Ipsi 
Contra
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6.7 Immunohistochemical image analysis. 
To analyze the images of slides prepared for immunohistochemistry, we used a 
Zeiss Axioskop microscope (Zeiss, Germany) fitted with epifluorescence optics.  This 
system uses an X-cite fluorescence source (Photonic Solutions, Inc. Canada) to ensure 
even illumination and images were captured using a Qimaging, Retga Exi camera.  
Images were digitized and transferred to Northern Eclipse imaging software (Empix 
Imaging Inc., Mississauga, ON, Canada), and the fluorescent labeling intensities of 
individual neurons and were quantified using a specifically designed program for our 
laboratory.  The software program was designed to measure the intensity of the 
fluorescent signal in the cytoplasm (or nucleus), as well as the mean diameter of that 
neuron. 
Four animals were used in each group.  In each contralateral and ipsilateral DRG, 
at least 200 neurons that were DAPI positive (i.e. nucleus was visible) were manually 
traced and included in the quantification process.  Each individual neuron was quantified 
for the GAP-43 and ATF3 labeling intensities, as well as the size of the individual 
neuron.   The same technique was used for the ipsilateral DRGs.  A similar quantification 
method was used for dorsal root transection experiments. 
For double labeling with two different antibodies, the software was designed to 
measure the intensity of the two different antibodies in the exact same neuronal 
cytoplasm (or nucleus) giving us the advantage of quantifying and correlating the 
expression of antibodies in individual neurons.  The labeling intensity data were 
transferred to Excel program (Microsoft) spreadsheets, for further statistical and 
graphical analyses. 
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6.8 Statistical analysis of immunohistochemical data. 
 The relative changes in immunofluorescence labeling intensities from one group 
to another were recorded for sections mounted on the same slide to avoid bias resulting 
from slide to slide variations.  Data from at least 800 DRG neurons from 4 different rats 
were included to calculate the mean labeling intensity in each experimental group (both 
contralateral and ipsilateral).  For the peripheral transection experiments, the mean 
labeling intensity of at least 800 DAPI positive neurons from the contralateral DRG of 
four different animals were normalized to 1.  The mean labeling intensity of about a 
similar number of ipsilateral neurons from the same animals were included and compared 
to the normalized contralateral.  
 In double labeling experiments (example: GAP-43 and ATF3) slides were 
prepared as in Figure 6-2. The fluorescence measurements of cytoplasmic and nuclear 
intensities were taken using a specific filter that detected the secondary antibody 
conjugated to GAP-43 first.  The filter was changed so that it could detect the secondary 
antibody conjugated to ATF3.  Thus, this process generated, for each neuron, two sets of 
data one for each of the primary antibodies tested.  This process repeated to collect at 
data from at least 200 neurons from each animal.  This entire process was repeated to 
include data from the rest of the 3 animals.  The resulting data would have a total of 4 
contalateral set of measurements and 4 corresponding ipsilateral set of measurements.  
The contralateral data for all of the 4 different animals were normalized to 1.  The 
ipsilateral cytoplasmic labeling intensity data were compared to the normalized 
contralateral cytoplasmic; and the ipsilateral nuclear labeling intensity data were 
compared to the normalized contralateral nuclear labeling intensity data.   
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To ascertain whether changes between ipsilateral and contralateral labeling 
intensities were significant, Kruskal-Wallis nonparametric ANOVA test was performed.  
This particular test was employed because our data collected did not assume a normal 
Gaussian distribution, and to ensure that we collected data from a heterogeneous neuronal 
size range.  This analysis was done using Prism software (Prism v.4 GraphPad Software 
Inc., San Diego, CA) to compare the cytoplasmic and nuclear labeling intensities of each 
transcription factor in individual sensory neurons in each of the three treatment groups 
(vehicle, dbcAMP, and FGF-2). In each experimental mini-pump group, we measured the 
mean labeling intensities of each transcription factor of contra-and ipsilateral neurons in 
four different animals, and the selection of neurons was based on DAPI staining. This 
particular ANOVA test was followed by Dunn’s multiple comparison tests to determine 
significant differences between specific groups of data. Statistical significance was 
accepted at P < 0.05 level. 
Scatter plots were generated whereby the neuronal diameter data for each animal 
was plotted against the mean fluorescent labeling intensity for each of the antibodies 
tested.  This type of graph provides qualitative assessment of the overall neuronal 
response to experimental conditions.  Moreover, any variation between the responses of 
size subpopulations of neurons to a particular experimental condition can be easily seen, 
and subjected to further quantitative statistical analyses. 
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CHAPTER 7 
7.0 RESULTS 
 
 
7.1 Normal injury response to peripheral sciatic nerve transection 
7.1.1 GAP-43 and ATF3 expression seven days after injury. 
GAP-43 is normally expressed at low levels in uninjured neurons and is confined 
primarily to the small diameter neurons (Figure 7-1 A).  Seven days following peripheral 
sciatic nerve transection, GAP-43 expression is elevated in the majority of neurons, 
including large diameter neurons (Figure 7-1 B).  The nuclei of injured DRG neurons that 
are GAP-43 positive often exhibit an eccentric localization, displaying a typical 
chromatolytic morphology.  In order to minimize sampling bias based on the size of the 
neuronal perikarya, only neurons that display a clear DAPI nuclear stain were included in 
the statistical calculations represented in the bar graphs below.  
Western blot analysis of DRG neurons with anti- GAP-43 shows a specific band 
at MW 43 kDa corresponding to GAP-43, which is increased in the ipsilateral DRG 
(Figure 7-1 C).   
Immunohistochemical results show that one week following sciatic nerve 
transection (N=4), GAP-43 and ATF3 are both upregulated in L4 DRG ipsilateral to the 
injury (Figure 7-2 A and C), and in L5 DRG (Figure 7-3A and C), when compared to the 
corresponding contralateral controls. Upregulated ATF3 is principally localized in the 
nuclei of injured neurons; whereas, GAP-43 is localized principally in the cytoplasm of 
injured neurons.   
Western blot analysis of DRG neurons using affinity purified polyclonal antibody 
raised against a peptide mapping the C-terminus of human ATF3 shows a band at about 
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MW 26 kDa (Figure 7-3 E).  This band was prominent in samples from ipsilateral injured 
DRG, but undetectable in samples from contralateral vontrol DRG.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7-1. GAP-43 expression increases in DRG 7 d following sciatic nerve 
transection.  Representative micrographs display the effect of injury on the expression of 
GAP-43 in the DRG neurons.  (A) In uninjured DRG (contralateral), GAP-43 (green) is 
expressed at low levels in the neurons, especially in the small diameter neurons (small 
arrows).  (B) In injured DRG (ipsilateral) GAP-43 expression is more pronounced and 
includes large diameter neurons (block arrows), which also display visible chromatolytic 
morphology.  Cell nuclei are stained with DAPI (blue). (C) Western blot analysis for 
GAP-43 in L4 and L5 DRG neurons confirms the immunohistochemical data. Lane 1, 
ipsilateral; lane 2 contralateral to the injury. Scale bar represents 100 µm. 
 
Contralateral 
A B
Ipsilateral 
C 
GAP-43   
Ipsi   Contra 
1 2
91 
 
   
 
Figure 7-2.  ATF3 and GAP-43 expression increases in L4 DRG 7 d following sciatic 
nerve transection.  Micrographs of identical sections of L4 DRG neurons double labeled 
with ATF3 (red, A and B) and GAP-43 (green, C and D).  (A) In injured DRG 
(ipsilateral), ATF3 (red) expression is enhanced compared to contralateral DRG (B).   
GAP-43 (green) expression is increased in ipsilateral (C) compared to the contralateral 
(D).  Scale bar represents 100 µm. 
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Figure 7-3. ATF3 and GAP-43 expression increases in L5 DRG 7 d following sciatic 
nerve transection.  Micrographs of identical sections of L5 DRG neurons double labeled 
with ATF3 (red, A and B) and GAP-43 (green, C and D).  (A) In injured DRG 
(ipsilateral), ATF3 (red) expression is enhanced compared to contralateral DRG (B).   
GAP-43 (green) expression is increased in ipsilateral (C) compared to the contralateral 
(D).  Arrow in (B) points to occasional ATF3 positive neurons.  (E) Western blot analysis 
for ATF3 in L4 and L5 DRG neurons confirms the immunohistochemical data. Lane 1, 
ipsilateral; lane 2 contralateral to the injury. Scale bar in micrographs represents 100 µm. 
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The nuclear and cytoplasmic labeling intensity of ATF3 and GAP-43 were 
measured in both contralateral (uninjured) and ipsilateral (cut) DRG neurons double 
labeled with both antibodies.  In all cases, the mean contralateral value was normalized to 
1 and the average values for ATF3 and or GAP-43 in ipsilateral injured DRG neurons 
were compared to the normalized contralateral value.  A combined number of about 800 
neurons from four different rats were used in each experimental group.  Analysis of the 
data using two-way ANOVA followed by Kruskal Wallis test was performed comparing 
the combined number of neurons.  Nuclear ATF3 values in the transected nerve (2.58 + 
0.02) were significantly higher than measured in the contralateral, uninjured nerve (P < 
0.001).  The cytoplasmic ATF3 values also showed a significantly higher level than the 
contralateral side (1.17 + 0.02) (P < 0.001).  GAP-43 expression was significantly higher 
value in the injured nerve than in the contralateral nerve (1.39 + 0.02) (P < 0.001) (Figure 
7-4).  Thus, quantification of the immunohistochemical data from DRG neurons show 
that sciatic nerve transection at mid-thigh level significantly increases the expression of 
the transcription factor ATF3 and that of GAP-43.  
Northern Eclipse imaging analysis was used to quantify the labeling intensity of 
ATF3 and GAP-43 as a function of neuronal diameter.  The image analysis takes into 
account the average grey area of the fluorescence emitted by the conjugated secondary 
antibody to the primary antibody.  Manual tracing of individual neurons and of their 
respective nuclei generate numbers reflective of both neuronal diameter and labeling 
intensity values which can be entered in Excel and or Prism, where they can be analyzed.  
This type of data presentation shows changes in the pattern of labeling intensity values 
across the variable sizes of the subpopulation of DRG neurons. 
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Figure 7-4. Quantification of ATF3 and GAP-43 immunohistochemical staining 
intensity in L5 DRG 7 d following sciatic nerve transection. The mean 
immunoreactivity (IR) + SEM of normalized data to control (blue bars) values.  DRG 
neurons ipsilateral (red bars) to transection show a significant (*** P < 0.001) increase in 
the expression of ATF3 and GAP-43.  Each bar represents the mean value of 800 or more 
neurons from 4 different rats.   
 
No statistical analyses were done on this and on the following scatter plots 
presented throughout the remainder of this thesis.  We used at least four different rats.  
All four different animals show a similar pattern when we plotted the GAP-43 and ATF3 
labeling intensity values against the neuronal diameter.  Representative scatter plot values 
of nuclear (Figure 7-5 A), cytoplasmic ATF3 (Figure 7-5 B) as well as the cytoplasmic 
GAP-43 (Figure 7-5 C) are shown.  There was a noticeable increase in the nuclear ATF3 
labeling intensity as a result of injury across the the size range of DRG neurons.  
However, the increase in the cytoplasmic ATF3 levels was uneven, with the larger 
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neurons expressing markedly higher levels of intensity.  GAP-43 was increased across 
the injured neuronal subpopulation.      
 
7.1.1.1 GAP-43 and ATF3 expression 14 days after injury. 
 To determine if the injury effects last longer than 1 week, we studied the 
expression of both GAP-43 and ATF3 at 14 days following peripheral sciatic nerve 
transection.  The expression of both GAP-43 and that of ATF3 remained high (Figure 7-
6).  However, at 14 days, ATF3 expression was more pronounced in the injured nuclei of 
small to medium diameter neurons than compared with the nuclei of the large diameter 
neurons.   
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Figure 7-5. Sciatic nerve transection at mid-thigh level increases the expression of 
nuclear and cytoplasmic ATF3, and GAP-43 7 days after injury. Representative 
scatter plot of immunoreactivity (IR) of nuclear ATF3 (A), cytoplasmic ATF3 (B), and 
GAP-43 (C) in L5 DRG neurons comparing the contralateral (blue diamonds) with 
ipsilateral (red diamonds) data.  L4 showed similar results (data not shown). 
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Figure 7-6. ATF3 and GAP-43 expression increases in L4 DRG 14 d following sciatic 
nerve transection.  Micrographs of identical sections of L4 DRG neurons double labeled 
with ATF3 (red, A and B) and GAP-43 (green, C and D).  (A) In injured DRG 
(ipsilateral), ATF3 (red) expression is enhanced compared to contralateral DRG (B).   
GAP-43 (green) expression is increased in ipsilateral (C) compared to the contralateral 
(D).  Scale bar represents 100 µm. 
 
Analysis of the data at 14 d after sciatic nerve transection data by two-way 
ANOVA followed by Kruskal Wallis test revealed nuclear ATF3 values in the transected  
nerve (4.20+ 0.05), were significantly higher than the contralateral, uninjured nerve (P < 
0.001).  The cytoplasmic ATF3 values also showed a significantly higher level than the 
contralateral side (1.50 + 0.02) (P < 0.001).  GAP-43 expression was also significantly 
higher in the injured DRG neurons than in the contralateral side (1.80 + 0.04) (P < 0.001) 
(Figure 7-7).  Although the elevated nuclear and cytoplasmic ATF3 expression and GAP-
43 expression were similar to the pattern observed with the 7 d injured DRG neurons, the 
amount of increase was higher in the 14 d injured DRG neurons than the 7 d injured DRG 
GAP-43 
Ipsilateral Ipsilateral 
Contralateral Contralateral 
C 
D 
ATF3 
B 
A 
98 
 
neurons for nuclear ATF3 (4 fold vs 3 fold), cytoplasmic ATF3 (1.5 fold vs.1.2fold), and 
of GAP-43 (1.8 fold vs.1.4 fold).           
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Figure 7-7. Quantification of ATF3 and GAP-43 immunohistochemical staining 
intensity in L4 DRG 14 d following nerve transection. The mean immunoreactivity 
(IR) + SEM of normalized data to control (blue bars) values.  DRG neurons ipsilateral 
(red bars) to transection show a significant (*** P < 0.001) increase in the expression 
of ATF3 and GAP-43.  Each bar represents the mean value of 800 or more neurons 
from 4 different rats.   
 
Representative scatter plots of nuclear (Figure 7-8 A), cytoplasmic ATF3 (Figure 
7-8 B) as well as the cytoplasmic GAP-43 (Figure 7-8 C) were examined.  There was a 
noticeable increase in the nuclear across all neuronal diameters, and cytoplasmic ATF3 
labelling intensity as a result of injury especially in the small to medium neurons (20 – 40 
µm in diameter).  GAP-43 expression was increased as well across the entire size range 
of injured neurons.    
99 
 
When comparing the results obtained from the 14 d injury to those obtained from 
7 d injury, there was a noticeable increase in the expressions of nuclear ATF3 and GAP-
43. There was an increase in the neuronal response to peripheral injury, especially during 
the second week of injury. 
 
7.1.2 GAP-43 and c-Jun expression seven days after injury. 
Immunohistochemical results showed that when the sciatic nerve was transected, 
GAP-43 and c-Jun were both upregulated in DRG neurons (Figure 7-9 A and C).  c-Jun 
was expressed at basal low levels in some of the nuclei of uninjured neurons (Figure 7-9 
B).  When DRG neurons were injured, c-Jun was more enhanced and upregulated in the 
nuclei of all neuronal subpopulation of cells, whereas, GAP-43 was upregulated in the 
cytoplasm.  While all GAP-43 positive injured neurons were also c-Jun  positive, not all 
c-Jun positive injured neurons were GAP-43 positive (Figure 7-10,  white arrows).  
    7.1.3 GAP-43 and STAT3 expression seven days after injury. 
Immunohistochemical results showed that when the sciatic nerve was severed at 
mid-thigh level, GAP-43 expression was upregulated in DRG neurons ipsilateral to the 
transection.  Total STAT3 expression did not change as a result of injury, beyond the 
basal contralateral levels (Figure 7-13).  However, a more careful look at the nuclei of 
injured neurons, a slight increase could be seen from the micrographs (Figure 7-13).    
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Figure 7-8. Sciatic nerve transection at mid-thigh level significantly increases the 
expression of nuclear and cytoplasmic ATF3, and GAP-43 14 days after injury. 
Representative scatter plot of immunoreactivity (IR) of nuclear ATF3 (A), cytoplasmic 
ATF3 (B), and GAP-43 (C) in L4 DRG neurons comparing the contralateral (blue 
diamonds) with the ipsilateral (red diamonds) data.  L5 showed similar results (data not 
shown). 
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Figure 7-9. c-Jun and GAP-43 expression increases in L5 DRG 7 d following sciatic 
nerve transection.  Micrographs of identical sections of L4 DRG neurons double labeled 
with c-Jun (red, A and B) and GAP-43 (green, C and D).  (A) In injured DRG 
(ipsilateral), c-Jun (red) expression is enhanced compared to contralateral DRG (B), 
which expresses low (basal) levels of c-Jun as seen in the nuclei.   GAP-43 (green) 
expression is increased in ipsilateral (C) compared to the contralateral (D).    White 
arrows point to injured neurons that express elevated levels of both c-Jun and GAP-43; 
Yellow arrows point to injured neurons that express elevated c-Jun, but not GAP-43.  
Scale bar represents 100 µm. 
 
 
Figure 7-10. Colocalization of GAP-43 and c-Jun in injured neurons. 
c-Jun (red) expression is, for the most part, colocalized with GAP-43 (green).  A small 
percentage of neurons exist that express c-Jun, but not GAP-43 (arrows).  Scale bar 
represents 100 µm.  
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Analysis of the data by two-way ANOVA followed by Kruskal Wallis test 
showed that nuclear c-Jun values in the injured neurons (1.58 + 0.06), were significantly 
higher than in the contralateral, uninjured neurons (P < 0.001).  The cytoplasmic c-Jun 
values of the injured DRG showed no significant difference (P > 0.05) from the 
contralateral side (0.97+ 0.05 vs 1.00 + 0.04).  GAP-43 was significantly higher in the 
injured DRG neurons compared to the contralateral neurons (1.33 + 0.06), (P < 0.01) 
(Figure 7-11). 
Representative scatter plot of nuclear (Figure 7-12 A) and cytoplasmic c-Jun 
(Figure 7-12 B) as well as cytoplasmic GAP-43 (Figure 7-12 C) are shown.  There was a 
noticeable increase in the nuclear c-Jun labeling intensity as a result of injury across the 
neuronal subpopulations, a trend that has also been observed in the injured cytoplasmic 
GAP-43 levels for all sizes of neurons, whereas there was no difference in the 
cytoplasmic expression of c-Jun for all neurons between injured vs. contralateral side.  
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Figure 7-11. Quantification of c-Jun and GAP-43 immunohistochemical staining 
intensity in L5 DRG 7 d following sciatic nerve transection.  The mean 
immunoreactivity + SEM of normalized data to control (blue bars) values.  Nuclei of 
DRG neurons ipsilateral (red bars) to the transection show a significant (*** P < 0.001) 
increase in the expression of nuclear c-Jun, and GAP-43 (** P < 0.01).  No difference is 
observed in the cytoplasmic c-Jun values. Each bar represents the mean value of 800 or 
more neurons from 4 different rats.   
 
 
 
 
 
104 
 
 
 
 
Figure 7-12.  Sciatic nerve transection at mid-thigh level notably increases the 
expression of nuclear c-Jun, and GAP-43 7 days after injury. Representative scatter 
plot of immunoreactivity (IR) of nuclear c-Jun (A), cytoplasmic c-Jun (B), and GAP-43 
(C) in L5 DRG neurons comparing the contralateral (blue diamonds) with the ipsilateral 
(red diamonds) data.  L4 showed similar results (data not shown). 
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Figure 7-13.  Total STAT3 expression changes slightly but GAP-43 expression 
increases in L5 DRG 7 d following sciatic nerve transection.  Micrographs of identical 
sections of L5 DRG neurons double labeled with total STAT3 (red, A and B) and GAP-
43 (green, C and D).  (A) In injured DRG (ipsilateral), STAT3 (red) expression increase 
slightly compared to contralateral DRG (B), especially when the injured nuclei are 
closely observed.   GAP-43 (green) expression is increased in ipsilateral (C) compared to 
the contralateral (D).  Scale bar represents 100 µm. 
 
 
 
 
Analysis of the data by two-way ANOVA followed by Kruskal Wallis test 
showed that there was no significant difference between injured and uninjured nuclear or 
cytoplasmic total STAT3 (P < 0.05) following peripheral nerve transection. GAP-43 was 
significantly higher in the injured DRG neurons compared to the contralateral neurons 
(1.70 + 0.01), (P < 0.001) (Figure 7-14). 
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Figure 7-14. Quantification of total STAT3 and GAP-43 immunohistochemical 
staining intensity in L5 DRG 7 d following sciatic nerve transection.  The mean 
immunoreactivity + SEM of normalized data to control (blue bars) values.  Both 
cytoplasmic and nuclear STAT3 of DRG neurons did not change significantly as a result 
of peripheral transection, while GAP-43 expression dramatically increased (*** P < 
0.001).  Each bar represents the mean value of 800 or more neurons from 4 different rats.   
 
Representative scatter plot of nuclear STAT3 (Figure 7-15 A), cytoplasmic 
STAT3 (Figure 7-15 B) as well as the cytoplasmic GAP-43 (Figure 7-15 C) are shown.  
There was no apparent increase in total STAT3 labeling intensity whether observed in the 
nucleus or the cytoplasm as a result of injury.  GAP-43 (Figure 7-15 C) levels, however, 
showed a typical pattern of increased expression as a result of injury, across the neuronal 
subpoulation.   
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Figure 7-15. Sciatic nerve transection at mid-thigh level does not dramatically 
increases the expression of total STAT3. Representative scatter plot IR of nuclear (A) 
and cytoplasmic (B) STAT3 and GAP-43 (C) in L5 DRG neurons comparing the 
contralateral (blue diamonds) with the ipsilateral (red diamonds) data.  No noticeable 
increase is seen in the expression of STAT3, whether in the nuclei or in the cytoplasm of 
injured neurons.   
 
 
 
7.1.4 GAP-43 and pSTAT3 expression seven days after inury. 
Immunohistochemical results showed that when the sciatic nerve was transected, 
phosphorylated STAT3 in the nucleus and GAP-43 expression in the cytoplasm were 
upregulated in injured DRG neurons (Figure 7-16 A and B).  While the majority of GAP-
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43 positive neurons were also pSTAT3 positive, not all pSTAT3 positive neurons were 
GAP-43 positive (arrows in Figure 7-16).    
 
Figure 7-16. Sciatic nerve transection at mid-thigh level significantly increases the 
expression of GAP-43 and nuclear phosphorylated pSTAT3 in injured DRG 
neurons. Micrographs of identical sections of L4 DRG neurons double labeled with 
pSTAT3 (red, A and B) and GAP-43 (green, C and D).  (A) In injured DRG (ipsilateral), 
pSTAT3 (red) expression is enhanced compared to contralateral DRG (B).   GAP-43 
(green) expression is increased in ipsilateral (C) compared to the contralateral (D). 
Arrows point to injured neurons that are pSTAT3 positive, but GAP-43 negative.  Scale 
bar represents 100 µm. 
 
 
 
Analysis of the data by two-way ANOVA followed by Kruskal Wallis test 
showed a significant increase in the nuclear pSTAT3 in injured DRG neurons (1.47 + 
0.04264), (P < 0.001).  Cytoplasmic pSTAT3 expression showed a significant but slight 
decrease (0.89 + 0.02619) (P < 0.05) in the injured neurons. GAP-43 expression was 
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significantly higher in the injured DRG neurons compared to the contralateral neurons 
(1.20 + 0.03), (P < 0.01) (Figure 7-17). 
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Figure 7-17. Quantification of pSTAT3 and GAP-43 immunohistochemical staining 
intensity in L5 DRG 7 d following sciatic nerve transection.  The mean immuno-
reactivity + SEM of normalized data to control (blue bars) values.  Both GAP-43 (***P < 
0.001) and nuclear pSTAT3 (***P < 0.001) of DRG are elevated as a result of 
transection.  Cytoplasmic pSTAT3 is also reducedas a result of peripheral nerve injury.  
Each bar represents the mean value of 800 or more neurons from 4 different rats.   
 
Representative Scatter plot of nuclear (Figure 7-18 A), cytoplasmic pSTAT3 
(Figure 7-18 B) as well as the cytoplasmic GAP-43 (Figure 7-18 C) are shown.  A 
noticeable increase could be seen in the nuclear pSTAT3 expression as a result of injury 
across the neuronal size range.  GAP-43 expression levels were also increased spanning 
the entire neuronal population.   
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Figure 7-18. Sciatic nerve transection at mid-thigh level increases the expression of 
nuclear pSTAT3. Representative scatter plot of nuclear pSTAT3 (A) and cytoplasmic 
pSTAT3 (B), as well as cytoplasmic GAP-43 (C) in L5 DRG neurons, comparing 
contralateral (blue diamonds) with ipsilateral (red diamonds) analysis.   Expression of 
nuclear pSTAT3 is increased as a result of peripheral nerve transection.  L4 showed 
similar results (data not shown). 
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7.2 Injury response to dorsal root transection. 
7.2.1 GAP-43 and ATF3 expression seven days after injury. 
Immunohistochemical results show that when dorsal root transection was 
performed, the levels of GAP-43 and ATF3 do not change beyond basal levels in the 
DRG (Figure 7-19).  No evidence for chromatolysis can be observed.    This absence of 
ATF 3 immunoreactivity is very important since it contrasts with what we observed 
following peripheral nerve transection.  Moreover, it confirms earlier studies that suggest 
a retrograde repressive signal(s) is derived from peripheral target tissue. These repressive 
signal(s) normally communicate through peripheral, but not central branches. Some peri-
neuronal cells can be immunoreactive to ATF3.     
 
Figure 7-19. Dorsal root transection  does not change the expression of GAP-43 or 
ATF3 7 days after injury. Micrographs of identical sections of L4 DRG neurons double 
labeled with ATF3 (red, A and B) and GAP-43 (green, C and D. (A) In injured DRG 
(ipsilateral), ATF3 (red) expression does not change compared to contralateral DRG (B).   
GAP-43 (green) expression similarily does not increase in ipsilateral (C) compared to the 
contralateral (D).  Scale bar represents 100 µm. 
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Analysis of the data by two-way ANOVA followed by Kruskal Wallis showed no 
significant changes in the nuclear ATF3 in centrally injured DRG neurons (1.03 + 0.050) 
(P >0.05).  Similarly, cytoplasmic ATF3 (1.01 + 0.02) (P > 0.05), and GAP-43 (0.93 + 
0.02) (P >0.05) did not change in centrally injured neurons (Figure 7-20). 
ATF3 and GAP-43 (dorsal root transection)
Nu
cle
ar 
AT
F3
Cy
top
las
mi
c A
TF
3
GA
P-
43
 
0
1
2
Contralateral
Ipsilateral
N
or
m
al
iz
ed
 la
be
lli
ng
 in
te
ns
ity
 
Figure 7-20.  Quantification of ATF3 and GAP-43 immunohistochemical staining 
intensity in L5 DRG 7 d following dorsal root transection.  The mean 
immunoreactivity + SEM of normalized data to control (blue bars) values.  GAP-43 (P 
>0.05), nuclear and cytoplasmic ATF3 (P >0.05) do not change.  Each bar represents the 
mean value of 800 or more neurons from 4 different rats.   
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A representative scatter plot of measurements of the immunoreactivity of nuclear 
and cytoplasmic ATF3, and that of GAP-43 revealed no dramatic changes resulting from 
dorsal root transection (Figure 7-21 A and B, and C).  These results are in agreement with 
immunohistochemical data as analyzed statistically.  It is noteworthy that the results 
obtained from dorsal root transection experiments are in sharp contrast to those obtained 
from our peripheral sciatic nerve transection experiments (compare photomicrographs in 
Figures 7-2 and 7-3 to those in Figure 7-19), in which both ATF3 and GAP-43 increased 
significantly in the DRG. 
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Figure 7-21. Dorsal transection does not induce changes in the expression of nuclear 
or cytoplasmic ATF3. Representative scatter plot of immunoreactivity of nuclear (A) 
and cytoplasmic (B) ATF3, and (C) GAP-43 in L5 DRG neurons comparing the 
contralateral (blue diamonds) with the ipsilateral data (red diamonds). 
 
 
 
7.2.2 GAP-43 and c-Jun expression seven days after injury. 
Although the perineuronal GAP-43 immunolabelling appears to be more intense 
in the ipsilateral DRG neurons, no increase was noted within the DRG neurons.  
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Immunolabelling indicative of c-Jun expression did not change beyond basal levels as a 
result of dorsal root transection (Figure 7-22).  This finding is very important since it 
contrasts with the pattern of c-Jun expression following peripheral sciatic nerve 
transection, where a marked increase in nuclear c-Jun and GAP-43 expression was noted.  
Moreover, the lack of increased expression of c-Jun resembles the absence of increased 
exression of ATF3 and GAP-43 as a result of dorsal root transection. 
 
Figure 7-22. Dorsal root transection  does not change the expression of GAP-43 or c-
Jun 7 days after injury.  Micrographs of identical sections of L5 DRG neurons double 
labeled with c-Jun (red, A and B) and GAP-43 (green, C and D. (A) In injured DRG 
(ipsilateral), c-Jun (red) expression does not change compared to contralateral DRG (B).   
GAP-43 (green) expression similarily does not increase in ipsilateral (C) compared to the 
contralateral (D).  Scale bar represents 100 µm. 
 
Analysis of the data by two-way ANOVA followed by two-way ANOVA 
followed by Kruskal Wallis showed no significant changes in the nuclear or the 
cytoplasmic c-Jun in centrally injured DRG neurons (1.04 + 0.02) and (1.01 + 0.02), 
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respectively, (P >0.05).  Similarly, GAP-43 (0.95 + 0.01) did not change in centrally 
injured neurons (P >0.05) (Figure 7-23). 
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Figure 7-23. Quantification of c-Jun and GAP-43 immunohistochemical staining 
intensity in L5 DRG 7 d following dorsal root transection.  The mean 
immunoreactivity + SEM of normalized data to control (blue bars) values.  GAP-43 (P 
>0.05), nuclear and cytoplasmic c-Jun (P >0.05) do not change.  Each bar represents the 
mean value of 800 or more neurons from 4 different rats.  
 
 
A careful examination of the representative scatter plots revealed no dramatic 
changes in c-Jun or GAP-43 immunoreactivity as a result of dosal root transection across 
the size range of DRG neurons,  In agreement with immunohistochemical and statistical 
data (Figure 7-24 A and B, and C).  The results here, especially of nuclear c-Jun, are in 
contrast to the results obtained form peripheral sciatic nerve transection, where a higher 
nuclear expression was noted. 
117 
 
 
 
 
 
Figure 7-24. Dorsal transection does not induce changes in the expression of nuclear 
or cytoplasmic c-Jun. Representative scatter plot of immunoreactivity of nuclear (A) 
and cytoplasmic (B) c-Jun, and (C) GAP-43 in L5 DRG neurons comparing contralateral 
(blue diamonds) with ipsilateral (red diamonds).  
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7.2.3 GAP-43 and STAT3 expression seven days after injury. 
 In contrast to ATF3 and c-Jun, STAT3 is unique because it is the only 
transcription factor we tested that was upregulated following dorsal root transection.  Not 
only was the increase noted in the cytoplasmic domain, but also in the nuclei of injured 
DRG.  Small to medium neurons display higher labeling intensity.  No change in GAP-43 
is observed.  Immunohisto-chemical micrographs clearly demonstrate this increase 
(Figure 7-25).  Total STAT3 results here are also in contrast to the results obtained from 
peripheral nerve transection, where no significant change was observed. 
 
Figure 7-25. Dorsal root transection increases the levels of cytoplasmic STAT3 7 
days after injury. Micrographs of identical sections of L5 DRG neurons double labeled 
with total STAT3 (red, A and B) and GAP-43 (green, C and D. (A) In injured DRG 
(ipsilateral), cytoplasmic and nuclear total STAT3 (red) expression increases compared to 
contralateral DRG (B).   GAP-43 (green) expression does not increase in ipsilateral (C) 
compared to the contralateral (D).  Scale bar represents 100 µm. 
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 Analysis of the data by two-way ANOVA followed by Kruskal Wallis test 
confirmed the cytoplasmic (1.319 + 0.18, P< 0.001) and nuclear (1.46 + 0.02, P< 0.001) 
increases of total STAT3 in the neurons ipsilateral to the dorsal root transection (Figure 
7-26).     
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Figure 7-26. Quantification of total STAT3 and GAP-43 immunohistochemical 
staining intensity in L5 DRG 7 d following dorsal root transection.  The mean 
immunoreactivity + SEM of normalized data to control (blue bars) values. Total STAT3 
expression increases significantly in the nuclei (***P<0.001), and in the cytoplasm of 
injured neurons (***P<0.001).  No significant changes are observed in GAP-43 (P 
>0.05).  Each bar represents the mean value of 800 or more neurons from 4 different rats.  
 
 Scatter plot of DRG neurons from this experiment confirmed that total STAT3 
increased in the cytoplasm and nuclei DRG neurons ipsilateral to dorsal transection, 
especially in the small to medium sized neurons, while GAP-43 expression remained 
unchanged (Figure 7-27). 
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Figure 7-27. Dorsal root transection induces changes in the expression of nuclear 
and cytoplasmic total STAT3. Representative scatter plot of immunoreactivity of 
nuclear (A) and cytoplasmic (B) STAT3, and (C) GAP-43 in L5 DRG neurons comparing 
contralateral (blue diamonds) with ipsilateral (red diamonds). 
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7.2.4 GAP-43 and pSTAT3 expression seven days after injury. 
 The activated (phosphorylated) form of STAT3 is translocated to the nucleus.  
Here we observed an increase in the expression of pSTAT3 in the nuclei of DRG neurons 
ipsilateral to dorsal root transection (Figure7-28).  This increase in pSTAT3 was seen 
across the entire size population of DRG neurons.      
 
Figure 7-28. Dorsal root transection  increases the levels of nuclear pSTAT3 7 days 
after injry. Micrographs of identical sections of L5 DRG neurons double labeled with 
pSTAT3 (red, A and B) and GAP-43 (green, C and D). (A) In injured DRG (ipsilateral), 
nuclear pSTAT3 (red) expression increases compared to contralateral DRG (B).  GAP-43 
(green) expression does not increase in ipsilateral (C) compared to the contralateral (D).  
Arrows point to nuclei that are pSTAT3 +.  Scale bar represents 100 µm. 
 
 Analysis of the data by two-way ANOVA followed by Kruskal Wallis test 
confirmed that pSTAT3 expression significantly increases (1.11 + 0.02, P< 0.001) in the 
nuclei of DRG neurons ipsilateral to the dorsal root transection, while no changes are 
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seen in GAP-43 expression (Figure 7-29).  The results here are similar to the pattern 
observed in peripheral nerve transection experiments.      
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Figure 7-29. Quantification of total pSTAT3 and GAP-43 immunohistochemical 
staining intensity in L5 DRG 7 d following dorsal root transection.  The mean 
immunoreactivity + SEM of normalized data to control (blue bars) values.  
Phosphorylated pSTAT3 expression increases significantly in the nuclei (***P<0.001), 
but not in the cytoplasm of injured neurons.  No significant changes are observed in 
GAP-43 (P >0.05) of DRG neurons that have undergone dorsal root transection.  Each 
bar represents the mean value of 800 or more neurons from 4 different rats. 
 
 
Scatter plot of DRG neurons from this experiment confirmed pSTAT3 
immunoreactivity increases in the nuclei of DRG neurons ipsilateral to dorsal root 
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transection with no obvious relation to neuronal size, while GAP-43 expression remains 
unchanged (Figure 7-30). 
 
 
 
Figure 7-30. Dorsal root transection induces changes in the expression of nuclear 
pSTAT3. Representative scatter plot is shown of immunoreactivity of nuclear (A) and 
cytoplasmic (B) pSTAT3, and (C) GAP-43 in L5 DRG neurons comparing contralateral 
(blue diamonds) with ipsilateral (red diamonds). 
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 Table7-1 summarizes the results that compares the effects of peripheral 
transection and that of dorsal root transection.  The expression of GAP-43, ATF3, and    
c-Jun was upregulation as a result of peripheral transection.  However, STAT3 expression  
was upregulated as a result of dorsal root transection.   
 
Table 7-1. Summary of results comparing peripheral nerve transection with dorsal root 
transection. 
Protein Peripheral transection Dorsal root transection 
GAP-43  + 
ATF3 nuclear  + 
ATF3 cytoplasmic  + 
c-Jun nuclear  + 
c-Jun cytoplasmic + + 
STAT3 nuclear +  
STAT3 cytoplasmic +  
pSTAT3 nuclear   
pSTAT3 cyoplasmic  + 
This table summarizes the results obtained from peripheral transection vs. dorsal transection.  Proteins 
examined are listed in the far left column.  Red arrows indicate an increase, whereas blue arrows indicate a 
decrease in the expression, as judged by measuring immuofluorescence intensity.   
 
 
7.3 Modification of normal DRG neuronal injury response by FGF-2 and cAMP. 
Previous in vitro work from our lab showed that cultured DRG neurons 
suppressed GAP-43 expression as a result of FGF-2 administration.  Additionally, 
cultured adult rat DRG neurons exposed to membrane-permeable analogs of cyclic AMP 
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and adenyl cyclase activators downregulated GAP-43 protein expression and mRNA in a 
dose-dependent manner (Andersen et al., 2000).  We were interested in testing whether 
FGF-2 could downregulate GAP-43 in vivo.  We asked if a continuous administration of 
FGF-2 for seven days through surgically implanted minipump at the proximal cut end of 
the injured sciatic nerve would modulate the expression of GAP-43 in DRG neurons. 
 
7.3.1 Effect of FGF-2 and cAMP on GAP-43 expression. 
In order to test if materials available at the proximal cut end of the sciatic nerve 
could be retrogradely transported, we carried out a pilot study using FluoroGold® (FG) 
filled minipumps.  FG was infused at the nerve lesion site fir 7 days.  The majority of 
injured DRG neurons showed positive  FG staining (Figure 7-31).  This would indicate 
that dbcAMP and/or FGF-2, available at a cut axon tip, might also be retrogradely 
transported to DRG neurons.  Alternatively, dbcAMP and/or FGF-2 at the cut end could 
initiate a biochemical response in situ whose products could be retrogradely transported.  
To our surprise, FGF-2 applied through our model system did not suppress GAP-43 
expression in peripherally injured DRG neurons.  In contrast FGF-2 increased the 
expression of GAP-43 in the neurons ipsilateral to the nerve transection, and also, in the 
contralateral uninjured DRG neurons.  
    
7.3.1.1 Western analysis.  
 Western blot analysis showed a specific band at the 45 KD level corresponding to 
GAP-43 (Figure 7-32).  This band is only reactive in the injured DRG neurons ipsilateral 
to transected sciatic nerve.  Faint bands are present in the contralateral lanes, confirming 
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the basal levels of GAP-43 expression.  The contralateral GAP-43 is more visible in both 
dbcAMP and FGF-2 lanes, and is almost non-detectable in the contralateral vehicle 
treated group.  Optical scanning was uses to quantify the amount of increase of GAP-43 
immunoreactivity on the ipsilateral side in each experimental condition compared to the 
normalized control values.  FGF-2 administered in vivo via minipump significantly (P < 
0.05) increases GAP-43 expression in the ipsilateral DRG neurons.   
 
Figure 7-31. Retrograde FluoroGold® (FG) labeling of injured DRG neurons.  
Accumulation of FG retrograde tracer in DRG neurons after Fluorogold was delivered to 
the cut end of sciatic nerve by osmotic minipump for seven days.  The majority of the 
neurons retrogradely transport Fluorogold from the minipumps.  Some neurons are more 
brightly stained than others (arrows).  Scale bar represents 100 µm.   
 
 
 
 
 
 
Fluorogold 
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          +  ++ 
      1.15 + 0.01 1.5 + 0.01 
 
Figure 7-32. dbcAMP and FGF-2 minipump infusion increases GAP-43 levels in 
DRG neurons.   As a result of treatment with dbcAMP and FGF-2, the injured DRG 
neurons upregulated GAP-43 expression 1.15, and 1.5 fold relative to loading control 
(GAPDH) respectively.   
 
 
7.3.1.2 Immunohistochemistry. 
Figure 7-33 A, B, and C show typical immunohistochemical photomicrographs.  
These are representatives of the images used in the quantification method, and statistical 
analysis.  The expression of GAP-43 was increased in the ipsilateral vehicle control 
ganglion.  The increase is enhanced as a result of cAMP, and FGF-2 treatment in the 
small to medium diameter neurons.  A careful examination of the photomicrographs 
showed that almost the entire subpopulation of neurons expressed elevated GAP-43 
levels in the case of vehicle treatment.  When treated with dbcAMP, the small to medium 
diameter neurons were more brightly stained with GAP-43, compared with the rest of the 
neuronal subpopulation of cells.  When FGF-2 was introduced, the small to medium 
diameter neurons were also more brightly stained.    
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Scatter plot of the quantification data clearly depicted the enhanced expression of 
GAP-43 in the small to medium neurons (20-40 µm), when treated with dbcAMP or with 
FGF-2 (Figure 34 A, B, and C).  
  
 
 
 
Figure 7-33. FGF-2 and dbcAMP minipump infusions increase GAP-43 levels in 
DRG neurons.   As a result of treatment with dbcAMP and FGF-2, the injured 
(ipsilateral, right panel) DRG neurons upregulated GAP-43 expression, especially in the 
small diameter neurons (arrows), when compared to the vehicle ipsilateral (top right), 
where the expression spans the entire neuronal subpopulation.  Scale bar represents 100 
µm. 
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Figure 7-34. FGF-2 and dbcAMP minipump infusions increase GAP-43 levels in 
DRG neurons.   Representative scatter plot is shown for the quantification of the 
micrographs in Figure 7-33.  Plots of (A) Vehicle, (B) cAMP, and (C) FGF-2 confirm the 
western and histochemical data. 
 
 
 
7.3.1.3 Cytoplasmic localization. 
Two-way ANOVA followed by Dunn’s multiple comparison tests were carried 
out on the normalized values of the immunoreactivity.  The results show significant 
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increase in GAP-43 expression as a result of FGF-2 and of cAMP (P< 0.001).  Ipsilateral 
FGF-2 (2.637 + 0.05570) and contralateral FGF-2 (1.6150 +0.032900) values are higher 
compared to vehicle values.  dbcAMP treated also show higher contralateral and 
ipsilateral values (1.1470 + 0.021260) and (2.501 + 0.06198), respectively (Figure 7-35).   
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Figure 7-35. Quantification of GAP-43 immunohistochemical staining intensity in 
L5 DRG 7 d following vehicle, FGF-2 and dbcAMP minipump surgical 
implantation.  The mean immunoreactivity + SEM of normalized data to control 
(contralateral vehicle) (blue bars) values.  FGF-2 and dbcAMP cause GAP-43 expression 
to increase significantly in DRG neurons (***P<0.001) ipsilateral (red) and contralateral 
(blue) columns.  Each bar represents the mean value of 800 or more neurons from 4 
different rats. 
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7.3.2 Effect of FGF-2 and cAMP on ATF3 expression  
7.3.2.1 Western analysis. 
 Western blot analysis showed a specific band at just below the 20 KD level 
corresponding to ATF3 (Figure 7-36).  This band is only reactive in the injured DRG 
neurons ipsilateral to transected sciatic nerve, and virtually non-existent in the 
contralateral lanes.  FGF-2 administered in vivo via minipump did not lower injury 
induced ATF3 expression in the ipsilateral DRG neurons.  
 
 
 
 
 
 
 
Figure 7-36.  dbcAMP and FGF-2 minipump infusion does not suppress ATF3 levels 
in injured DRG neurons.  Western blot analysis for ATF3 in L4 and L5 DRG neurons. 
No visible suppression of injury-induced ATF3 expression as a result of treatment with 
dbcAMP and FGF-2.  GAPDH is used as internal loading control. 
 
7.3.2.2 Immunohistochemistry. 
Figure 7-37 (A) vehicle, (B) dbcAMP, and (C) FGF-2 treated DRG show typical 
immunohistochemical photomicrographs.  These are representative images used in the 
quantification method and statistical analyses.  The expression of ATF3 is increased in 
both the nucleus and the cytoplasm in the ipsilateral micrographs. dbcAMP and FGF-2 
treatment did not alter the dramatic ATF3 induction seen in the vehicle.   
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Figure 7-37. FGF-2 and dbcAMP minipump infusions do not suppress the overall 
increase in ATF3 levels in injured DRG neurons.   As a result of treatment with (B) 
dbcAMP and (C) FGF-2, ATF3 expression in the injured (ipsilateral, right panel) DRG 
neurons is not suppressed, when compared to vehicle (A) filled minipump, quantified 
below.  Scale bar represents 100 µm. 
 
7.3.2.2.1 Nuclear localization. 
Two-way ANOVA followed by Dunn’s multiple comparison tests were carried out on the 
normalized values of the immunoreactivity.  The results show significant decrease in 
nuclear ATF3 expression as a result of FGF-2 and of cAMP treatment when compared to 
the vehicle control (P< 0.001).  Ipsilateral FGF-2 (15.05 + 0.46) is significantly lower 
compared to normalized vehicle values.  dbcAMP treated also show lower ipsilateral 
Ipsilateral ATF3 Contralateral ATF3 
Ipsilateral ATF3 Contralateral ATF3 
Ipsilateral ATF3 Contralateral ATF3 
A) Vehicle 
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values (15.73 + 0.53) (Figures 7-38  B, D, and F) lower scatter plots and (7-39 bar 
graphs). 
 
 
Figure 7-38. FGF-2 and dbcAMP minipump infusions did not repress the overall 
injury induced ATF3 levels in DRG neurons.   Scatter plot quantification of the 
immunehistochemistry of cytoplasmic (A, C, and E) and nuclear (B, D, and F) ATF3 
following treatment with vehicle (A and B), cAMP (C and D), FGF-2 (E and F). 
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Figure 7-39. FGF-2 and dbcAMP decrease nuclear ATF3 expression ipsilateral to 
the surgical manipulation.  FGF-2 and cAMP cause a significant decrease in the nuclear 
ATF3 levels (***P<0.001).  Each bar represents the mean value of 800 or more neurons 
from 4 different rats. 
 
 
7.3.2.2.2 Cytoplasmic localization. 
Ipsilateral cytoplasmic ATF3 expression as a result of FGF-2 and of cAMP 
delivery was decreased when compared to vehicle.  Ipsilateral FGF-2 (3.508000 + 
0.102400) was significantly lower, while contralateral FGF-2 (3.703 + 0.12090) was 
higher when normalized to vehicle values (P< 0.001).  dbcAMP treated neurons also 
showed lower ipsilateral values (2.600000 + 0.117300) and higher contralateral values 
(3.182 + 0.09839), respectively (Figures 7-38 A, C, and E) upper scatter plots and 7-40 
bar graphs. Contralateral effects as a result of treatments can be observed. 
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Figure 7-40. FGF-2 and cAMP decrease cytoplasmic ATF3 expression ipsilaterally 
and increase the contralateral expression. 
 FGF-2 and cAMP cause a marked reduction in ipsilateral cytoplasmic ATF3 expression 
(***P<0.001) when compared to vehicle ipsilateral.  Ipsilateral (red) and contralateral 
(blue) data.  Each bar represents the mean value of 800 or more neurons from 4 different 
rats. 
 
7.3.3 Effect of FGF-2 and dbcAMP on c-Jun expression  
7.3.3.1 Western analysis 
Western blot analysis showed a specific band at just below the 37 KD level 
corresponding to c-Jun (Figure 7-41).  Chronic cAMP and FGF-2 administration via 
minipump increased c-Jun expression in injured DRG neurons.  The basal level of 
expression did not change as a result of peripheral nerve transection in the vehicle treated 
animals.  However, dbcAMP applied in vivo to the proximal cut end of the nerve induced 
c-Jun expression compared to contralateral.  This induction is also seen with FGF-2.    
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             FGF-2       dbcAMP  Vehicle   
                                          __________  _________   __________     
           Ipsi    Cont    Ipsi    Cont   Ipsi    Cont 
 
Figure 7-41. FGF-2 and dbcAMP increases c-Jun expression ipsilateral and 
contralateral to the surgical manipulation.  FGF-2 and dbcAMP application cause a 
noticeable elevation in c-Jun expression.  GAP-43 immunolabelling is also included on 
this blot to confirm the presence of an injury response.   
 
7.3.3.2 Immunohistochemistry 
There is a constitutive c-Jun expression in the contralateral DRG neurons.  Injury 
induces an upregulation in c-Jun in the nuclei and in the cytoplasm of injured DRG 
neurons.  This injury-induced upregulation of nuclear c-Jun is further enhanced by 
dbcAMP and FGF-2 delivered to the cut end of the nerve (Figure 7-42 A, B, and C, and 
Figure 7-43 B, D, and F, lower scatter plots).    
Scatter plots clearly show an increase in nuclear c-Jun as a result of FGF-2 
application to the cut end of the sciatic nerve.   
 
 
 
GAP-43
c-Jun
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Figure 7-42. FGF-2 and dbcAMP minipump infusions do not repress injury induced 
c-Jun levels in DRG neurons. There is a constitutive level of cytoplasmic and nuclear 
expression in contralateral DRG neurons.  These images are used in the quantification 
and statistical analyses below, and statistical analysis (A) vehicle, (B) dbcAMP, and (C) 
FGF-2.  Scale bar represents 100 µm. 
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Figure 7-43. FGF-2 and dbcAMP minipump infusions did not repress injury 
induced c-Jun levels in DRG neurons.   Scatter plot quantification of the 
immunohistochemistry of cytoplasmic (A, C, and E) and nuclear (B, D, and F) c-Jun.  
Plots of vehicle (A and B), dbcAMP (C and D), FGF-2 (E and F).  FGF-2 minipump 
infusions increase nuclear c-Jun levels in DRG neurons, while cAMP decreases nuclear 
c-Jun, confirming the Western blot and histochemical dat 
 
7.3.3.2.1 Nuclear localization. 
Statistical analysis shows significant decrease in nuclear c-Jun expression in 
injured neurons as a result of cAMP application (1.20 + 0.01 vs. 1.27 + 0.01, P< 0.001).  
In contrast, FGF-2 (1.38 + 0.01, P< 0.001) caused a significant increase compare to the 
vehicle control (Figure 7-44).  Interestingly, FGF-2 applicaion also appeared to cause an 
increase in nuclear c-Jun on the uninjured contralateral side. 
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Figure 7-44. dbcAMP decreases nuclear c-Jun, while FGF-2 increases nuclear c-Jun 
expression.  dbcAMP causes a significant reduction in nuclear c-Jun expression 
(***P<0.001) (Ipsilateral (red) and contralateral (blue) data).  Each bar represents the 
mean value of 800 or more neurons from 4 different rats. 
 
7.3.3.2.2 Cytoplasmic localization. 
 Statistical analysis show significant (P< 0.001) decreases in expression of c-Jun in 
the cytoplasm of cAMP and of FGF-2 treated DRG neurons.  cAMP cytoplasmic value 
was lowered to (1.082 + 0.01312), and that of FGF-2 to (1.209 + 0.0140), Figure 7-43 
upper plots, and Figure 7-45). 
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Figure 7-45. Both dbcAMP and FGF-2 decrease cytoplasmic c-Jun. dbcAMP and 
FGF-2 cause a significant reduction in cytoplasmic c-Jun expression (***P<0.001). 
(Ipsilateral (red) and contralateral (blue) data).  Each bar represents the mean value of 
800 or more neurons from 4 different rats. 
 
7.3.4 Effect of cAMP and FGF-2 on STAT3 expression  
 
7.3.4.1 Western analysis 
Western blot analysis showed a specific band at the 90 KD level corresponding to 
STAT3 (Figure 7-46).  The blot in Figure 7-46 shows that cAMP and FGF-2 
administration in vivo via minipump suppressed injury induced STAT3 expression. 
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Figure 7-46. FGF-2 and dbcAMP suppress injury induced STAT3 expression.  FGF-
2 and dbcAMP suppress injury induced STAT3 expression. GAP-43 immunolabelling is 
also included on this blot to confirm the expression of an injury response, and GAPDH as 
internal loading control.   
 
7.3.4.2 Immunohistochemistry 
There is a constitutive STAT3 expression in the contralateral DRG neurons.  
Injury induces an upregulation in STAT3 in the nuclei and in the cytoplasm of injured 
DRG neuron.  This injury-induced upregulation of total STAT3 is reduced by cAMP and 
FGF-2 delivery to the cut end of the nerve (Figures 7-47 A, B, and C, and 7-48 B, D, and 
F).    
Scatter plot of the cytoplasmic and nuclear STAT3 shows an increase in the 
nuclear STAT3, especially in the nuclei of small neurons (Figure 8 A and B). 
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7.3.4.2.1 Nuclear localization. 
Statistical analysis  shows a significant decrease in nuclear STAT3 expression as 
a result of cAMP but not FGF-2 (0.9233 + 0.01648, P< 0.001) (Figure 7-49).   
7.3.4.2.2 Cytoplasmic localization. 
Statistical analysis show significant decrease in cytoplasmic STAT3 expression as 
a result of cAMP (0.94 + 0.01, **P< 0.01), and of FGF-2 (0.90 + 0.01, P<0.05) (Figure 
7-50).   
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Figure 7-47 A, B, and C shows typical immunohistochemical photomicrographs of 
total STAT3 expression in response to dbcAMP and FGF-2.  There is a constitutive 
level of cytoplasmic and nuclear expression in contralateral DRG neurons.  These images 
are used in the quantification method, and statistical analysis (A) vehicle, (B) dbcAMP, 
and (C) FGF-2. 
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Figure 7-48. FGF-2 minipump infusion does not change nuclear or cytoplasmic total 
STAT3 levels in DRG neurons, while cAMP decreases nuclear STAT3.   Scatter plots 
quantification of the immunohistochemistry of cytoplasmic and nuclear STAT3.  Plots of 
(A, and B) Vehicle, (C and D) dbcAMP, and (E and F) FGF-2 confirm the 
immunohistochemical data. 
 
145 
 
Nuclear STAT3
Ve
hic
le
cA
MP
FG
F2
0.0
0.5
1.0
1.5
2.0
Contralateral
Ipsilateral
***
***
***
***
TreatmentN
or
m
al
iz
ed
 N
uc
le
ar
 p
ST
AT
3 
la
be
lli
ng
 in
te
ns
ity
 
Figure 7-49. dbcAMP decrease nuclear STAT3, while FGF-2 does not change 
nuclear STAT3 expression.  dbcAMP causes a significant reduction in nuclear STAT3 
expression compared to injury response alone (***P<0.001), ipsilateral (red) and 
contralateral (blue) data.  Each bar represents the mean value of 800 or more neurons 
from 4 different rats. 
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Figure 7-50. FGF-2 and dbcAMP decrease cytoplasmic STAT3 expression.  dbcAMP 
causes a significant reduction in cytoplasmic STAT3 expression compared to injury alone 
(**P<0.001), ipsilateral (red) and contralateral (blue) data.  Each bar represents the mean 
value of 800 or more neurons from 4 different rats. 
 
 
 
7.4.5 Effect of cAMP and FGF-2 on pSTAT3 expression  
 
7.4.5.1 Western analysis 
Western blot analysis showed a specific band at the 90 KD level corresponding to 
pSTAT3 (Figure 7-54).  The level of pSTAT3 immunoreactivity on these blots did not 
show a consistant change as a result of chronic dbcAMP or FGF-2 infusion on either the 
ipsilateral or contralateral sides.  No quantification was done on this blot.  A sample is 
shown in Figure 7-51. 
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Vehicle cAMP  FGF-2 
___________   __________   ___________ 
              Contra     Ipsi    Contra     Ipsi      Contra     Ipsi 
 
Figure 7-51. FGF-2 and dbcAMP do not show substantial difference on pSTAT3 
expression ipsilateral and contralateral to the surgical manipulation.  FGF-2 and 
dbcAMP did not induce a measureable change in pSTAT3 expression. 
 
7.4.5.2 Immunohistochemistry 
There is a constitutive pSTAT3 expression in the contralateral DRG neurons.  
Injury induces an upregulation in pSTAT3 in the nuclei and in the cytoplasm of injured 
DRG neuron.  This injury-induced upregulation of pSTAT3 is further enhanced by cAMP 
and FGF-2 delivery to the cut end of the nerve (Figures 7-52 A, B, and C, and 7-53 B, D, 
and F).    
 
 
 
pSTAT3 
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Figure 7-52 A, B, and C shows typical immunohistochemical photomicrographs of 
total pSTAT3.  There is a constitutive level of cytoplasmic and nuclear expression in 
contralateral DRG neurons.  These images are used in the quantification method, and 
statistical analysis (A) vehicle, (B) dbcAMP, and (C) FGF-2.  Arrows point to nuclei that 
express pSTAT3 as a result of injury.   
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Figure 7-53. FGF-2 and dbcAMP minipump infusions increase nuclear pSTAT3 
levels in DRG neurons, while dbcAMP increases cytoplasmic pSTAT3.   Scatter plots 
quantification of the immunohistochemistry of cytoplasmic and nuclear pSTAT3.  Plots 
of (A, and B) Vehicle, (C and D) dbcAMP, and (E and F) FGF-2 confirm the 
immunohistochemical data. 
 
7.4.5.2.1 Nuclear localization. 
Statistical analysis shows a significant increase in nuclear pSTAT3 expression as 
a result of FGF-2 (4.395 + 0.18960, P< 0.001), but not dbcAMP (Figure 7-54). 
Contralateral effects are observed.  
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Figure 7-54. FGF-2 increase nuclear pSTAT3, while dbcAMP does not change 
injury induced nuclear pSTAT3.  FGF-2 causes a significant elevation in nuclear 
pSTAT3 expression (***P<0.001), ipsilateral (red) and contralateral (blue) columns. 
 
7.4.5.2.2 Cytoplasmic localization. 
Statistical results show significant increase in cytoplasmic pSTAT3 expression as 
a result of cAMP (3.189 + 0.10380, **P< 0.001), but not FGF-2 (Figure 7-55).   
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Figure 7-55. dbcAMP increase cytoplasmic pSTAT3, while FGF-2 does not change 
injury induced cytoplasmic pSTAT3.  dbcAMP causes a significant elevation in 
cytoplasmic pSTAT3 expression (***P<0.001), ipsilateral (red) and contralateral (blue) 
columns. 
 
 
 Table 7-2 summarizes the results of minipump implantation containing vehicle, 
dbcAMP, or FGF-2.  It appears that neither cAMP nor FGF-2 suppressed the injury 
induced upregulation of GAP-43.  However, injury induced upregulation of ATF3 and   
c-Jun, although not completelt suppressed, seems to be downregulated by cAMP, and or 
FGF-2.  pSTAT3, on the other hand, is upregulated by FGF-2 infusion. 
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Table 7-2. Summary of the results of minipump implantation. 
Protein 
 
Vehicle dbcAMP FGF-2 
GAP-43  
 
 
 
 
 
ATF3 nuclear  
 
  
ATF3 cytoplasmic  
 
  
c-Jun nuclear  
 
  
 
c-Jun cytoplasmic  
 
  
pSTAT3 nuclear  
 
+ 
 
 
pSTAT3 cyoplasmic  
 
 + 
 
This table summarizes the results obtained from minipump implantation containing vehicle, dbcAMp, or 
FGF-2.  Proteins examined are listed in the far left column.  Red arrows indicate an increase, whereas blue 
arrows indicate a decrease in the expression, as judged by measuring immuofluorescence intensity.   
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CHAPTER 8 
8.0 DISCUSSION 
 
8.1 Adequacy of experimental design and techniques. 
8.1.1. Peripheral nerve transection versus central transection.  
The pseudounipolar neurons of the DRG have two branches, a peripheral branch 
that is capable of mounting a robust regenerative response after nerve injury, and a 
central branch extending into the dorsal column of the spinal cord that does not 
regenerate as well.  However, a conditioning lesion introduced to the peripheral branch 
can cause the lesioned central branch to re-grow into the dorsal column.  This unique 
anatomy of the DRG neurons, the fundamentally opposing effects that injury to either 
branch can produce, and the easy accessibility to manipulate either branch make this 
model system an excellent testing grounds to study the molecular events influencing 
nerve regeneration.  In our peripheral versus central root transection model, we 
introduced the injury on one side of the animal and used the un-operated contralateral 
side as our internal control because no immunohistochemical difference in GAP-43 
expression has been reported between un-operated controls and contralateral controls 
(Schreyer and Skene, 1991; 1993).  
Peripheral sciatic nerve transection at mid-thigh is not expected to induce all L4 
and L5 DRG neurons to display the injured phenotype because some of these neurons 
may innervate proximal structures (Devor et al., 1985) or may extend axonal branches to 
nerves other than the sciatic (Devor et al., 1984; Langford and Coggeshall, 1981; 
McMahon and Wall, 1987; Pierau et al., 1982; Taylor and Pierau, 1982). 
 
 
154 
 
8.1.2. Chronic infusion technique. 
The chronic infusion technique used in this project has been modified from an 
already reported method (McDonald and Zochodne, 2003).  In that report, the authors 
stressed that two criteria must be met in order to ensure a successful in vivo delivery 
system.  Firstly, a successful delivery system must allow for long-term administration and 
secondly, the model must allow a direct, local delivery (McDonald and Zochodne, 2003). 
Delivery by repeated injection will necessarily result in uneven, pulsatile dose levels.  
Moreover, it is well established that stress caused by handling of the animal for repeated 
injections can create difficulty in interpreting the results.  
By using implantable osmotic minipumps we have developed a model that 
features smooth, continuous flow of known concentrations of the drugs of interest 
(dbcAMP, and FGF-2), directly delivered to the transected site, and over a well defined 
period of time (seven days) without the added stress of repetitive injections. The method 
fits the two criteria of successful delivery.  Further, by confining the cut nerve end and 
the pump catheter within a small plastic chamber, the method employed here assures 
direct delivery to the cut end of the sciatic nerve.  Our current project provides evidence 
that immunohistochemical analyses of the expression of early transcription factors and 
growth associated proteins known to be part of the peripheral nerve regeneration response 
are quantifiable seven days after nerve transection.  
 FluoroGold filled minipump results showed that the large majority of injured 
DRG neurons could obtain the tracer dye after delivery from the pump, and retrogradely 
transport it to their cell bodies.  About 30% of DRG neurons showed very intense 
retrograde FluoroGold labeling, while most of the remainder showed some detectable 
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labelling.  This finding is of importance since it confirms effective delivery and 
availability for transport of compounds present in the minipumps.  Although we could not 
quantify the efficiency of FluoroGold labeling in the absence of a marker for Fluorogold 
unlabelled neurons, our results appear to be in concert with those of (Liabotis and 
Schreyer, 1995), who reported over 60% retrograde labeling of DRG neurons following 
sciatic nerve transection at the mid-thigh level. 
 
8.1.3. Technical limitations 
Despite the overall success of the technique, limitations do exist. The selection 
process of the neuron size was entirely based on the DAPI counterstain.  Given that 
injured DRG neurons would exhibit an excentric nuclear position within the cytoplasm, 
our different neuronal sizes, may not reflect the actual neuronal size of the injured 
neurons.   
Moreover, our technique does not entirely preclude some systemic effects that 
may be generated as a result of leakage of FGF-2 or dbcAMP from the chamber region.  
This may explain some of the contralateral effects that we observed (see below).  Another 
limitation to our experimental design is the motility of the animals post-operatively.  
Normal or pathological behavior following surgery could move the chamber or the 
minipump from their ideal surgical positions.  Some rats chewed on their paws, possibly 
introducing additional inflammatory signals from the periphery.  
Our Western blot analyses proved to be a unique challenge, since we attempted to 
probe for changes in low-abundance transcription factors in the DRG neurons.  The DRG 
are small in size, and include neuronal cell bodies, axons, myelin and glial cells.  In order 
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to obtain the adequate amounts of proteins for Western analysis, we needed to perform 
the experimental surgical procedures and implants on a large number of animals.  This 
provided some technical limitations.  For future studies using our current technique, 
Western analysis could be improved, if a greater number of animals are utilized in each 
group.    
 
8.2 New findings. 
8.2.1. Peripheral vs. Central root transection.   
 Our peripheral nerve transection results confirm previously reported in vivo work 
regarding the induction of GAP-43 and of specific injury-induced transcription factors.   
 
8.2.1.1. GAP-43 expression 
 The expression of GAP-43, a membrane phosphoprotein, dramatically increases 
as a result of peripheral nerve transection in DRG neurons (Schreyer and Skene, 1991; 
1993; Woolf et al., 1990) .  Elevation of GAP-43 mRNA has previously been detected 24 
hours following peripheral nerve transection (Chong et al., 1994).  GAP-43 protein 
expression is induced at least five-fold as early as two days after sciatic verve transection, 
and this increase persists for up to 80 days following injury (Sommervaille et al., 1991).  
Our results of GAP-43 upregulation in response to injury ranged between 1.5 to 3 fold.  
This induction of GAP-43 is in agreement with the reported literature describing GAP-43 
as a protein of the peripheral injury response (Liabotis and Schreyer, 1995; Schreyer and 
Skene, 1993).  
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 GAP-43 upregulation did not occur in our dorsal transection experiments, in 
agreement with the previously reported literature (Chong et al., 1994; Piehl et al., 1993; 
Schreyer and Skene, 1993).  Because the strong effect following peripheral nerve 
transection was not seen following central root transection, injury associated upregulation 
of GAP-43 has been proposed to be controlled by a mechanism unique to the peripheral 
branches.  These and other observations support the hypothesis that GAP-43 induction in 
DRG neurons is caused by loss of controlling element(s), normally originating only from 
peripheral target tissue (Schreyer and Skene, 1993).  
 
8.2.1.2. ATF3 expression. 
We show in this study that ATF3 is also induced in DRG neurons after peripheral, 
but not central axonal injury.  ATF3 is thought to contribute to nerve regeneration by 
increasing the intrinsic growth state of injured neurons.  Our finding that ATF3 is 
expressed seven days after peripheral nerve transection is in agreement with previously 
published reports (Seijffers et al., 2006; Seijffers et al., 2007).  Our results show that 
ATF3 expression remained high even fourteen days after peripheral injury, indicating a 
persistent role in the regenerative response that is closely correlated with GAP-43 
expression. Our results showing a lack of ATF3 expression as a result of dorsal root 
transection are in agreement with reported data (Seijffers, 2006).  Another study, 
however, showed upregulation of ATF3 in L5 DRG neurons (Huang, 2006) after dorsal 
root transection.  This study differs from our experiment in that the authors examined 
ATF3 expression only 1 day after dorsal transection, and spinal cord hemisection.  
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Generally, any upregulation of ATF3 expression  as a result of dorsal transection appear, 
therefore, to be short lived.   
ATF3 is a transcription factor that is synthesized in the cytoplasm via the normal 
cellular process of protein synthesis.  Upon activation it is translocated to the nucleus 
where it can produce its biological effects (Isacsson et al., 2005).  Our results showed an 
increase in ATF3 expression in both the cytoplasm and the nucleus of the peripherally 
transected nerve.  The increase in the cytoplasm is indicative of an increase in the 
synthesis of ATF3.  Once synthesized, it is then translocated to the nucleus where we 
observed it to be abundantly expressed. 
8.2.1.2.1 GAP-43 and ATF3 expression 7 d vs 14 d comparison. 
 When comparing the results of 7 d vs. 14 d peripheral sciatic nerve transection, a 
continuing increase in the injury response can be readily observed.  Nuclear ATF3 
expression increased 4 fold in 14 d injured DRG neurons vs. 3 fold increase in the 7 d 
injured DRG neurons.  Cytoplasmic ATF3 expression increased 1.5 fold in the 14 d 
injured DRG neurons vs. the 7 d injured DRG neurons.  GPA-43 expression increased  2 
fold in the 14 d injured DRG neurons vs. 1.4 fold increase in the 7 d injured DRG 
neurons.  The increase in our GAP-43 results could be attributed to the increased 
expression of the small, medium and large diameter subpopulation of injured neurons, in 
agreement with previously published work (Schreyer and Skene, 1993; Sommervaille et 
al., 1991). 
The increase in our ATF3 expression is also in agreement with previously 
reported data demonstrating that sciatic nerve transection induced an upregulation of 
ATF3 immunoreactivity in 82% of L4 DRG cells 14 days post transection (Averill et al., 
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2004).  These authors attributed the ATF3 increase to a loss of target derived 
neurotrophic factors such as NGF and GDNF (Averill et al., 2004).   
More of the 14 d injured small to medium diameter neurons expressed ATF3 than 
in the 7 d injury model.  This implies that, as part of the regenerative process, injured 
DRG neurons might differentially in a coordinated fashion express ATF3 depending on 
the size of the injured neurons.    
While there is a clear and robust increase in the expression of GAP-43 and ATF3 
as a result of peripheral nerve transection, the expression of both GAP-43 and ATF3 
remained unchanged as a result of dorsal root transection.  This implies that signals that 
control the expression of ATF3 and GAP-43 do not originate from the central branch of 
the DRG; rather, the un-interrupted, continuous flow of factors from the peripheral 
branch maintains the suppressed state of both GAP-43 and ATF3.  
8.2.1.3. c-Jun expression. 
We find that c-Jun expression is markedly upregulated, and localized primarily in 
neuronal nuclei, seven days following peripheral nerve transection, in agreement with 
previous studies (Jenkins and Hunt, 1991; Jenkins et al., 1993; Leah et al., 1993).  Our 
present results also indicate that c-Jun expression is very similar to GAP-43 expression, 
although a small number of injured neurons upregulated nuclear c-Jun expression without 
simultaneously upregulating GAP-43.  The observed failure of upregulation of c-Jun 
expression in DRG neurons following dorsal root transection is also similar to the pattern 
of GAP-43 expression.  Peripheral axotomy may cause, in addition to loss of peripheral 
target-drived factors, metabolic and morphological changes in the cell body leading to an 
increase in transcription factors including c-Jun.  This ‘loss’ of peripheral target factors, 
160 
 
however, appearently does not occur as a result of dorsal root transection, and this has 
been related to the reduced regenerative capacity of the central axon.  Trophic and other 
target derived elements that are available through the peripheral branch of DRG could 
ameliorate the upregulation of c-Jun in DRG neurons subjected to dorsal root transection. 
The contention of the influence of target-derived factors on the expression of 
regeneration associated or growth associated proteins  within the injured DRG neurons is 
supported further by the conditioning lesion effect on regrowth of central axons in a 
favorable environment (Richardson and Issa, 1984; Richardson and Verge, 1986; 1987). 
The failure to upregulate c-Jun expression following dorsal transection contrasts 
somewhat with a previous report that a small percentage (18 %) of DRG neurons 
upregulate c-Jun expression following dorsal root transection (Broude et al., 1997).  We 
feel that our robust c-Jun immunohistochemical technique was adequate to detect low 
level changes.  It is possible that the surgical approach used in the previous study resulted 
in more inadvertent damage of peripheral axons at the surgical site than ours did. 
It is not completely understood whether c-Jun regulates the expression of GAP-43 
either directly or indirectly.  However, the increased expression of GAP-43 following 
peripheral nerve transection could be one of the events initiated by c-Jun activation.  It 
would be of interest to determine if there is a direct pathway(s) linking the transcription 
factor c-Jun to transcriptional regulation of GAP-43 (see below). 
 
8.2.1.4. Coordinated expression of c-Jun and ATF3  
ATF3 and c-Jun belong to the same ATF/CREB family of transcription factors 
and can form a heterodimer (Hai and Curran 1991; Hsu, Laz et al. 1991; Chu, Tan et al. 
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1994).  Furthermore, c-Jun increases in sensory neurons after peripheral nerve transection 
(Leah, Herdegen et al. 1991; Broude, McAtee et al. 1997) similar to ATF3 expression in 
the present study.  It is thus tempting to speculate that such heterodimers are a key 
modulator of gene expression of key growth associated proteins during the regenerative 
process.  ATF3/c-Jun heterodimers are known to bind to different sites activating the 
expression of a number of genes.  In contrast, ATF3 homodimers tend to act as repressors 
of gene expression (Hai and Hartman, 2001).  However, we found that uninjured DRG 
neurons weakly express c-Jun protein, in contrast to the lack of constitutive expression of 
ATF3. Thus, in intact DRG neurons, c-Jun but not ATF3 may play a role in the 
maintenance of normal phenotype in some neurons. 
 Our results indicate that cytoplasmic c-Jun expression in peripherally axotomized 
neurons does not change, whereas, cytoplasmic ATF3 expression is upregulated.  This 
supports the idea that the rate of ATF3 protein synthesis could be increased as a result of 
injury, while the rate of c-Jun protein synthesis may not be affected. The dramatic 
increase in the nuclear expression of both ATF3 and c-Jun supports the notion that the 
rate of phosphorylation and translocation to the nucleus of both proteins is enhanced 
following injury.  Given that no increase in protein synthesis of ATF3 is detected, and 
that basal level of c-Jun expression exists prior to injury, buttresses the argument that c-
Jun and ATF3 may not have a common mechanism of transcriptional regulation.  
Alternatively, once the injury occurs, ATF3 synthesis and activation, in concert with 
other transcription factors, may control subsequent c-Jun activation.   
It is reasonable to consider ATF-3 to be a key regulator of intrinsic growth in 
DRG neurons because it is induced in all sensory neurons after peripheral nerve injury 
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(Benn, Perrelet et al. 2002).  However, ATF-3 overexpression does not increase c-Jun 
expression (Seijffers, Allchorne et al. 2006).  ATF-3 may act in some neurons in concert 
with c-Jun to regulate the expression of target genes and thereby promote regeneration. 
The growth-promoting action of ATF-3 may not be dependent upon c-Jun, but may be 
dependent on other transcription factors across the entire population of DRG neurons.  
ATF-3 may be just one of a multitude of factors that contribute to neurite outgrowth, 
perhaps by orchestrating the gene expression responses in injured neurons.  ATF3 
regulates the expression of Hsp27 (Lindwall and Kanje, 2005; Nakagomi et al., 2003), 
one of the injury-induced markers that responds to peripheral, but not central nerve 
transection (Costigan, 1998, Lewis 1999) (Costigan et al., 1998; Lewis et al., 1999).  Our 
finding that ATF3 is correlated with GAP-43 supports the idea that this transcription 
factor drives expression of at least some aspects of the intrinsic growth capacity of 
peripherally injured DRG neurons.  
  
8.2.1.5. Coordinated expression of c-Jun and GAP-43. 
 Our results showed that while c-Jun expression was, for the most part, colocalized 
with GAP-43 in injured DRG neurons, a small percentage of injured neurons expressed 
only c-Jun, but not GAP-43 (Figure 7-10, white arrows).  A correlation between c-Jun 
and GAP-43 expression in the DRG neurons of injured sciatic nerve has been previously 
reported (Bisby et al., 1995; Broude et al., 1997; Seo et al., 2009).  However, in injured , 
regenerating retinal ganglion cells c-Jun expressing neurons were twice as numerous as 
GAP-43 expressing neurons (Schaden et al., 1994).   Our results are in agreement with 
the latter study, since we observed a difference between injured neurons that expressed c-
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Jun and those that expressed GAP-43.  In the present study we showed that while all 
GAP-43 positive injured neurons were also c-Jun positive, not all c-Jun positive injured 
neurons were GAP-43 positive.  This implies that the molecular regulatory mechanism or 
pathway that regulates both c-Jun and GAP-43 may not be active in all injured neuronal 
subpopulations.  Alternatively, since we did not study the size relationship between the 
injured neurons that express either or both c-Jun and GAP-43, it would be tempting to 
suggest a differential regulatory mechanism that would be size-dependent.  It would be of 
interest to investigate the existence of such a regulatory mechanism in our injury model. 
       
8.2.1.6. STAT3 expression.          
Our findings with pSTAT3 activation as a result of peripheral nerve transection 
are in agreement with previously reported data (Haas et al., 1999; Qiu et al., 2005; 
Schwaiger et al., 2000). The earliest detection time of pSTAT3 was reported to be 6 
hours post lesion (Lee et al., 2004).  The increase in pSTAT3 expression in DRG neurons 
in correlation with the elevated expression of GAP-43 suggests that this transcription 
factor may contribute to the survival and axonal regeneration of injured sensory neurons.   
STAT3 is expressed early following peripheral axon injury, and is activated 
persistently until the time that peripheral re-innervation takes place (Schwaiger et al., 
2000).  This pattern is very similar to GAP-43 expression where it diminishes once the 
normal peripheral target tissues are re-innervated (Schreyer and Skene, 1991).   STAT3 is 
phosphorylated at Tyr705 residue by JAK kinase in response to cytokine or growth factor 
activation of a cell surface receptor. STAT3 is also phosphorylated by PKC at a different 
amino acid residue, Ser727, similar to serine phosphorylation of GAP-43 (Tsai et al., 
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2007).  Following phosphorylation by receptor tyrosine kinases, pSTAT3 then forms 
homo- or heterodimers that translocate to the cell nucleus where they act as transcription 
activators.  Given the similarity of the pattern of expression and the fact that GAP-43 
regulation is associated with the presence of AP-1 site, there is a possibility that pSTAT3 
homodimers may alone activate the AP-1 site as a result of phosphorylation of PKC or 
JAK pathways.  Alternatively, pSTAT3 can heterodimerize with other transcription 
factors to potentially influence GAP-43 gene regulation through its AP-1 site.  
Cytokines such as IL-6, CNTF and LIF, which are released from Schwann cells 
and are retrogradely transported to the neuronal cell body after peripheral nerve injury, 
have been suggested to control STAT3 phosphorylation (Curtis et al., 1993; Curtis et al., 
1994).  Furthermore, a cooperative transcriptional activity of c-Jun and STAT3 has been 
documented (Schaefer et al., 1995; Zhang et al., 1999). It is possible that STAT3 could 
modulate the pattern of transcriptional activity of c-Jun, or ATF3 (Schwaiger et al., 
2000).   
In contrast to the situation seen following peripheral nerve injury, our studies 
show for the first time that total pSTAT3 expression is also increased following central 
root transection of DRG neurons, a pattern that is markedly different from the pattern 
observed for GAP-43, ATF3 and c-Jun.  This implies that pSTAT3 expression is not 
governed by the same mechanisms that control expression of these three other proteins.  
It further casts doubt on whether activation of STAT3 is directly involved in regulating 
transcription of GAP-43 at all.   
The discrepancy between the response of STAT3 following central axotomy and 
the failure of other transcription factors to respond following central root transection 
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suggests a fundamental difference in the mechanisms governing these responses.  The 
previously described sensitivity of STAT3 to Schwann cell-derived inflammatory 
cytokines supports the idea that positive inflammatory signals may induce STAT3 
transcription and activation when the dorsal root is injured, as well as when the peripheral 
nerve is injured. 
8.2.1.7. Multiple elements of an injury response  
The activation of the intrinsic growth capacity of the DRG neurons may involve a 
number of transcription factors.  Our study focused on ATF3, c-Jun, and STAT3.  
Whether one of these transcription factors acts as an upstream regulator of the others 
cannot be resolved using the techniques reported here.  A recent report (Kiryu-Seo et al., 
2008) indicates that the ATF3, c-Jun, and STAT3 transcription factors must first interact 
with yet another transcription factor, specificity transcription protein-1 (Sp1).  This report 
suggests that Sp1 recruits ATF3, c-Jun, and STAT3 to obtain the requisite synergistic 
effect. Further, this report also identifies ATF3 as one of the most critical and one of the 
earliest transcription factors activated after nerve injury (Kiryu-Seo et al., 2008).  
MAPKs induce the expression of AP-1 family transcription factors such as Fos 
and Jun and activate the transcriptional activity of AP-1 site containing genes by 
phosphorylation of transcription factor activation domains. Homodimers of Jun and 
heterodimers of Jun/Fos and ATF/CREB bZIP transcription factors all recognize the AP-
1 site (Hai and Curran, 1991).  The ATF3 transcription factor heterodimerizes with 
transcription factors that contain leucine zipper domains.  These include c-Jun, c-fos and 
CREB, all upregulated in DRG neurons by nerve injury. ATF3 may also interact with 
other transcription factors that lack a leucine zipper region, and that are upregulated after 
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peripheral injury, such as STAT3. This could be via co-activators or by synergizing with 
transcription factors that bind to adjacent DNA binding sites (Seijffers et al., 2007).  It is 
well documented that ATF3 is required, but may not be sufficient for the conditioning 
lesion regrowth of the central branch of the injured DRG neurons (Seijffers et al., 2007).  
There are STAT-binding sites in the promoters of many immediate early genes (c-
Jun, ATF3, and c-fos) that may potentially bind to the AP-1 site in the GAP-43 gene. In 
another mechanistic possibility, STAT3 and c-Jun can form a ternary complex that 
specifically recognizes the AP-1 site (Yoo et al., 2001).  Activation of the AP-1 appears 
to be one of the key regulators of GAP-43 expression.  Thus, the activation of STAT3 
and/or c-Jun may be required for GAP-43 elevation as a result of peripheral nerve 
transection, and as part of the DRG neuronal injury response mechanism.  
 
8.2.2. Minipump infusion of FGF-2 or dbcAMP. 
Previous work in our laboratory demonstrated that bath-applied FGF-2 or 
dbcAMP could suppress the upregulation of GAP-43 expression that occurs when adult 
DRG neurons are excised and maintained in tissue culture (Schreyer, 2004). A key 
finding of the present study is that chronic infusion of FGF-2 or dbcAMP at the site of 
peripheral axon transection in vivo did not suppress injury induced upregulation of GAP-
43 in DRG neurons.  In fact, FGF-2 and dbcAMP each modestly enhanced injury-
induced GAP-43 expression, in sharp contrast with our in vitro findings.  The present 
observations thus argue against a role for extracellular FGF-2 or intracellular cAMP in 
mediating a chronic repressive signal derived from peripheral targets, and whose absence 
results in GAP-43 upregulation. 
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Previous studies found that microinjection of dbcAMP in lumbar DRG neurons 
enhances the regeneration of injured central sensory axon branches. The injured axons 
regrow into the spinal cord lesion, often traversing the injury site, mimicking the effect of 
a conditioning peripheral nerve lesion (Neumann et al., 2002).  Sensory neurons exposed 
to cAMP analogs in vivo, and subsequently cultured in vitro, show enhanced growth of 
neurites and an ability to overcome inhibition by CNS myelin (Han et al., 2004; Qiu et 
al., 2002a; Qiu et al., 2002b). Thus, activation of cAMP signaling increases the intrinsic 
growth capacity of injured sensory axons of peripheral nerves.  However, it fails to 
increase the rate of peripheral axon regeneration (Han et al., 2004).  Intra-ganglionic 
injection of dbcAMP also induces IL6 and LIF mRNAs and increases the accumulation 
of pSTAT3 in neuronal nuclei. This dbcAMP activation of cytokines and pSTAT3 can be 
partially blocked by a pharmacological inhibitor of JAK 2 kinase (Wu et al., 2007). This 
indicates that increased cyclic AMP activity on axonal regeneration of primary sensory 
neurons is mediated by cytokine synthesis within the DRG (Wu et al., 2007), a potential 
positive signal associated with inflammation. 
Cultures of the PC12 cell line which are deficient in GAP-43 can undergo 
dbcAMP-mediated neurite outgrowth (Baetge and Hammang, 1991).  Conversely, PC12 
cells that are deficient in dbcAMP-dependent protein kinase can undergo differentiation 
(Ginty et al., 1991; Scheibe et al., 1991).  Therefore, it seems that dbcAMP can increase 
the intrinsic growth capacity of regenerating peripheral nerves, in the presence and 
activation of GAP-43, or in the absence of GAP-43.  Phosphorylation of GAP-43 itself is 
not affected by dbcAMP (Van Hooff et al., 1988). 
168 
 
One of the striking findings of our present work is the inductive effect that 
dbcAMP and FGF-2 had on the expression of GAP-43, especially causing the injured 
small to medium diameter neurons to elevate the expression of GAP-43 (Figure 7-34).   
Direct intraganglionic injection of dbcAMP increases tubulin expression in the 
DRG (Han et al., 2004). Because Tα1 tubulin and GAP-43 expression have been reported 
to be coregulated in response to neurotrophins (Kobayashi et al., 1997) and brief 
electrical stimulation in the regenerating femoral nerve (Al-Majed et al., 2004), and 
because another tubulin isoform beta3-tubulin (βIII tubulin) gene is induced through an 
AP-1 site (Saussede-Aim et al., 2009), a site that is also shared with GAP-43 promoter, 
our results of increased GAP-43 expression as a result of dbcAMP are not surprising.   
Evidence exists demonstrating the inductive effect of FGF-2 on the expression of 
GAP-43 in CNS and PNS neurons.  FGF-2 increases the level of GAP-43 mRNA in O2A 
progenitor cells in vitro (Deloulme et al., 1993).  FGF-2 also promotes GAP-43 
translocation from the cytosol to the membrane and, at the same time, stimulates GAP-43 
phosphorylation (Tejero-Diez et al., 2000).  In addition, FGF-2 elevates the synthesis of 
GAP-43 in injured retinal ganglion cells, suggesting a pivotal role in injury response and 
subsequent axonal growth (Soto et al., 2003).  Finally, Schwann cells overexpressing 
FGF-2 transplanted in peripherally injured sciatic nerve increased GAP-43 mRNA levels 
in DRG neurons (Haastert et al., 2008).  These results taken together are in support of our 
findings regarding the inductive effect of FGF-2 on the expression of GAP-43.       
Another important finding in our current work is that FGF-2 did not suppress 
GAP-43 levels in injured neurons.  This is also in contrast to in vitro results showing a 
suppressive activity of FGF-2 on GAP-43 expression (Schreyer, 2004).  Our in vivo 
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results agree with published work that shows FGF-2 effectively induces levels of GAP-43 
expression through activation of the AP-1 site (Yang et al., 2008).  Therefore FGF-2, like 
cAMP, appears to produce opposing effects on DRG neurons depending on whether they 
are applied to cut axon ends in vivo or by bath application in vitro. 
We find that cytoplasmic ATF3 levels are reduced as a result of one week of 
continuous dbcAMP infusion.  This may be explained by the fact that ATF3 biosynthesis, 
but not phosphorylation and nuclear translocation, may be  impaired possibly via 
activation of calcineurin, a cyclosporin-sensitive, calcium-regulated, calmodulin 
dependent serine/threonine phosphatase (Rusnak and Mertz, 2000).  Calcineurin has been 
shown to be an inhibitor of ATF3 synthesis (Mayer, Dexheimer et al. 2008). Calcineurin 
is also involved in nuclear import of transcription factors (Polizotto and Cyert 2001), and 
regulates the K(ATP) channel by inhibiting PKA-dependent phosphorylation of the 
channel as well as PKA itself (Orie et al., 2009).  Such a regulatory mechanism may 
explain the reduction of the cytosolic ATF3 caused by dbcAMP.  Alternatively, ATF3 
may heterodimerize with other bZIP and non bZIP family transcription factors.  When 
such protein-protein interaction occurs, it may alter the protein tertiary structure to a form 
that our antibody does not recognize. 
Direct interaction between ATF3 and other transcription factors to regulate gene 
expression is well documented.  ATF3 may be activated independently of cyclic AMP.  
Cyclic AMP-independent ATF family members have been reported to interact with 
NFκB and function in the activation of the E-selectin promoter in response to cytokines 
(Kaszubska et al., 1993).  Specifically, the promoter element that ATF3 binds differs by a 
single nucleotide substitution from the dbcAMP-responsive element consensus sequence, 
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and operates in a dbcAMP-independent manner to induce transcription (Kaszubska et al., 
1993).   
Sequence analysis of the ATF3 gene 5'-flanking region revealed a consensus 
TATA box and a number of transcription factor binding sites including the AP-1, 
ATF/CRE, NFκB, E2F, and Myc/Max binding sites.  In addition, c-Jun was shown to 
activate the ATF3 promoter, possibly through the JNK/SAPK pathway (Liang et al., 
1996). 
The amount of transection-induced GAP-43 expression in DRG neurons is 
independent of the distance of the injury from the neuronal cell bodies (Liabotis and 
Schreyer, 1995).  ATF3 induction, on the other hand is dependent on the distance 
between the injury site and the cell body (Tsujino et al., 2000) in DRG neurons.  This 
supports the notion that the molecular pathways regulating GAP-43 could be different 
and may be independent of the pathways controlling ATF3 expression, despite the fact 
that both have the AP-1 site common in their regulatory mechanism.  In addition, this 
may explain the reason why cAMP induced GAP-43, and, simultaneously, suppressed 
ATF3 in vivo in our minipump model.  Therefore, based on our current findings in vivo, 
cAMP and FGF-2 act to increase the expression of GAP-43, but suppress that of ATF3.   
Our experiments show for the first time that dbcAMP delivered at a peripheral 
nerve transection site suppressed all injury induced transcription factors studied, with the 
exception of pSTAT3.  Increased accumulation of pSTAT3 in the neuronal nuclei as a 
result of peripheral nerve transection is in agreement with the literature (Lee et al., 2004; 
Wu et al., 2007).  DbcAMP induced pSTAT3 expression in DRG neurons was blocked 
by a JAK2 inhibitor (Wu et al., 2007). We found that dbcAMP increased the level of 
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cytoplasmic pSTAT3 expression, indicating that the rate of phosphorylation of this 
transcription factor is increased.  We also found that dbcAMP applied to the proximal cut 
end of the nerve did not suppress pSTAT3 accumulation in the nucleus. 
 
8.3. Epac Signaling mechanisms. 
Recent results indicate the existence of a signaling pathway from cAMP to PKC 
that is independent of PKA (Parada et al., 2005), but involves the cAMP-activated 
guanine exchange factor Epac (Hucho et al., 2005).  Epac appears to mediate cyclic 
AMP-dependent axon growth, guidance and regeneration and enhancement of DRG 
neurite outgrowth in vitro (Murray and Shewan, 2008). For example, siRNA mediated 
knockdown of Epac reduces DRG neurite outgrowth (Murray and Shewan, 2008).  Thus, 
in addition to mediating cAMP-dependent axon growth and guidance, Epac may offer an 
important target for inducing axon regeneration in vivo (Murray and Shewan, 2008).  
Thus it is possible that cAMP can influence neuronal phenotype either through the Epac 
system, or through the MAPK pathway, or both.  
8.4. Differences between in vitro versus in vivo conditions. 
Our finding that FGF-2 or dbcAMP applied at the injury site can each enhance the 
upregulation of GAP-43 that follows peripheral nerve transection in vivo stands in 
contrast to previous observations that FGF-2 and dbcAMP can each, or in combination, 
suppress the upregulation of GAP-43 expression that occurs in adult DRG neurons in 
vitro (Schreyer, 2004) . Standard culture conditions create an artificial and possibly 
impoverished extracellular environment which causes specific subpopulations of adult 
DRG neurons to de novo synthesize and store transmitters that are not normally 
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encountered in vivo (Schoenen et al., 1989).  Thus, culture conditions alone may explain 
why DRG neurons react differently to FGF-2 or dbcAMP.  It is also likely that there is a 
difference in the electrical activity of DRG neurons maintained (injured) in vivo or in 
vitro. Finally, although the DRG neurons in our minipump studies were axotomized and 
deprived of retrograde signals from their peripheral targets, cultured neurons are deprived 
of signals from both their peripheral and central (spinal cord and medulla) target fields. 
DRG neurons adopt a unique morphology in culture, extending dendrites and or 
other cellular processes that are absent in in vivo conditions.  When dissociated DRG 
neurons are maintained in tissue culture conditions the entire neuron is exposed to 
materials (dbcAMP, and FGF-2) that are delivered into the culture medium.  In our in 
vivo model, FGF-2 and or dbcAMP were specifically delivered to the cut end of the 
sciatic nerve.  This may explain the discrepancy between the effects of these reagents on 
GAP-43 expression.  In normal in vivo conditions, potential members of FGF-2 receptor 
family such as FGFR1, 2 and other members may be localized to the nerve endings where 
target tissues are innervated.  We introduced our injury at the mid-thigh level, breaking 
the cellular continuity with any FGF-2 receptors that are present at the nerve endings.  
Similarly, receptors for ligands that cause an increase in intracellular cAMP levels could 
also be absent at the cut axon stump.  This could also potentially explain the difference 
between FGF-2 and cAMP effects we observed in vivo and the previous observations in 
vitro.    
A an additional possible explanation of the discrepancy observed between in vivo 
and in vitro results may be related to the presence of Sprouty2 as a modulator of FGF-2 
influence.  As a result of in vivo implantation Sprouty2 expression may have increased to 
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a level that negatively affects FGF-2 signaling through the MEK/ERK pathway. 
Moreover, it has been reported that local application of FGF-2 increases the rate of 
infection at the local site of delivery (Kalicke et al., 2007).  It is thereofre possible that, as 
a result of the presence of FGF-2 at the cut site of the nerve, increased rates of infection 
may have ensued.  This could have casued increased secretion of cytokines or other 
factors that may have influenced the otherwise normal pathways of FFG-2 or cAMP. 
 
8.5 Contralateral effects. 
Published data on the occurrence of contralateral effects following unilateral peripheral 
nerve injury are numerous and it is suggested that these differences can be accounted for 
by the methodology and type of detection method used (Booth and Brown, 1993; Dubovy 
et al., 2006; Dubovy et al., 2007).  The presence of contralateral effects as a result of 
ipsilateral manipulations implies the existence of unrecognized signaling mechanisms 
that link the two sides of the body.  In particular, there may be a central mechanism 
signaling via the system of interneurons within the spinal cord (Koltzenburg et al., 1999).  
The general circulation may be a second, nonspecific way for delivery of factors from 
injured nerve to the contralateral DRG which are not directly associated with the injured 
nerve.  In our minipump experiments, we observed some contralateral effects.  We 
suggest that these effects may have originated as a result of some molecules escaping the 
chamber unit into the systemic circulation.    
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8.6 Interactions between FGF-2 and cAMP in inducing changes in GAP-43 
expression 
Activated receptors that influence cAMP production are bound to the 
heterotrimeric G proteins and receptor occupation can activate the G protein α-subunit. 
The α-subunit, in turn, hydrolyses GTP to GDP, resulting in the disscociation of the α-
subunit. This α-subunit activates adenylyl cyclase, which in turn generates cAMP from 
ATP.  The intracellular increase in cAMP leads to the activaition of protein kinase A 
(PKA). PKA phosphorylates, among other proteins, the transcription factor CREB, which 
binds to genes containing a cAMP-response element (CRE). These response elements 
may include elements that control the expression of immediate early genes, ATF3 being 
one example.  CREB phosphorylation can also induce or suppress the expression of other 
delayed response genes.  PKA has been implicated in the activation of c-Jun transcription 
factor and other transcription factors may also be activated by PKA.   
In addition, cAMP acting through the guanine exchange factor Epac can be an 
access point for cross-talk to other pathways.  For example, the ras/MAPK pathway can 
be activated by Epac.  This MAPK pathway is also subject to extracellular activation by 
mitogens or growth factors such as FGF-2. Thus, the divergent complexity of cAMP 
pathways renders cAMP potentially one of the most pivotal biochemical pathways in the 
process of peripheral nerve regeneration.  
FGF-2 can bind to several different FGF receptors (FGFR1-4).  This leads to 
activation of MAPK which, in turn, can induce or suppress the expression of transcription 
factors that may regulate the injury response.  Activation of specific cell signaling 
pathways is dependent upon the interaction of specific FGF ligands and FGF receptors 
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and cell type.  In addition, some FGF/FGF receptor complexes are translocated to the 
nucleus where they signal gene expression. Recent work suggests that some FGF 
isoforms may function as nuclear signaling factors without ever being secreted (Gringel 
et al., 2004). 
The possibilities of cross talk between cAMP and FGF-2 pathways are numerous.  
In endothelial cells, FGF-2 induced raf/MAPK is inhibited by increasing intracellular 
cAMP levels, possibly mediated by PKA. Moreover, elevations in cAMP/PKA activity 
inhibit mitogen-induced cell proliferation. These findings demonstrate that the 
cAMP/PKA signaling pathway is potentially an important physiological inhibitor of 
mitogen activation of the MAPK cascade and cell proliferation (D'Angelo et al., 1997).  
 
8.7 Positive and negative signaling that modulates changes in GAP-43 expression 
A framework of the steps leading to a successful regeneration based on the 
conveyance of a positive signal from the injury site has been proposed by Ambron and 
Walters (Ambron and Walters, 1996), in their studies of the marine mollusk Aplysia 
californica.  Successful nerve regeneration depends on transcriptional activation as a 
result of signals from the site of injury reaching the nucleus. The first stage is proposed to 
be initiated by action potentials induced by injury. These action potentials reach the cell 
body and act via calcium and cAMP to switch on early genes.  The second stage is 
initiated at the site of injury, where MAP-kinases are locally activated, then retrogradely 
transported through the axons back to the nucleus, triggering yet additional changes.  The 
third stage is modulated by signals that originate from growth factors and cytokines 
released extraneuronally by cells at the site of injury.  Finally, as regenerating axons 
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make contact with the peripheral target, signals from target derived growth factors and 
signaling cues arrive at the cell body to stop the regenerative process (Ambron and 
Walters, 1996).   
Our observation of an increase of total STAT3 and pSTAT3 expression following 
central root transection of DRG neurons indicate that the elements that control STAT 3 
synthesis and phosphorylation do not originate from the peripheral target tissue. As a 
result of central root transection, cytokines such as IL-6, CNTF and LIF, which are 
released from cells a the site of injury, can be retrogradely transported to the neuronal cell 
body and act as positive signals to upregulate the expression and activation of STAT3. 
After peripheral nerve transection many adaptive changes are influenced by 
altered availability of neurotrophic factors to the injured neurons.  Administration of 
exogenous NGF, for example, counteracts many degenerative changes observed in the 
axotomized DRG neurons which are nerve growth factor-responsive (Verge et al., 1996).   
Changes of retrogradely transported neurotrophins other than NGF also cause 
upregulation of vasoactive intestinal peptide (VIP), neuropeptide Y (NPY) and galanin in 
well defined neuronal subpopulations (Hokfelt et al., 1994; Kashiba et al., 1992).  
In our model, ATF3 and c-Jun may represent examples of negative regulation by 
target derived factor(s).  Uninjured neurons do not express ATF3 and very little c-Jun.  
Once the peripheral target has been disconnected, by peripheral nerve transection, ATF3 
and c-Jun are robustly upregulated in the majority of injured neurons.  However, central 
root transection does not affect ATF3 and c-Jun expression presumably because access to 
retrograde signals derived from the periphery is left intact.   
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8.8 Possible mechanism of GAP-43 upregulation 
The influence of cAMP on transcriptional regulation is mediated by cAMP 
response elements (CRE) transcription factors.  PKA mediated phosphorylation of CRE 
binding protein (CREB) at serine 133 is required for transcriptional activation (Gonzalez 
and Montminy, 1989; Gonzalez et al., 1989).   
The intricate signal transduction pathways of PKA and PKC represent integrated 
signaling avenues that provide multiple levels of regulation and remarkable sensitivity in 
responding to neuronal injury.  Cross-talk between these pathways may be the norm 
rather than the exception, providing the neuron with greater sensitivity in discerning the 
multiple extracellular signals that are active during the course of the regenerative 
response.  This level of complexity of interactions renders neurons more responsive to 
endogenous and perhaps exogenous modulators of the neuronal regenerative reponse, and 
provides exquisite control of gene expression.  Peripheral nerve injury causes the release 
of a number of cytokines which have been documented to play an important role in the 
initiation, and maintenance of the regenerative response typically seen following 
peripheral nerve injury.  It seems that the JAK/STAT pathway activation  could be one of 
the  main mediators in the signal transduction pathway of cytokines in response to our 
peripheral injury model.  However, since we did not observe identical response to that of 
GAP-43 expression as a result of dorsal root transection, it would seem unlikely that 
JAK/STAT pathway controls GAP-43 expression.  Phosphorylation of STAT3 on 
position Tyr705 and enhanced nuclear translocation was found within 3 h in injured 
neurons, lasting longer than 3 months (Schwaiger et al., 2000).  Thus, while STAT3 
activation might be an important step in the overall sensory neuron response to injury, it 
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could influence the expression of growth associated proteins other than GAP-43.  
Alternatively, STAT3 activation may modify the neuronal responsiveness to other 
signaling molecules that, under normal circumstances, would not be active.  Differential 
upregulation of certain receptors, for example NP-1, selectively in large diameter neurons 
as a result of peripheral nerve transection has been demonstrated (Gavazzi et al., 2000).  
It would also reasonable to suggest that, not only certain signaling pathways may be 
activated as a result of STAT3 activation, but also selected size of neurons may become 
more sensitized to specific signaling pathways.   
Based on our findings and those of others (Kiryu-Seo et al., 2008) a mechanism 
leading to elevated GAP-43 expression in vivo can be proposed:  
Immediately following a peripheral nerve injury, specificity transcription protein-1 (Sp1)   
is activated.  STAT3, one of the earliest transcription factors is then phosphorylated.  Sp1 
recruits STAT3 to initiate JAK/STAT3 signaling pathway leading to upregulation of 
growth associated proteins other than GAP-43.  As the time course of injury proceeds, 
ATF3 is activated.  Sp1 then recruits both STAT3 and ATF3 to activate the program of 
GAP-43 upregulation.  c-Jun then follows, providing additional synergistic effect on the 
expression of GAP-43 expression (Figure 8-1).  
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Figure 8-1. Proposed mechanism of GAP-43 upregulation as a result of 
phosphorylation of STAT3, ATF3, and c-Jun.  Phosphorylated STAT3 is recruited 
first by Sp1, and GAPs are upregulated.  When ATF3 is activated, it is also recruited by 
Sp1 leading to the upregulation of GAP-43.  When c-Jun is activated, the synergy 
between the three transcription factors leads to the upregulation of GAP-43.   
 
 
180 
 
CHAPTER 9 
9.0 CONCLUSION 
 
 GAP-43 expression is upregulated as a result of peripheral, but not central axonal 
branch injury in DRG neurons.  Key transcription factors ATF3, c-Jun, and STAT3 
showed a distinct pattern of expression, with ATF3 and c-Jun expression closely 
resembling GAP-43 expression.  STAT3 cytoplasmic expression was the exception, since 
it did not change as a result of peripheral nerve transection, but was upregulated as a 
result of dorsal root transection.   
These results support a multifactorial scheme of injury response as a result of 
peripheral and central axon branch injuries.  Specifically, peripheral branch injurymay 
cause a robust regenerative response, because interruption of signals originating from 
peripheral target tissues control the normally suppressed state of growth associated 
proteins and genes.   However, the increase in cytoplasmic expression of STAT3 
observed as a result of dorsal root transection supports the idea that damage to the DRG 
central axonal branch may generate positive, inflammatory signals  that have 
fundamentally different effects from those available in the peripheral target tissues. 
Chronic infusion of dbcAMP or FGF-2 did not suppress injury induced 
expressions of GAP-43.  This is in sharp contrast to earlier in vitro studies that showed 
dose-dependent and synergistic repressive properties of dbcAMP and FGF-2.  Injury 
induced upregulation of the other transcription factors were, however, repressed as a 
result of dbcAMP and FGF-2 administration.  STAT3 revealed a pattern of response to 
cAMP and FGF-2 that is similar to that of GAP-43.   
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9.1 Future directions. 
 The injury response of peripheral nerves involves a complex series of metabolic 
and neuronal cell biologic events that take into account synthesis, sorting and assembly, 
and transport of specialized growth associated proteins to the site of injury that will 
eventually lead to successful regeneration.  This process must be initiated, maintained, 
and then terminated once the proper target tissues have been re-innervated.  We have 
investigated one growth factor, and one intracellular messenger.  The methodology 
employed in our work can act as a blueprint for the study of other growth factors and 
intracellular molecules to be investigated in detail in vivo.   
The time course for the activation of immediate early genes ATF3 and c-Jun must 
be more carefully addressed in future studies, perhaps by using a more sensitive 
technique such as real time polymerase chain reaction in order to clarify several 
important questions: 
What are the key transcription factors expressed as a result of peripheral nerve 
injury, and which are the first to be expressed?  How intricately are those transcription 
factors coregulated? Is there a “master” transcription factor that governs all subsequent 
response? Is there a time course for the neuronal size subsets such that one subset 
responds to nerve injury before another? Each of these questions addresses part of the 
puzzle of peripheral nerve regeneration, and may provide further insight into the chain of 
causation of the metabolic response to nerve injury.  
 
 
 
182 
 
REFERENCES 
 
Abdulla FA, Smith PA. 2001a. Axotomy- and autotomy-induced changes in Ca2+ and 
K+ channel currents of rat dorsal root ganglion neurons. J Neurophysiol 
85(2):644-658. 
Abdulla FA, Smith PA. 2001b. Axotomy- and autotomy-induced changes in the 
excitability of rat dorsal root ganglion neurons. J Neurophysiol 85(2):630-643. 
Abe K, Namikawa K, Honma M, Iwata T, Matsuoka I, Watabe K, Kiyama H. 2001. 
Inhibition of Ras extracellular-signal-regulated kinase (ERK) mediated signaling 
promotes ciliary neurotrophic factor (CNTF) expression in Schwann cells. J 
Neurochem 77(2):700-703. 
Adler R, Landa KB, Manthorpe M, Varon S. 1979. Cholinergic neuronotrophic factors: 
intraocular distribution of trophic activity for ciliary neurons. Science 
204(4400):1434-1436. 
Aebischer P, Salessiotis AN, Winn SR. 1989. Basic fibroblast growth factor released 
from synthetic guidance channels facilitates peripheral nerve regeneration across 
long nerve gaps. J Neurosci Res 23(3):282-289. 
Agthong S, Kaewsema A, Tanomsridejchai N, Chentanez V. 2006. Activation of MAPK 
ERK in peripheral nerve after injury. BMC Neurosci 7:45. 
Airaksinen MS, Meyer M. 1996. Most classes of dorsal root ganglion neurons are 
severely depleted but not absent in mice lacking neurotrophin-3. Neuroscience 
73(4):907-911. 
Akassoglou K, Kombrinck KW, Degen JL, Strickland S. 2000. Tissue plasminogen 
activator-mediated fibrinolysis protects against axonal degeneration and 
demyelination after sciatic nerve injury. J Cell Biol 149(5):1157-1166. 
Al-Majed AA, Neumann CM, Brushart TM, Gordon T. 2000. Brief electrical stimulation 
promotes the speed and accuracy of motor axonal regeneration. J Neurosci 
20(7):2602-2608. 
Al-Majed AA, Tam SL, Gordon T. 2004. Electrical stimulation accelerates and enhances 
expression of regeneration-associated genes in regenerating rat femoral 
motoneurons. Cell Mol Neurobiol 24(3):379-402. 
Aldskogius H, Risling M. 1981. Effect of sciatic neurectomy on neuronal number and 
size distribution in the L7 ganglion of kittens. Exp Neurol 74(2):597-604. 
Aldskogius H, Svensson M. 1988. Effect on the rat hypoglossal nucleus of vinblastine 
and colchicine applied to the intact or transected hypoglossal nerve. Exp Neurol 
99(2):461-473. 
Alexander KA, Cimler BM, Meier KE, Storm DR. 1987. Regulation of calmodulin 
binding to P-57. A neurospecific calmodulin binding protein. J Biol Chem 
262(13):6108-6113. 
Alexander KA, Wakim BT, Doyle GS, Walsh KA, Storm DR. 1988. Identification and 
characterization of the calmodulin-binding domain of neuromodulin, a 
neurospecific calmodulin-binding protein. J Biol Chem 263(16):7544-7549. 
Alvarez J, Giuditta A, Koenig E. 2000. Protein synthesis in axons and terminals: 
significance for maintenance, plasticity and regulation of phenotype. With a 
critique of slow transport theory. Prog Neurobiol 62(1):1-62. 
183 
 
Ambron RT, Walters ET. 1996. Priming events and retrograde injury signals. A new 
perspective on the cellular and molecular biology of nerve regeneration. Mol 
Neurobiol 13(1):61-79. 
Andersen PL, Webber CA, Kimura KA, Schreyer DJ. 2000. Cyclic AMP prevents an 
increase in GAP-43 but promotes neurite growth in cultured adult rat dorsal root 
ganglion neurons. Exp Neurol 166(1):153-165. 
Andres KH, von During M, Schmidt RF. 1985. Sensory innervation of the Achilles 
tendon by group III and IV afferent fibers. Anat Embryol (Berl) 172(2):145-156. 
Angeletti PU, Levi-Montalcini R, Calissano P. 1968. The nerve growth factor (NGF): 
chemical properties and metabolic effects. Adv Enzymol Relat Areas Mol Biol 
31:51-75. 
Arntz C, Kanje M, Lundborg G. 1989. Regeneration of the rat sciatic nerve after different 
conditioning lesions: effects of the conditioning interval. Microsurgery 10(2):118-
121. 
Arrigo AP. 2007. The cellular "networking" of mammalian Hsp27 and its functions in the 
control of protein folding, redox state and apoptosis. Adv Exp Med Biol 594:14-
26. 
Arvidson B. 1977. Cellular uptake of exogenous horseradish peroxidase in mouse 
peripheral nerve. Acta Neuropathol 37(1):35-41. 
Arvidsson J, Ygge J, Grant G. 1986. Cell loss in lumbar dorsal root ganglia and 
transganglionic degeneration after sciatic nerve resection in the rat. Brain Res 
373(1-2):15-21. 
Asato F, Butler M, Blomberg H, Gordh T. 2000. Variation in rat sciatic nerve anatomy: 
implications for a rat model of neuropathic pain. J Peripher Nerv Syst 5(1):19-21. 
Auld DS, Robitaille R. 2003. Perisynaptic Schwann cells at the neuromuscular junction: 
nerve- and activity-dependent contributions to synaptic efficacy, plasticity, and 
reinnervation. Neuroscientist 9(2):144-157. 
Averill S, Michael GJ, Shortland PJ, Leavesley RC, King VR, Bradbury EJ, McMahon 
SB, Priestley JV. 2004. NGF and GDNF ameliorate the increase in ATF3 
expression which occurs in dorsal root ganglion cells in response to peripheral 
nerve injury. Eur J Neurosci 19(6):1437-1445. 
Baetge EE, Hammang JP. 1991. Neurite outgrowth in PC12 cells deficient in GAP-43. 
Neuron 6(1):21-30. 
Bahadori MH, Al-Tiraihi T, Valojerdi MR. 2001. Sciatic nerve transection in neonatal 
rats induces apoptotic neuronal death in L5 dorsal root ganglion. J Neurocytol 
30(2):125-130. 
Bailey SB, Eichler ME, Villadiego A, Rich KM. 1993. The influence of fibronectin and 
laminin during Schwann cell migration and peripheral nerve regeneration through 
silicon chambers. J Neurocytol 22(3):176-184. 
Baizer L, Fishman MC. 1987. Recognition of specific targets by cultured dorsal root 
ganglion neurons. J Neurosci 7(8):2305-2311. 
Barbin G, Manthorpe M, Varon S. 1984. Purification of the chick eye ciliary 
neuronotrophic factor. J Neurochem 43(5):1468-1478. 
Barbut D, Polak JM, Wall PD. 1981. Substance P in spinal cord dorsal horn decreases 
following peripheral nerve injury. Brain Res 205(2):289-298. 
Barde YA. 1990. The nerve growth factor family. Prog Growth Factor Res 2(4):237-248. 
184 
 
Barde YA, Edgar D, Thoenen H. 1982. Purification of a new neurotrophic factor from 
mammalian brain. EMBO J 1(5):549-553. 
Benowitz LI, Routtenberg A. 1997. GAP-43: an intrinsic determinant of neuronal 
development and plasticity. Trends Neurosci 20(2):84-91. 
Benowitz LI, Schmidt JT. 1987. Activity-dependent sharpening of the regenerating 
retinotectal projection in goldfish: relationship to the expression of growth-
associated proteins. Brain Res 417(1):118-126. 
Berta T, Poirot O, Pertin M, Ji RR, Kellenberger S, Decosterd I. 2008. Transcriptional 
and functional profiles of voltage-gated Na(+) channels in injured and non-injured 
DRG neurons in the SNI model of neuropathic pain. Mol Cell Neurosci 
37(2):196-208. 
Beuche W, Friede RL. 1986. Myelin phagocytosis in Wallerian degeneration of 
peripheral nerves depends on silica-sensitive, bg/bg-negative and Fc-positive 
monocytes. Brain Res 378(1):97-106. 
Bhave G, Gereau RWt. 2004. Posttranslational mechanisms of peripheral sensitization. J 
Neurobiol 61(1):88-106. 
Bisby MA. 1985. Enhancement of the conditioning lesion effect in rat sciatic motor 
axons after superimposition of conditioning and test lesions. Exp Neurol 
90(2):385-394. 
Bisby MA, Keen P. 1986. Regeneration of primary afferent neurons containing substance 
P-like immunoreactivity. Brain Res 365(1):85-95. 
Bisby MA, Pollock B. 1983. Increased regeneration rate in peripheral nerve axons 
following double lesions: enhancement of the conditioning lesion phenomenon. J 
Neurobiol 14(6):467-472. 
Bisby MA, Tetzlaff W. 1992. Changes in cytoskeletal protein synthesis following axon 
injury and during axon regeneration. Mol Neurobiol 6(2-3):107-123. 
Bisby MA, Tetzlaff W, Brown MC. 1995. Cell body response to injury in motoneurons 
and primary sensory neurons of a mutant mouse, Ola (Wld), in which Wallerian 
degeneration is delayed. J Comp Neurol 359(4):653-662. 
Bishop B. 1982. Neural plasticity: Part 3. Responses to lesions in the peripheral nervous 
system. Phys Ther 62(9):1275-1282. 
Bixby JL, Lilien J, Reichardt LF. 1988. Identification of the major proteins that promote 
neuronal process outgrowth on Schwann cells in vitro. J Cell Biol 107(1):353-
361. 
Black JA, Cummins TR, Plumpton C, Chen YH, Hormuzdiar W, Clare JJ, Waxman SG. 
1999. Upregulation of a silent sodium channel after peripheral, but not central, 
nerve injury in DRG neurons. J Neurophysiol 82(5):2776-2785. 
Bondoux-Jahan M, Sebille A. 1986. Electrophysiological study of conditioning lesion 
effect on rat sciatic nerve regeneration following either prior section or freeze. I. 
Intensity and time course. Brain Res 382(1):39-45. 
Bonilla IE, Tanabe K, Strittmatter SM. 2002. Small proline-rich repeat protein 1A is 
expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci 
22(4):1303-1315. 
Booth CM, Brown MC. 1993. Expression of GAP-43 mRNA in mouse spinal cord 
following unilateral peripheral nerve damage: is there a contralateral effect? Eur J 
Neurosci 5(12):1663-1676. 
185 
 
Bos TJ, Beug H, Graf T, Hayman M, Maki Y, Uckert W, Vogt PK. 1986. Two new 
retroviral onc genes, sea and jun. Princess Takamatsu Symp 17:23-30. 
Bosse F, Hasenpusch-Theil K, Kury P, Muller HW. 2006. Gene expression profiling 
reveals that peripheral nerve regeneration is a consequence of both novel injury-
dependent and reactivated developmental processes. J Neurochem 96(5):1441-
1457. 
Bosse F, Kury P, Muller HW. 2001. Gene expression profiling and molecular aspects in 
peripheral nerve regeneration. Restor Neurol Neurosci 19(1-2):5-18. 
Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 
72:248-254. 
Bray GM, Rasminsky M, Aguayo AJ. 1981. Interactions between axons and their sheath 
cells. Annu Rev Neurosci 4:127-162. 
Broude E, McAtee M, Kelley MS, Bregman BS. 1997. c-Jun expression in adult rat 
dorsal root ganglion neurons: differential response after central or peripheral 
axotomy. Exp Neurol 148(1):367-377. 
Buj-Bello A, Buchman VL, Horton A, Rosenthal A, Davies AM. 1995. GDNF is an age-
specific survival factor for sensory and autonomic neurons. Neuron 15(4):821-
828. 
Campana WM. 2007. Schwann cells: activated peripheral glia and their role in 
neuropathic pain. Brain Behav Immun 21(5):522-527. 
Campenot RB, MacInnis BL. 2004. Retrograde transport of neurotrophins: fact and 
function. J Neurobiol 58(2):217-229. 
Caroni P. 1998. Neuro-regeneration: plasticity for repair and adaptation. Essays Biochem 
33:53-64. 
Chen BP, Wolfgang CD, Hai T. 1996. Analysis of ATF3, a transcription factor induced 
by physiological stresses and modulated by gadd153/Chop10. Mol Cell Biol 
16(3):1157-1168. 
Chen Y, Aulia S, Tang BL. 2006. Myelin-associated glycoprotein-mediated signaling in 
central nervous system pathophysiology. Mol Neurobiol 34(2):81-91. 
Chen Z, Chai Y, Cao L, Huang A, Cui R, Lu C, He C. 2001. Glial cell line-derived 
neurotrophic factor promotes survival and induces differentiation through the 
phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathway 
respectively in PC12 cells. Neuroscience 104(2):593-598. 
Cheng HL, Randolph A, Yee D, Delafontaine P, Tennekoon G, Feldman EL. 1996. 
Characterization of insulin-like growth factor-I and its receptor and binding 
proteins in transected nerves and cultured Schwann cells. J Neurochem 66(2):525-
536. 
Chiaramello A, Neuman T, Peavy DR, Zuber MX. 1996. The GAP-43 gene is a direct 
downstream target of the basic helix-loop-helix transcription factors. J Biol Chem 
271(36):22035-22043. 
Chong MS, Fitzgerald M, Winter J, Hu-Tsai M, Emson PC, Wiese U, Woolf CJ. 1992. 
GAP-43 mRNA in Rat Spinal Cord and Dorsal Root Ganglia Neurons: 
Developmental Changes and Re-expression Following Peripheral Nerve Injury. 
Eur J Neurosci 4(10):883-895. 
186 
 
Chong MS, Reynolds ML, Irwin N, Coggeshall RE, Emson PC, Benowitz LI, Woolf CJ. 
1994. GAP-43 expression in primary sensory neurons following central axotomy. 
J Neurosci 14(7):4375-4384. 
Chong MS, Woolf CJ, Haque NS, Anderson PN. 1999. Axonal regeneration from injured 
dorsal roots into the spinal cord of adult rats. J Comp Neurol 410(1):42-54. 
Clarke D, Richardson P. 1994. Peripheral nerve injury. Curr Opin Neurol 7(5):415-421. 
Coggins PJ, Zwiers H. 1991. B-50 (GAP-43): biochemistry and functional 
neurochemistry of a neuron-specific phosphoprotein. J Neurochem 56(4):1095-
1106. 
Coleman MP, Perry VH. 2002. Axon pathology in neurological disease: a neglected 
therapeutic target. Trends Neurosci 25(10):532-537. 
Costigan M, Mannion RJ, Kendall G, Lewis SE, Campagna JA, Coggeshall RE, 
Meridith-Middleton J, Tate S, Woolf CJ. 1998. Heat shock protein 27: 
developmental regulation and expression after peripheral nerve injury. J Neurosci 
18(15):5891-5900. 
Cragg BG. 1970. What is the signal for chromatolysis? Brain Res 23(1):1-21. 
Csillik B, Knyihar-Csillik E, Tajti J. 1982. Blockade of retrograde axoplasmic transport 
induces transganglionic degenerative atrophy of central terminals of primary 
nociceptive neurons. Acta Biol Acad Sci Hung 33(2-3):149-156. 
Curtis R, Adryan KM, Zhu Y, Harkness PJ, Lindsay RM, DiStefano PS. 1993. 
Retrograde axonal transport of ciliary neurotrophic factor is increased by 
peripheral nerve injury. Nature 365(6443):253-255. 
Curtis R, Scherer SS, Somogyi R, Adryan KM, Ip NY, Zhu Y, Lindsay RM, DiStefano 
PS. 1994. Retrograde axonal transport of LIF is increased by peripheral nerve 
injury: correlation with increased LIF expression in distal nerve. Neuron 
12(1):191-204. 
Cyr JL, Brady ST. 1992. Molecular motors in axonal transport. Cellular and molecular 
biology of kinesin. Mol Neurobiol 6(2-3):137-155. 
D'Angelo G, Lee H, Weiner RI. 1997. cAMP-dependent protein kinase inhibits the 
mitogenic action of vascular endothelial growth factor and fibroblast growth 
factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 
67(3):353-366. 
Danielsen N, Pettmann B, Vahlsing HL, Manthorpe M, Varon S. 1988. Fibroblast growth 
factor effects on peripheral nerve regeneration in a silicone chamber model. J 
Neurosci Res 20(3):320-330. 
Davies AM. 1994a. The role of neurotrophins during successive stages of sensory neuron 
development. Prog Growth Factor Res 5(3):263-289. 
Davies AM. 1994b. The role of neurotrophins in the developing nervous system. J 
Neurobiol 25(11):1334-1348. 
Davies AM, Wright EM. 1995. Neurotrophic factors. Neurotrophin autocrine loops. Curr 
Biol 5(7):723-726. 
Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD. 
1993. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite 
CNTF receptor. Science 260(5115):1805-1808. 
187 
 
Delcroix JD, Valletta JS, Wu C, Hunt SJ, Kowal AS, Mobley WC. 2003. NGF signaling 
in sensory neurons: evidence that early endosomes carry NGF retrograde signals. 
Neuron 39(1):69-84. 
Delmas V, Sassone-Corsi P. 1994. The key role of CREM in the cAMP signaling 
pathway in the testis. Mol Cell Endocrinol 100(1-2):121-124. 
Deloulme JC, Laeng P, Janet T, Sensenbrenner M, Baudier J. 1993. Expression of 
neuromodulin (GAP-43) and its regulation by basic fibroblast growth factor 
during the differentiation of O-2A progenitor cells. J Neurosci Res 36(2):147-162. 
Deng YS, Zhong JH, Zhou XF. 2000. BDNF is involved in sympathetic sprouting in the 
dorsal root ganglia following peripheral nerve injury in rats. Neurotox Res 
1(4):311-322. 
Denny JB. 2006. Molecular Mechanisms, Biological Actions, and Neuropharmacology of 
the Growth-Associated Protein GAP-43. Curr Neuropharmacol 4(4):293-304. 
Dent EW, Meiri KF. 1992. GAP-43 phosphorylation is dynamically regulated in 
individual growth cones. J Neurobiol 23(8):1037-1053. 
Desouches C, Alluin O, Mutaftschiev N, Dousset E, Magalon G, Boucraut J, Feron F, 
Decherchi P. 2005. [Peripheral nerve repair: 30 centuries of scientific research]. 
Rev Neurol (Paris) 161(11):1045-1059. 
Devor M. 1999. Unexplained peculiarities of the dorsal root ganglion. Pain Suppl 6:S27-
35. 
Devor M. 2009. Ectopic discharge in Abeta afferents as a source of neuropathic pain. Exp 
Brain Res 196(1):115-128. 
Devor M, Govrin-Lippmann R, Frank I, Raber P. 1985. Proliferation of primary sensory 
neurons in adult rat dorsal root ganglion and the kinetics of retrograde cell loss 
after sciatic nerve section. Somatosens Res 3(2):139-167. 
Devor M, Wall PD, McMahon SB. 1984. Dichotomizing somatic nerve fibers exist in rats 
but they are rare. Neurosci Lett 49(1-2):187-192. 
Dijkhuizen PA, Hermens WT, Teunis MA, Verhaagen J. 1997. Adenoviral vector-
directed expression of neurotrophin-3 in rat dorsal root ganglion explants results 
in a robust neurite outgrowth response. J Neurobiol 33(2):172-184. 
DiStefano PS, Curtis R. 1994. Receptor mediated retrograde axonal transport of 
neurotrophic factors is increased after peripheral nerve injury. Prog Brain Res 
103:35-42. 
DiStefano PS, Friedman B, Radziejewski C, Alexander C, Boland P, Schick CM, Lindsay 
RM, Wiegand SJ. 1992. The neurotrophins BDNF, NT-3, and NGF display 
distinct patterns of retrograde axonal transport in peripheral and central neurons. 
Neuron 8(5):983-993. 
Dubovy P, Jancalek R, Klusakova I. 2006. A heterogeneous immunofluorescence 
staining for laminin-1 and related basal lamina molecules in the dorsal root 
ganglia following constriction nerve injury. Histochem Cell Biol 125(6):671-680. 
Dubovy P, Tuckova L, Jancalek R, Svizenska I, Klusakova I. 2007. Increased invasion of 
ED-1 positive macrophages in both ipsi- and contralateral dorsal root ganglia 
following unilateral nerve injuries. Neurosci Lett 427(2):88-93. 
Dumas M, Schwab ME, Thoenen H. 1979. Retrograde axonal transport of specific 
macromolecules as a tool for characterizing nerve terminal membranes. J 
Neurobiol 10(2):179-197. 
188 
 
Duobles T, Lima Tde S, Levy Bde F, Chadi G. 2008. S100beta and fibroblast growth 
factor-2 are present in cultured Schwann cells and may exert paracrine actions on 
the peripheral nerve injury. Acta Cir Bras 23(6):555-560. 
Dziennis S, Alkayed NJ. 2008. Role of signal transducer and activator of transcription 3 
in neuronal survival and regeneration. Rev Neurosci 19(4-5):341-361. 
Ebadi M, Bashir RM, Heidrick ML, Hamada FM, Refaey HE, Hamed A, Helal G, Baxi 
MD, Cerutis DR, Lassi NK. 1997. Neurotrophins and their receptors in nerve 
injury and repair. Neurochem Int 30(4-5):347-374. 
Egea J, Espinet C, Soler RM, Peiro S, Rocamora N, Comella JX. 2000. Nerve growth 
factor activation of the extracellular signal-regulated kinase pathway is modulated 
by Ca(2+) and calmodulin. Mol Cell Biol 20(6):1931-1946. 
Egusa H, Schweizer FE, Wang CC, Matsuka Y, Nishimura I. 2005. Neuronal 
differentiation of bone marrow-derived stromal stem cells involves suppression of 
discordant phenotypes through gene silencing. J Biol Chem 280(25):23691-
23697. 
Ellis RJ, van der Vies SM, Hemmingsen SM. 1989. The molecular chaperone concept. 
Biochem Soc Symp 55:145-153. 
Ernfors P, Wetmore C, Olson L, Persson H. 1990. Identification of cells in rat brain and 
peripheral tissues expressing mRNA for members of the nerve growth factor 
family. Neuron 5(4):511-526. 
Fang X, Djouhri L, McMullan S, Berry C, Waxman SG, Okuse K, Lawson SN. 2006. 
Intense isolectin-B4 binding in rat dorsal root ganglion neurons distinguishes C-
fiber nociceptors with broad action potentials and high Nav1.9 expression. J 
Neurosci 26(27):7281-7292. 
Fawcett JW. 1992. Intrinsic neuronal determinants of regeneration. Trends Neurosci 
15(1):5-8. 
Fawcett JW, Keynes RJ. 1990. Peripheral nerve regeneration. Annu Rev Neurosci 13:43-
60. 
Feasby TE, Bostock H, Sears TA. 1981. Conduction in regenerating dorsal root fibres. J 
Neurol Sci 49(3):439-454. 
Fedulova SA, Kostyuk PG, Veselovsky NS. 1981. Calcium channels in the somatic 
membrane of the rat dorsal root ganglion neurons, effect of cAMP. Brain Res 
214(1):210-214. 
Fernyhough P, Willars GB, Lindsay RM, Tomlinson DR. 1993. Insulin and insulin-like 
growth factor I enhance regeneration in cultured adult rat sensory neurones. Brain 
Res 607(1-2):117-124. 
Fields RD, Ellisman MH. 1986a. Axons regenerated through silicone tube splices. I. 
Conduction properties. Exp Neurol 92(1):48-60. 
Fields RD, Ellisman MH. 1986b. Axons regenerated through silicone tube splices. II. 
Functional morphology. Exp Neurol 92(1):61-74. 
Fink DJ, Purkiss D, Mata M. 1985. Rapid retrograde transport of proteins in sensory 
neurons in rats. Brain Res 345(2):394-397. 
Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME. 1997. 
CREB: a major mediator of neuronal neurotrophin responses. Neuron 19(5):1031-
1047. 
189 
 
Finkelstein DI, Bartlett PF, Horne MK, Cheema SS. 1996. Leukemia inhibitory factor is a 
myotrophic and neurotrophic agent that enhances the reinnervation of muscle in 
the rat. J Neurosci Res 46(1):122-128. 
Florkiewicz RZ, Baird A, Gonzalez AM. 1991a. Multiple forms of bFGF: differential 
nuclear and cell surface localization. Growth Factors 4(4):265-275. 
Florkiewicz RZ, Shibata F, Barankiewicz T, Baird A, Gonzalez AM, Florkiewicz E, Shah 
N. 1991b. Basic fibroblast growth factor gene expression. Ann N Y Acad Sci 
638:109-126. 
Florkiewicz RZ, Sommer A. 1989. Human basic fibroblast growth factor gene encodes 
four polypeptides: three initiate translation from non-AUG codons. Proc Natl 
Acad Sci U S A 86(11):3978-3981. 
Forman DS, McQuarrie IG, Labore FW, Wood DK, Stone LS, Braddock CH, Fuchs DA. 
1980. Time course of the conditioning lesion effect on axonal regeneration. Brain 
Res 182(1):180-185. 
Frey D, Laux T, Xu L, Schneider C, Caroni P. 2000. Shared and unique roles of CAP23 
and GAP43 in actin regulation, neurite outgrowth, and anatomical plasticity. J 
Cell Biol 149(7):1443-1454. 
Frisen J, Risling M, Theodorsson E, Fried K. 1992. NPY-like immunoreactivity in 
sensory nerve fibers in rat sciatic neuroma. Brain Res 577(1):142-146. 
Fu SY, Gordon T. 1997. The cellular and molecular basis of peripheral nerve 
regeneration. Mol Neurobiol 14(1-2):67-116. 
Furusho M, Dupree JL, Bryant M, Bansal R. 2009. Disruption of fibroblast growth factor 
receptor signaling in nonmyelinating Schwann cells causes sensory axonal 
neuropathy and impairment of thermal pain sensitivity. J Neurosci 29(6):1608-
1614. 
Gavazzi I, Stonehouse J, Sandvig A, Reza JN, Appiah-Kubi LS, Keynes R, Cohen J. 
2000. Peripheral, but not central, axotomy induces neuropilin-1 mRNA 
expression in adult large diameter primary sensory neurons. J Comp Neurol 
423(3):492-499. 
George R, Griffin JW. 1994. Delayed macrophage responses and myelin clearance during 
Wallerian degeneration in the central nervous system: the dorsal radiculotomy 
model. Exp Neurol 129(2):225-236. 
Geremia NM, Gordon T, Brushart TM, Al-Majed AA, Verge VM. 2007. Electrical 
stimulation promotes sensory neuron regeneration and growth-associated gene 
expression. Exp Neurol 205(2):347-359. 
Geremia NM, Pettersson LM, Hasmatali JC, Hryciw T, Danielsen N, Schreyer DJ, Verge 
VM. 2009. Endogenous BDNF regulates induction of intrinsic neuronal growth 
programs in injured sensory neurons. Exp Neurol 223(1):128-142. 
Gerthoffer WT, Gunst SJ. 2001. Invited review: focal adhesion and small heat shock 
proteins in the regulation of actin remodeling and contractility in smooth muscle. 
J Appl Physiol 91(2):963-972. 
Ghosh A, Greenberg ME. 1995. Calcium signaling in neurons: molecular mechanisms 
and cellular consequences. Science 268(5208):239-247. 
Ginty DD, Glowacka D, DeFranco C, Wagner JA. 1991. Nerve growth factor-induced 
neuronal differentiation after dominant repression of both type I and type II 
cAMP-dependent protein kinase activities. J Biol Chem 266(23):15325-15333. 
190 
 
Glass DJ, Nye SH, Hantzopoulos P, Macchi MJ, Squinto SP, Goldfarb M, Yancopoulos 
GD. 1991. TrkB mediates BDNF/NT-3-dependent survival and proliferation in 
fibroblasts lacking the low affinity NGF receptor. Cell 66(2):405-413. 
Glazner GW, Lupien S, Miller JA, Ishii DN. 1993. Insulin-like growth factor II increases 
the rate of sciatic nerve regeneration in rats. Neuroscience 54(3):791-797. 
Goldin AL, Barchi RL, Caldwell JH, Hofmann F, Howe JR, Hunter JC, Kallen RG, 
Mandel G, Meisler MH, Netter YB, Noda M, Tamkun MM, Waxman SG, Wood 
JN, Catterall WA. 2000. Nomenclature of voltage-gated sodium channels. Neuron 
28(2):365-368. 
Gonzalez GA, Montminy MR. 1989. Cyclic AMP stimulates somatostatin gene 
transcription by phosphorylation of CREB at serine 133. Cell 59(4):675-680. 
Gonzalez GA, Yamamoto KK, Fischer WH, Karr D, Menzel P, Biggs W, 3rd, Vale WW, 
Montminy MR. 1989. A cluster of phosphorylation sites on the cyclic AMP-
regulated nuclear factor CREB predicted by its sequence. Nature 337(6209):749-
752. 
Gotz R, Schartl M. 1994. The conservation of neurotrophic factors during vertebrate 
evolution. Comp Biochem Physiol Pharmacol Toxicol Endocrinol 108(1):1-10. 
Grabczyk E, Zuber MX, Federoff HJ, Ng SC, Pack A, Fishman MC. 1990. Cloning and 
Characterization of the Rat Gene Encoding GAP-43. Eur J Neurosci 2(10):822-
827. 
Gratto KA, Verge VM. 2003. Neurotrophin-3 down-regulates trkA mRNA, NGF high-
affinity binding sites, and associated phenotype in adult DRG neurons. Eur J 
Neurosci 18(6):1535-1548. 
Gravel C, Gotz R, Lorrain A, Sendtner M. 1997. Adenoviral gene transfer of ciliary 
neurotrophic factor and brain-derived neurotrophic factor leads to long-term 
survival of axotomized motor neurons. Nat Med 3(7):765-770. 
Gray TS, Morley JE. 1986. Neuropeptide Y: anatomical distribution and possible 
function in mammalian nervous system. Life Sci 38(5):389-401. 
Griffin JW, Thompson WJ. 2008. Biology and pathology of nonmyelinating Schwann 
cells. Glia 56(14):1518-1531. 
Grimes ML, Zhou J, Beattie EC, Yuen EC, Hall DE, Valletta JS, Topp KS, LaVail JH, 
Bunnett NW, Mobley WC. 1996. Endocytosis of activated TrkA: evidence that 
nerve growth factor induces formation of signaling endosomes. J Neurosci 
16(24):7950-7964. 
Gringel S, van Bergeijk J, Haastert K, Grothe C, Claus P. 2004. Nuclear fibroblast 
growth factor-2 interacts specifically with splicing factor SF3a66. Biol Chem 
385(12):1203-1208. 
Grothe C, Haastert K, Jungnickel J. 2006. Physiological function and putative therapeutic 
impact of the FGF-2 system in peripheral nerve regeneration--lessons from in 
vivo studies in mice and rats. Brain Res Rev 51(2):293-299. 
Grothe C, Meisinger C. 1995. Fibroblast growth factor (FGF)-2 sense and antisense 
mRNA and FGF receptor type 1 mRNA are present in the embryonic and adult rat 
nervous system: specific detection by nuclease protection assay. Neurosci Lett 
197(3):175-178. 
Grothe C, Meisinger C, Hertenstein A, Kurz H, Wewetzer K. 1997. Expression of 
fibroblast growth factor-2 and fibroblast growth factor receptor 1 messenger 
191 
 
RNAs in spinal ganglia and sciatic nerve: regulation after peripheral nerve lesion. 
Neuroscience 76(1):123-135. 
Grothe C, Nikkhah G. 2001. The role of basic fibroblast growth factor in peripheral nerve 
regeneration. Anat Embryol (Berl) 204(3):171-177. 
Grothe C, Wewetzer K. 1996. Fibroblast growth factor and its implications for 
developing and regenerating neurons. Int J Dev Biol 40(1):403-410. 
Guseva D, Chelyshev Y. 2006. The plasticity of the DRG neurons belonging to different 
subpopulations after dorsal rhizotomy. Cell Mol Neurobiol 26(7-8):1225-1234. 
Haas CA, Hofmann HD, Kirsch M. 1999. Expression of CNTF/LIF-receptor components 
and activation of STAT3 signaling in axotomized facial motoneurons: evidence 
for a sequential postlesional function of the cytokines. J Neurobiol 41(4):559-571. 
Haas CA, Hollerbach E, Deller T, Naumann T, Frotscher M. 2000. Up-regulation of 
growth-associated protein 43 mRNA in rat medial septum neurons axotomized by 
fimbria-fornix transection. Eur J Neurosci 12(12):4233-4242. 
Haastert K, Ying Z, Grothe C, Gomez-Pinilla F. 2008. The effects of FGF-2 gene therapy 
combined with voluntary exercise on axonal regeneration across peripheral nerve 
gaps. Neurosci Lett 443(3):179-183. 
Habener JF, Miller CP, Vallejo M. 1995. cAMP-dependent regulation of gene 
transcription by cAMP response element-binding protein and cAMP response 
element modulator. Vitam Horm 51:1-57. 
Hai T, Curran T. 1991. Cross-family dimerization of transcription factors Fos/Jun and 
ATF/CREB Alters DNA binding specificity. Proc Natl Acad Sci USA 88:3720-
3724 
 
Hai T, Hartman MG. 2001. The molecular biology and nomenclature of the activating 
transcription factor/cAMP responsive element binding family of transcription 
factors: activating transcription factor proteins and homeostasis. Gene 273(1):1-
11. 
Hai T, Liu F, Coukos WJ, Gree MR. 1989. Transcription factor ATF cDNA clones: An 
extensive family of leucine zipper proteins able to selectively form DNA- binding 
heterodimers  Gens and Development 3:2083-2090. 
Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U. 1999. ATF3 and stress 
responses. Gene Expr 7(4-6):321-335. 
Hall S. 2005. The response to injury in the peripheral nervous system. J Bone Joint Surg 
Br 87(10):1309-1319. 
Hall SM. 1989. Regeneration in the peripheral nervous system. Neuropathol Appl 
Neurobiol 15(6):513-529. 
Hall SM. 1993. Observations on the progress of Wallerian degeneration in transected 
peripheral nerves of C57BL/Wld mice in the presence of recruited macrophages. J 
Neurocytol 22(6):480-490. 
Hamburger V, Levi-Montalcini R. 1949. Proliferation, differentiation and degeneration in 
the spinal ganglia of the chick embryo under normal and experimental conditions. 
J Exp Zool 111(3):457-501. 
Hammarberg H, Piehl F, Cullheim S, Fjell J, Hokfelt T, Fried K. 1996. GDNF mRNA in 
Schwann cells and DRG satellite cells after chronic sciatic nerve injury. 
Neuroreport 7(4):857-860. 
192 
 
Han PJ, Shukla S, Subramanian PS, Hoffman PN. 2004. Cyclic AMP elevates tubulin 
expression without increasing intrinsic axon growth capacity. Exp Neurol 
189(2):293-302. 
Hanani M. 2005. Satellite glial cells in sensory ganglia: from form to function. Brain Res 
Brain Res Rev 48(3):457-476. 
Hanani M, Huang TY, Cherkas PS, Ledda M, Pannese E. 2002. Glial cell plasticity in 
sensory ganglia induced by nerve damage. Neuroscience 114(2):279-283. 
Hansson HA. 1993. Insulin-like growth factors and nerve regeneration. Ann N Y Acad 
Sci 692:161-171. 
Hanz S, Fainzilber M. 2006. Retrograde signaling in injured nerve--the axon reaction 
revisited. J Neurochem 99(1):13-19. 
Hanz S, Perlson E, Willis D, Zheng JQ, Massarwa R, Huerta JJ, Koltzenburg M, Kohler 
M, van-Minnen J, Twiss JL, Fainzilber M. 2003. Axoplasmic importins enable 
retrograde injury signaling in lesioned nerve. Neuron 40(6):1095-1104. 
Hartl M, Bader AG, Bister K. 2003. Molecular targets of the oncogenic transcription 
factor jun. Curr Cancer Drug Targets 3(1):41-55. 
Hausott B, Vallant N, Auer M, Yang L, Dai F, Brand-Saberi B, Klimaschewski L. 2009. 
Sprouty2 down-regulation promotes axon growth by adult sensory neurons. Mol 
Cell Neurosci 42(4):328-340. 
Hayashi H, Ichihara M, Iwashita T, Murakami H, Shimono Y, Kawai K, Kurokawa K, 
Murakumo Y, Imai T, Funahashi H, Nakao A, Takahashi M. 2000. 
Characterization of intracellular signals via tyrosine 1062 in RET activated by 
glial cell line-derived neurotrophic factor. Oncogene 19(39):4469-4475. 
Heerssen HM, Pazyra MF, Segal RA. 2004. Dynein motors transport activated Trks to 
promote survival of target-dependent neurons. Nat Neurosci 7(6):596-604. 
Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, 
Simmons L, Moffet B, Vandlen RA, Simpson LC, et al. 1994. GDNF: a potent 
survival factor for motoneurons present in peripheral nerve and muscle. Science 
266(5187):1062-1064. 
Herdegen T, Fiallos-Estrada CE, Schmid W, Bravo R, Zimmermann M. 1992. The 
transcription factors c-JUN, JUN D and CREB, but not FOS and KROX-24, are 
differentially regulated in axotomized neurons following transection of rat sciatic 
nerve. Brain Res Mol Brain Res 14(3):155-165. 
Hikawa N, Horie H, Takenaka T. 1993. Macrophage-enhanced neurite regeneration of 
adult dorsal root ganglia neurones in culture. Neuroreport 5(1):41-44. 
Himes BT, Tessler A. 1989. Death of some dorsal root ganglion neurons and plasticity of 
others following sciatic nerve section in adult and neonatal rats. J Comp Neurol 
284(2):215-230. 
Hirokawa N. 1997. The mechanisms of fast and slow transport in neurons: identification 
and characterization of the new kinesin superfamily motors. Curr Opin Neurobiol 
7(5):605-614. 
Hoffman PN. 1989. Expression of GAP-43, a rapidly transported growth-associated 
protein, and class II beta tubulin, a slowly transported cytoskeletal protein, are 
coordinated in regenerating neurons. J Neurosci 9(3):893-897. 
193 
 
Hoffman PN, Cleveland DW. 1988. Neurofilament and tubulin expression recapitulates 
the developmental program during axonal regeneration: induction of a specific 
beta-tubulin isotype. Proc Natl Acad Sci U S A 85(12):4530-4533. 
Hohn A, Leibrock J, Bailey K, Barde YA. 1990. Identification and characterization of a 
novel member of the nerve growth factor/brain-derived neurotrophic factor 
family. Nature 344(6264):339-341. 
Hokfelt T, Zhang X, Wiesenfeld-Hallin Z. 1994. Messenger plasticity in primary sensory 
neurons following axotomy and its functional implications. Trends Neurosci 
17(1):22-30. 
Hsu JC, Laz T, Mohn KL, Taub R. 1991. Identification of LRF-1, a leucine-zipper 
protein that is rapidly and highly induced in regenerating liver. Proc Natl Acad 
Sci U S A 88(9):3511-3515. 
Hu P, McLachlan EM. 2002. Macrophage and lymphocyte invasion of dorsal root ganglia 
after peripheral nerve lesions in the rat. Neuroscience 112(1):23-38. 
Hu Y, Leaver SG, Plant GW, Hendriks WT, Niclou SP, Verhaagen J, Harvey AR, Cui Q. 
2005. Lentiviral-mediated transfer of CNTF to schwann cells within reconstructed 
peripheral nerve grafts enhances adult retinal ganglion cell survival and axonal 
regeneration. Mol Ther 11(6):906-915. 
Hucho TB, Dina OA, Levine JD. 2005. Epac mediates a cAMP-to-PKC signaling in 
inflammatory pain: an isolectin B4(+) neuron-specific mechanism. J Neurosci 
25(26):6119-6126. 
Humbertson A, Jr., Zimmermann E, Leedy M. 1969. A chronological study of mitotic 
activity in satellite cell hyperplasia associated with chromatolytic neurons. Z 
Zellforsch Mikrosk Anat 100(4):507-515. 
Ibanez CF. 1995. Neurotrophic factors: from structure-function studies to designing 
effective therapeutics. Trends Biotechnol 13(6):217-227. 
Inaishi Y, Kashihara Y, Sakaguchi M, Nawa H, Kuno M. 1992. Cooperative regulation of 
calcitonin gene-related peptide levels in rat sensory neurons via their central and 
peripheral processes. J Neurosci 12(2):518-524. 
Inoue M, Nakayama C, Noguchi H. 1996. Activating mechanism of CNTF and related 
cytokines. Mol Neurobiol 12(3):195-209. 
Ip NY, Maisonpierre P, Alderson R, Friedman B, Furth ME, Panayotatos N, Squinto S, 
Yancopoulos GD, Lindsay RM. 1991. The neurotrophins and CNTF: specificity 
of action towards PNS and CNS neurons. J Physiol (Paris) 85(3):123-130. 
Ip NY, Yancopoulos GD. 1996. The neurotrophins and CNTF: two families of 
collaborative neurotrophic factors. Annu Rev Neurosci 19:491-515. 
Isacsson A, Kanje M, Dahlin LB. 2005. Induction of activating transcription factor 3 
(ATF3) by peripheral nerve compression. Scand J Plast Reconstr Surg Hand Surg 
39(2):65-72. 
Isenmann S, Klocker N, Gravel C, Bahr M. 1998. Short communication: protection of 
axotomized retinal ganglion cells by adenovirally delivered BDNF in vivo. Eur J 
Neurosci 10(8):2751-2756. 
Ishii DN, Glazner GW, Pu SF. 1994. Role of insulin-like growth factors in peripheral 
nerve regeneration. Pharmacol Ther 62(1-2):125-144. 
Ishii DN, Glazner GW, Whalen LR. 1993. Regulation of peripheral nerve regeneration by 
insulin-like growth factors. Ann N Y Acad Sci 692:172-182. 
194 
 
Ishii DN, Recio-Pinto E, Spinelli W, Mill JF, Sonnenfeld KH. 1985. Neurite formation 
modulated by nerve growth factor, insulin, and tumor promoter receptors. Int J 
Neurosci 26(1-2):109-127. 
Ishikawa K, Tanaka M, Black JA, Waxman SG. 1999. Changes in expression of voltage-
gated potassium channels in dorsal root ganglion neurons following axotomy. 
Muscle Nerve 22(4):502-507. 
Jahromi BS, Robitaille R, Charlton MP. 1992. Transmitter release increases intracellular 
calcium in perisynaptic Schwann cells in situ. Neuron 8(6):1069-1077. 
Jankowski MP, McIlwrath SL, Jing X, Cornuet PK, Salerno KM, Koerber HR, Albers 
KM. 2009. Sox11 transcription factor modulates peripheral nerve regeneration in 
adult mice. Brain Res 1256:43-54. 
Jenkins R, Hunt SP. 1991. Long-term increase in the levels of c-jun mRNA and jun 
protein-like immunoreactivity in motor and sensory neurons following axon 
damage. Neurosci Lett 129(1):107-110. 
Jenkins R, McMahon SB, Bond AB, Hunt SP. 1993. Expression of c-Jun as a response to 
dorsal root and peripheral nerve section in damaged and adjacent intact primary 
sensory neurons in the rat. Eur J Neurosci 5(6):751-759. 
Jenq CB, Jenq LL, Bear HM, Coggeshall RE. 1988. Conditioning lesions of peripheral 
nerves change regenerated axon numbers. Brain Res 457(1):63-69. 
Jessell T, Tsunoo A, Kanazawa I, Otsuka M. 1979. Substance P: depletion in the dorsal 
horn of rat spinal cord after section of the peripheral processes of primary sensory 
neurons. Brain Res 168(2):247-259. 
Jessen KR, Mirsky R. 2002. Signals that determine Schwann cell identity. J Anat 
200(4):367-376. 
Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ. 2002. p38 MAPK activation by NGF in 
primary sensory neurons after inflammation increases TRPV1 levels and 
maintains heat hyperalgesia. Neuron 36(1):57-68. 
Ji RR, Zhang Q, Pettersson RF, Hokfelt T. 1996. aFGF, bFGF and NGF differentially 
regulate neuropeptide expression in dorsal root ganglia after axotomy and induce 
autotomy. Regul Pept 66(3):179-189. 
Jones MG, Munson JB, Thompson SW. 1999. A role for nerve growth factor in 
sympathetic sprouting in rat dorsal root ganglia. Pain 79(1):21-29. 
Jongsma Wallin H, Danielsen N, Johnston JM, Gratto KA, Karchewski LA, Verge VM. 
2001. Exogenous NT-3 and NGF differentially modulate PACAP expression in 
adult sensory neurons, suggesting distinct roles in injury and inflammation. Eur J 
Neurosci 14(2):267-282. 
Julius D, Basbaum AI. 2001. Molecular mechanisms of nociception. Nature 
413(6852):203-210. 
Jungnickel J, Claus P, Gransalke K, Timmer M, Grothe C. 2004. Targeted disruption of 
the FGF-2 gene affects the response to peripheral nerve injury. Mol Cell Neurosci 
25(3):444-452. 
Jungnickel J, Haase K, Konitzer J, Timmer M, Grothe C. 2006. Faster nerve regeneration 
after sciatic nerve injury in mice over-expressing basic fibroblast growth factor. J 
Neurobiol 66(9):940-948. 
195 
 
Jungnickel J, Haastert K, Grzybek M, Thau N, Lipokatic-Takacs E, Ratzka A, Nolle A, 
Claus P, Grothe C. 2009. Mice lacking basic fibroblast growth factor showed 
faster sensory recovery. Exp Neurol. 
Jungnickel J, Klutzny A, Guhr S, Meyer K, Grothe C. 2005. Regulation of neuronal death 
and calcitonin gene-related peptide by fibroblast growth factor-2 and FGFR3 after 
peripheral nerve injury: evidence from mouse mutants. Neuroscience 
134(4):1343-1350. 
Kadoya T, Oyanagi K, Kawakami E, Hasegawa M, Inagaki Y, Sohma Y, Horie H. 2005. 
Oxidized galectin-1 advances the functional recovery after peripheral nerve 
injury. Neurosci Lett 380(3):284-288. 
Kai-Kai MA. 1989. Cytochemistry of the trigeminal and dorsal root ganglia and spinal 
cord of the rat. Comp Biochem Physiol A Comp Physiol 93(1):183-193. 
Kajander KC, Madsen AM, Iadarola MJ, Draisci G, Wakisaka S. 1996. Fos-like 
immunoreactivity increases in the lumbar spinal cord following a chronic 
constriction injury to the sciatic nerve of rat. Neurosci Lett 206(1):9-12. 
Kalicke T, Koller M, Frangen TM, Schlegel U, Sprutacz O, Printzen G, Muhr G, Arens 
S. 2007. Local application of basic fibroblast growth factor increases the risk of 
local infection after trauma: an in-vitro and in-vivo study in rats. Acta Orthop 
78(1):63-73. 
Kampinga HH. 2006. Chaperones in preventing protein denaturation in living cells and 
protecting against cellular stress. Handb Exp Pharmacol(172):1-42. 
Kandel ES, J. H., Jessel TM. 2000. Principles of Neural Science. 
Karchewski LA, Gratto KA, Wetmore C, Verge VM. 2002. Dynamic patterns of BDNF 
expression in injured sensory neurons: differential modulation by NGF and NT-3. 
Eur J Neurosci 16(8):1449-1462. 
Karimi-Abdolrezaee S, Schreyer DJ. 2002. Retrograde repression of growth-associated 
protein-43 mRNA expression in rat cortical neurons. J Neurosci 22(5):1816-1822. 
Karimi-Abdolrezaee S, Verge VM, Schreyer DJ. 2002. Developmental down-regulation 
of GAP-43 expression and timing of target contact in rat corticospinal neurons. 
Exp Neurol 176(2):390-401. 
Karin M, Liu Z, Zandi E. 1997. AP-1 function and regulation. Curr Opin Cell Biol 
9(2):240-246. 
Kashiba H, Senba E, Kawai Y, Ueda Y, Tohyama M. 1992. Axonal blockade induces the 
expression of vasoactive intestinal polypeptide and galanin in rat dorsal root 
ganglion neurons. Brain Res 577(1):19-28. 
Kaszubska W, Hooft van Huijsduijnen R, Ghersa P, DeRaemy-Schenk AM, Chen BP, 
Hai T, DeLamarter JF, Whelan J. 1993. Cyclic AMP-independent ATF family 
members interact with NF-kappa B and function in the activation of the E-selectin 
promoter in response to cytokines. Mol Cell Biol 13(11):7180-7190. 
Katoh-Semba R, Kaisho Y, Shintani A, Nagahama M, Kato K. 1996. Tissue distribution 
and immunocytochemical localization of neurotrophin-3 in the brain and 
peripheral tissues of rats. J Neurochem 66(1):330-337. 
Katsura H, Obata K, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, Dai Y, 
Fukuoka T, Sakagami M, Noguchi K. 2007. Activation of extracellular signal-
regulated protein kinases 5 in primary afferent neurons contributes to heat and 
cold hyperalgesia after inflammation. J Neurochem 102(5):1614-1624. 
196 
 
Kenney AM, Kocsis JD. 1997a. Temporal variability of jun family transcription factor 
levels in peripherally or centrally transected adult rat dorsal root ganglia. Brain 
Res Mol Brain Res 52(1):53-61. 
Kenney AM, Kocsis JD. 1997b. Timing of c-jun protein induction in lumbar dorsal root 
ganglia after sciatic nerve transection varies with lesion distance. Brain Res 
751(1):90-95. 
Kenney AM, Kocsis JD. 1998. Peripheral axotomy induces long-term c-Jun amino-
terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and 
junD in adult rat dorsal root ganglia In vivo. J Neurosci 18(4):1318-1328. 
Kerezoudi E, King RH, Muddle JR, O'Neill JA, Thomas PK. 1995. Influence of age on 
the late retrograde effects of sciatic nerve section in the rat. J Anat 187 ( Pt 1):27-
35. 
Kim DS, Choi JO, Rim HD, Cho HJ. 2002. Downregulation of voltage-gated potassium 
channel alpha gene expression in dorsal root ganglia following chronic 
constriction injury of the rat sciatic nerve. Brain Res Mol Brain Res 105(1-2):146-
152. 
Kim DS, Lee SJ, Park SY, Yoo HJ, Kim SH, Kim KJ, Cho HJ. 2001a. Differentially 
expressed genes in rat dorsal root ganglia following peripheral nerve injury. 
Neuroreport 12(15):3401-3405. 
Kim DS, Yoon CH, Lee SJ, Park SY, Yoo HJ, Cho HJ. 2001b. Changes in voltage-gated 
calcium channel alpha(1) gene expression in rat dorsal root ganglia following 
peripheral nerve injury. Brain Res Mol Brain Res 96(1-2):151-156. 
Kiryu-Seo S, Kato R, Ogawa T, Nakagomi S, Nagata K, Kiyama H. 2008. Neuronal 
injury-inducible gene is synergistically regulated by ATF3, c-Jun, and STAT3 
through the interaction with Sp1 in damaged neurons. J Biol Chem 283(11):6988-
6996. 
Kiryu-Seo S, Sasaki M, Yokohama H, Nakagomi S, Hirayama T, Aoki S, Wada K, 
Kiyama H. 2000. Damage-induced neuronal endopeptidase (DINE) is a unique 
metallopeptidase expressed in response to neuronal damage and activates 
superoxide scavengers. Proc Natl Acad Sci U S A 97(8):4345-4350. 
Klettner A. 2004. The induction of heat shock proteins as a potential strategy to treat 
neurodegenerative disorders. Drug News Perspect 17(5):299-306. 
Kline DG, Hayes GJ, Morse AS. 1964a. A Comparative Study of Response of Species to 
Peripheral-Nerve Injury. I. Severance. J Neurosurg 21:968-979. 
Kline DG, Hayes GJ, Morse AS. 1964b. A Comparative Study of Response of Species to 
Peripheral-Nerve Injury. Ii. Crush and Severance with Primary Suture. J 
Neurosurg 21:980-988. 
Kobayashi NR, Fan DP, Giehl KM, Bedard AM, Wiegand SJ, Tetzlaff W. 1997. BDNF 
and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, 
stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal 
regeneration. J Neurosci 17(24):9583-9595. 
Koeppen AH. 2004. Wallerian degeneration: history and clinical significance. J Neurol 
Sci 220(1-2):115-117. 
Koltzenburg M, Wall PD, McMahon SB. 1999. Does the right side know what the left is 
doing? Trends Neurosci 22(3):122-127. 
197 
 
Korsching S. 1993. The neurotrophic factor concept: a reexamination. J Neurosci 
13(7):2739-2748. 
Korsching S, Thoenen H. 1983. Quantitative demonstration of the retrograde axonal 
transport of endogenous nerve growth factor. Neurosci Lett 39(1):1-4. 
Korsching S, Thoenen H. 1985. Nerve growth factor supply for sensory neurons: site of 
origin and competition with the sympathetic nervous system. Neurosci Lett 54(2-
3):201-205. 
Kovalsky Y, Amir R, Devor M. 2009. Simulation in sensory neurons reveals a key role 
for delayed Na+ current in subthreshold oscillations and ectopic discharge: 
implications for neuropathic pain. J Neurophysiol 102(3):1430-1442. 
Kristensson K, Olsson T. 1981. Peripheral nerve repair. Int Rehabil Med 3(4):175-178. 
Lallemend F, Lefebvre PP, Hans G, Rigo JM, Van de Water TR, Moonen G, Malgrange 
B. 2003. Substance P protects spiral ganglion neurons from apoptosis via PKC-
Ca2+-MAPK/ERK pathways. J Neurochem 87(2):508-521. 
Lamballe F, Klein R, Barbacid M. 1991a. The trk family of oncogenes and neurotrophin 
receptors. Princess Takamatsu Symp 22:153-170. 
Lamballe F, Klein R, Barbacid M. 1991b. trkC, a new member of the trk family of 
tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 66(5):967-979. 
Landry M, Holmberg K, Zhang X, Hokfelt T. 2000. Effect of axotomy on expression of 
NPY, galanin, and NPY Y1 and Y2 receptors in dorsal root ganglia and the 
superior cervical ganglion studied with double-labeling in situ hybridization and 
immunohistochemistry. Exp Neurol 162(2):361-384. 
Langford LA, Coggeshall RE. 1981. Branching of sensory axons in the peripheral nerve 
of the rat. J Comp Neurol 203(4):745-750. 
Lankford K, Cypher C, Letourneau P. 1990. Nerve growth cone motility. Curr Opin Cell 
Biol 2(1):80-85. 
Lapchak PA, Miller PJ, Jiao S, Araujo DM, Hilt D, Collins F. 1996. Biology of glial cell 
line-derived neurotrophic factor (GDNF): implications for the use of GDNF to 
treat Parkinson's disease. Neurodegeneration 5(3):197-205. 
Latchman DS. 2005. HSP27 and cell survival in neurones. Int J Hyperthermia 21(5):393-
402. 
Laux T, Fukami K, Thelen M, Golub T, Frey D, Caroni P. 2000. GAP43, MARCKS, and 
CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin 
dynamics through a common mechanism. J Cell Biol 149(7):1455-1472. 
Lawson SN. 1992. Morphological and biochemical cell types of sensory neurons. 
Sensory Neurons, Diversity, Development and Plasticity. New York: Oxfor 
University Press. p 27-59. 
Leah JD, Herdegen T, Murashov A, Dragunow M, Bravo R. 1993. Expression of 
immediate early gene proteins following axotomy and inhibition of axonal 
transport in the rat central nervous system. Neuroscience 57(1):53-66. 
Ledda M, De Palo S, Pannese E. 2004. Ratios between number of neuroglial cells and 
number and volume of nerve cells in the spinal ganglia of two species of reptiles 
and three species of mammals. Tissue Cell 36(1):55-62. 
Lee KA, Hai TY, SivaRaman L, Thimmappaya B, Hurst HC, Jones NC, Green MR. 
1987. A cellular protein, activating transcription factor, activates transcription of 
198 
 
multiple E1A-inducible adenovirus early promoters. Proc Natl Acad Sci U S A 
84(23):8355-8359. 
Lee N, Neitzel KL, Devlin BK, MacLennan AJ. 2004. STAT3 phosphorylation in injured 
axons before sensory and motor neuron nuclei: potential role for STAT3 as a 
retrograde signaling transcription factor. J Comp Neurol 474(4):535-545. 
Lee SE, Shen H, Taglialatela G, Chung JM, Chung K. 1998. Expression of nerve growth 
factor in the dorsal root ganglion after peripheral nerve injury. Brain Res 796(1-
2):99-106. 
Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, 
Barde YA. 1989. Molecular cloning and expression of brain-derived neurotrophic 
factor. Nature 341(6238):149-152. 
Leinninger GM, Backus C, Uhler MD, Lentz SI, Feldman EL. 2004. Phosphatidylinositol 
3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in 
dorsal root ganglia neurons. FASEB J 18(13):1544-1546. 
Leitner ML, Molliver DC, Osborne PA, Vejsada R, Golden JP, Lampe PA, Kato AC, 
Milbrandt J, Johnson EM, Jr. 1999. Analysis of the retrograde transport of glial 
cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests 
that in vivo signaling for the GDNF family is GFRalpha coreceptor-specific. J 
Neurosci 19(21):9322-9331. 
Leong J, Hayes A, Austin L, Morrison W. 1999. Muscle protection following motor 
nerve repair in combination with leukemia inhibitory factor. J Hand Surg Am 
24(1):37-45. 
Levi-Montalcini R. 1964. The Nerve Growth Factor. Ann N Y Acad Sci 118:149-170. 
Levi-Montalcini R. 1975. Nerve Growth Factor. Science 187(4172):113. 
Levi-Montalcini R. 1976. The nerve growth factor: its widening role and place in 
neurobiology. Adv Biochem Psychopharmacol 15:237-250. 
Levi-Montalcini R. 1979. Trophic, tropic and transforming effects of the nerve growth 
factor on its target cells. Bull Mem Acad R Med Belg 134(4):217-228. 
Levi-Montalcini R. 1987. The nerve growth factor thirty-five years later. In Vitro Cell 
Dev Biol 23(4):227-238. 
Levi-Montalcini R, Angeletti PU. 1968. Nerve growth factor. Physiol Rev 48(3):534-569. 
Levi-Montalcini R, Calissano P. 1979. The nerve-growth factor. Sci Am 240(6):68-77. 
Lewis SE, Mannion RJ, White FA, Coggeshall RE, Beggs S, Costigan M, Martin JL, 
Dillmann WH, Woolf CJ. 1999. A role for HSP27 in sensory neuron survival. J 
Neurosci 19(20):8945-8953. 
Li CY, Song YH, Higuera ES, Luo ZD. 2004. Spinal dorsal horn calcium channel 
alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced 
tactile allodynia. J Neurosci 24(39):8494-8499. 
Li GD, Wo Y, Zhong MF, Zhang FX, Bao L, Lu YJ, Huang YD, Xiao HS, Zhang X. 
2002. Expression of fibroblast growth factors in rat dorsal root ganglion neurons 
and regulation after peripheral nerve injury. Neuroreport 13(15):1903-1907. 
Liabotis S, Schreyer DJ. 1995. Magnitude of GAP-43 induction following peripheral 
axotomy of adult rat dorsal root ganglion neurons is independent of lesion 
distance. Exp Neurol 135(1):28-35. 
Liang G, Wolfgang CD, Chen BP, Chen TH, Hai T. 1996. ATF3 gene. Genomic 
organization, promoter, and regulation. J Biol Chem 271(3):1695-1701. 
199 
 
Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. 1993. GDNF: a glial cell line-derived 
neurotrophic factor for midbrain dopaminergic neurons. Science 260(5111):1130-
1132. 
Lindsay RM. 1988. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but 
are not required for survival of adult sensory neurons. J Neurosci 8(7):2394-2405. 
Lindsay RM. 1996a. Role of neurotrophins and trk receptors in the development and 
maintenance of sensory neurons: an overview. Philos Trans R Soc Lond B Biol 
Sci 351(1338):365-373. 
Lindsay RM. 1996b. Therapeutic potential of the neurotrophins and neurotrophin-CNTF 
combinations in peripheral neuropathies and motor neuron diseases. Ciba Found 
Symp 196:39-48; discussion 48-53. 
Lindwall C, Kanje M. 2005. Retrograde axonal transport of JNK signaling molecules 
influence injury induced nuclear changes in p-c-Jun and ATF3 in adult rat sensory 
neurons. Mol Cell Neurosci 29(2):269-282. 
Liss AG, af Ekenstam FW, Wiberg M. 1994. Cell loss in sensory ganglia after peripheral 
nerve injury. An anatomical tracer study using lectin-coupled horseradish 
peroxidase in cats. Scand J Plast Reconstr Surg Hand Surg 28(3):177-188. 
Liu CN, Wall PD, Ben-Dor E, Michaelis M, Amir R, Devor M. 2000. Tactile allodynia in 
the absence of C-fiber activation: altered firing properties of DRG neurons 
following spinal nerve injury. Pain 85(3):503-521. 
Liu H, Tang S, Liu S. 1999. [Signal of the cytoplasmic regions of leukemia inhibitory 
factor receptor (LIFR) alpha-subunit and gp130 involves Stat3 activation in 
leukemic U937 cells]. Zhonghua Xue Ye Xue Za Zhi 20(12):621-623. 
Liu HH, Brady ST. 2004. cAMP, tubulin, axonal transport, and regeneration. Exp Neurol 
189(2):199-203. 
Liu YC, Storm DR. 1989. Dephosphorylation of neuromodulin by calcineurin. J Biol 
Chem 264(22):12800-12804. 
Liu YC, Storm DR. 1990. Regulation of free calmodulin levels by neuromodulin: neuron 
growth and regeneration. Trends Pharmacol Sci 11(3):107-111. 
LoPachin RM, Lehning EJ. 1997. Mechanism of calcium entry during axon injury and 
degeneration. Toxicol Appl Pharmacol 143(2):233-244. 
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the 
Folin phenol reagent. J Biol Chem 193(1):265-275. 
Lu D, Chen J, Hai T. 2007. The regulation of ATF3 gene expression by mitogen-
activated protein kinases. Biochem J 401(2):559-567. 
Lu X, Richardson PM. 1991. Inflammation near the nerve cell body enhances axonal 
regeneration. J Neurosci 11(4):972-978. 
Lu X, Richardson PM. 1993. Responses of macrophages in rat dorsal root ganglia 
following peripheral nerve injury. J Neurocytol 22(5):334-341. 
Lu X, Richardson PM. 1995. Changes in neuronal mRNAs induced by a local 
inflammatory reaction. J Neurosci Res 41(1):8-14. 
Luk HW, Noble LJ, Werb Z. 2003. Macrophages contribute to the maintenance of stable 
regenerating neurites following peripheral nerve injury. J Neurosci Res 73(5):644-
658. 
Lukyanetz EA. 1997. Evidence for colocalization of calcineurin and calcium channels in 
dorsal root ganglion neurons. Neuroscience 78(3):625-628. 
200 
 
Lundborg G, Dahlin L, Danielsen N, Zhao Q. 1994. Trophism, tropism, and specificity in 
nerve regeneration. J Reconstr Microsurg 10(5):345-354. 
Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, Yaksh TL. 
2001. Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel 
subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 
21(6):1868-1875. 
Lutz BS, Wei FC, Ma SF, Chuang DC. 1999. Effects of insulin-like growth factor-1 in 
motor nerve regeneration after nerve transection and repair vs. nerve crushing 
injury in the rat. Acta Neurochir (Wien) 141(10):1101-1106. 
Ma C, Shu Y, Zheng Z, Chen Y, Yao H, Greenquist KW, White FA, LaMotte RH. 2003. 
Similar electrophysiological changes in axotomized and neighboring intact dorsal 
root ganglion neurons. J Neurophysiol 89(3):1588-1602. 
Maher MP, Wu NT, Guo HQ, Dubin AE, Chaplan SR, Wickenden AD. 2009. HCN 
channels as targets for drug discovery. Comb Chem High Throughput Screen 
12(1):64-72. 
Mandemakers WJ, Barres BA. 2005. Axon regeneration: it's getting crowded at the gates 
of TROY. Curr Biol 15(8):R302-305. 
Maness LM, Kastin AJ, Weber JT, Banks WA, Beckman BS, Zadina JE. 1994. The 
neurotrophins and their receptors: structure, function, and neuropathology. 
Neurosci Biobehav Rev 18(1):143-159. 
Margolis FL, Verhaagen J, Biffo S, Huang FL, Grillo M. 1991. Regulation of gene 
expression in the olfactory neuroepithelium: a neurogenetic matrix. Prog Brain 
Res 89:97-122. 
Martini R. 1994. Expression and functional roles of neural cell surface molecules and 
extracellular matrix components during development and regeneration of 
peripheral nerves. J Neurocytol 23(1):1-28. 
Martini R, Fischer S, Lopez-Vales R, David S. 2008. Interactions between Schwann cells 
and macrophages in injury and inherited demyelinating disease. Glia 56(14):1566-
1577. 
Mason MR, Lieberman AR, Grenningloh G, Anderson PN. 2002. Transcriptional 
upregulation of SCG10 and CAP-23 is correlated with regeneration of the axons 
of peripheral and central neurons in vivo. Mol Cell Neurosci 20(4):595-615. 
Masure HR, Alexander KA, Wakim BT, Storm DR. 1986. Physicochemical and 
hydrodynamic characterization of P-57, a neurospecific calmodulin binding 
protein. Biochemistry 25(23):7553-7560. 
Matheson CR, Carnahan J, Urich JL, Bocangel D, Zhang TJ, Yan Q. 1997. Glial cell line-
derived neurotrophic factor (GDNF) is a neurotrophic factor for sensory neurons: 
comparison with the effects of the neurotrophins. J Neurobiol 32(1):22-32. 
Matsuda S, Baluk P, Shimizu D, Fujiwara T. 1996. Dorsal root ganglion neuron 
development in chick and rat. Anat Embryol (Berl) 193(5):475-480. 
Matsuda S, Kobayashi N, Wakisaka H, Saito S, Saito K, Miyawaki K, Mominoki K, 
Shigemoto K, Murakami S, Fujiwara T. 2000. Morphological  transformation of 
the sensory ganglion neurons and satellite cells. Biomedical Reviews 11:39-52. 
Matsuda S, Uehara Y. 1984. Prenatal development of the rat dorsal root ganglia. A 
scanning electron-microscopic study. Cell Tissue Res 235(1):13-18. 
201 
 
Max SR, Schwab M, Dumas M, Thoenen H. 1978. Retrograde axonal transport of nerve 
growth factor in the ciliary ganglion of the chick and the rat. Brain Res 
159(2):411-415. 
McDonald DS, Zochodne DW. 2003. An injectable nerve regeneration chamber for 
studies of unstable soluble growth factors. J Neurosci Methods 122(2):171-178. 
McKay Hart A, Brannstrom T, Wiberg M, Terenghi G. 2002. Primary sensory neurons 
and satellite cells after peripheral axotomy in the adult rat: timecourse of cell 
death and elimination. Exp Brain Res 142(3):308-318. 
McKeehan WL, Wang F, Kan M. 1998. The heparan sulfate-fibroblast growth factor 
family: diversity of structure and function. Prog Nucleic Acid Res Mol Biol 
59:135-176. 
McKnight GS. 1991. Cyclic AMP second messenger systems. Curr Opin Cell Biol 
3(2):213-217. 
McLean WG, Roberts RE, Mullins FH. 1995. Post-translational modifications of 
microtubule- and growth-associated proteins in nerve regeneration and 
neuropathy. Biochem Soc Trans 23(1):76-80. 
McMahon SB, Armanini MP, Ling LH, Phillips HS. 1994. Expression and coexpression 
of Trk receptors in subpopulations of adult primary sensory neurons projecting to 
identified peripheral targets. Neuron 12(5):1161-1171. 
McMahon SB, Wall PD. 1987. Physiological evidence for branching of peripheral 
unmyelinated sensory afferent fibers in the rat. J Comp Neurol 261(1):130-136. 
McPhail LT, Fernandes KJ, Chan CC, Vanderluit JL, Tetzlaff W. 2004. Axonal reinjury 
reveals the survival and re-expression of regeneration-associated genes in 
chronically axotomized adult mouse motoneurons. Exp Neurol 188(2):331-340. 
McQuarrie IG. 1978. The effect of a conditioning lesion on the regeneration of motor 
axons. Brain Res 152(3):597-602. 
McQuarrie IG, Grafstein B, Gershon MD. 1977. Axonal regeneration in the rat sciatic 
nerve: effect of a conditioning lesion and of dbcAMP. Brain Res 132(3):443-453. 
Meiri KF, Gordon-Weeks PR. 1990. GAP-43 in growth cones is associated with areas of 
membrane that are tightly bound to substrate and is a component of a membrane 
skeleton subcellular fraction. J Neurosci 10(1):256-266. 
Meiri KF, Hammang JP, Dent EW, Baetge EE. 1996. Mutagenesis of ser41 to ala inhibits 
the association of GAP-43 with the membrane skeleton of GAP-43-deficient 
PC12B cells: effects on cell adhesion and the composition of neurite cytoskeleton 
and membrane. J Neurobiol 29(2):213-232. 
Meiri KF, Pfenninger KH, Willard MB. 1986. Growth-associated protein, GAP-43, a 
polypeptide that is induced when neurons extend axons, is a component of growth 
cones and corresponds to pp46, a major polypeptide of a subcellular fraction 
enriched in growth cones. Proc Natl Acad Sci U S A 83(10):3537-3541. 
Meisinger C, Grothe C. 1997. Differential regulation of fibroblast growth factor (FGF)-2 
and FGF receptor 1 mRNAs and FGF-2 isoforms in spinal ganglia and sciatic 
nerve after peripheral nerve lesion. J Neurochem 68(3):1150-1158. 
Meisinger C, Hertenstein A, Grothe C. 1996a. Fibroblast growth factor receptor 1 in the 
adrenal gland and PC12 cells: developmental expression and regulation by 
extrinsic molecules. Brain Res Mol Brain Res 36(1):70-78. 
202 
 
Meisinger C, Zeschnigk C, Grothe C. 1996b. In vivo and in vitro effect of glucocorticoids 
on fibroblast growth factor (FGF)-2 and FGF receptor 1 expression. J Biol Chem 
271(28):16520-16525. 
Mescher A. 2009. Junqueira's Basic Histology. 
Michael-Titus AT, Revest P, Shortland P. 2010. The Nervous System: of the Body Series  
Mill JF, Chao MV, Ishii DN. 1985. Insulin, insulin-like growth factor II, and nerve 
growth factor effects on tubulin mRNA levels and neurite formation. Proc Natl 
Acad Sci U S A 82(20):7126-7130. 
Millan MJ. 1999. The induction of pain: an integrative review. Prog Neurobiol 57(1):1-
164. 
Miller FD, Tetzlaff W, Bisby MA, Fawcett JW, Milner RJ. 1989. Rapid induction of the 
major embryonic alpha-tubulin mRNA, T alpha 1, during nerve regeneration in 
adult rats. J Neurosci 9(4):1452-1463. 
Mirsky R, Jessen KR, Brennan A, Parkinson D, Dong Z, Meier C, Parmantier E, Lawson 
D. 2002. Schwann cells as regulators of nerve development. J Physiol Paris 96(1-
2):17-24. 
Mograbi B, Bocciardi R, Bourget I, Busca R, Rochet N, Farahi-Far D, Juhel T, Rossi B. 
2001. Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 
3-kinase and Akt activities exert opposing effects on the ERK pathway: 
importance for the rescue of neuroectodermic cells. J Biol Chem 276(48):45307-
45319. 
Mohiuddin L, Delcroix JD, Fernyhough P, Tomlinson DR. 1999. Focally administered 
nerve growth factor suppresses molecular regenerative responses of axotomized 
peripheral afferents in rats. Neuroscience 91(1):265-271. 
Mohiuddin L, Tomlinson DR. 1997. Impaired molecular regenerative responses in 
sensory neurones of diabetic rats: gene expression changes in dorsal root ganglia 
after sciatic nerve crush. Diabetes 46(12):2057-2062. 
Molliver DC, Wright DE, Leitner ML, Parsadanian AS, Doster K, Wen D, Yan Q, Snider 
WD. 1997. IB4-binding DRG neurons switch from NGF to GDNF dependence in 
early postnatal life. Neuron 19(4):849-861. 
Monaco S, Gehrmann J, Raivich G, Kreutzberg GW. 1992. MHC-positive, ramified 
macrophages in the normal and injured rat peripheral nervous system. J 
Neurocytol 21(9):623-634. 
Montminy M. 1997. Transcriptional regulation by cyclic AMP. Annu Rev Biochem 
66:807-822. 
Montminy MR, Gonzalez GA, Yamamoto KK. 1990a. Characteristics of the cAMP 
response unit. Metabolism 39(9 Suppl 2):6-12. 
Montminy MR, Gonzalez GA, Yamamoto KK. 1990b. Regulation of cAMP-inducible 
genes by CREB. Trends Neurosci 13(5):184-188. 
Morad M, Davies NW, Kaplan JH, Lux HD. 1988. Inactivation and block of calcium 
channels by photo-released Ca2+ in dorsal root ganglion neurons. Science 
241(4867):842-844. 
Morgan JI, Curran T. 1988. Calcium as a modulator of the immediate-early gene cascade 
in neurons. Cell Calcium 9(5-6):303-311. 
203 
 
Moskowitz PF, Smith R, Pickett J, Frankfurter A, Oblinger MM. 1993. Expression of the 
class III beta-tubulin gene during axonal regeneration of rat dorsal root ganglion 
neurons. J Neurosci Res 34(1):129-134. 
Mulderry PK. 1994. Neuropeptide expression by newborn and adult rat sensory neurons 
in culture: effects of nerve growth factor and other neurotrophic factors. 
Neuroscience 59(3):673-688. 
Murashov AK, Ul Haq I, Hill C, Park E, Smith M, Wang X, Goldberg DJ, Wolgemuth 
DJ. 2001. Crosstalk between p38, Hsp25 and Akt in spinal motor neurons after 
sciatic nerve injury. Brain Res Mol Brain Res 93(2):199-208. 
Murinson BB, Hoffman PN, Banihashemi MR, Meyer RA, Griffin JW. 2005. C-fiber 
(Remak) bundles contain both isolectin B4-binding and calcitonin gene-related 
peptide-positive axons. J Comp Neurol 484(4):392-402. 
Murphy M, Reid K, Ford M, Furness JB, Bartlett PF. 1994. FGF2 regulates proliferation 
of neural crest cells, with subsequent neuronal differentiation regulated by LIF or 
related factors. Development 120(12):3519-3528. 
Murray AJ, Shewan DA. 2008. Epac mediates cyclic AMP-dependent axon growth, 
guidance and regeneration. Mol Cell Neurosci 38(4):578-588. 
Nadeau S, Hein P, Fernandes KJ, Peterson AC, Miller FD. 2005. A transcriptional role 
for C/EBP beta in the neuronal response to axonal injury. Mol Cell Neurosci 
29(4):525-535. 
Nagy JI, Hunt SP. 1982. Fluoride-resistant acid phosphatase-containing neurones in 
dorsal root ganglia are separate from those containing substance P or 
somatostatin. Neuroscience 7(1):89-97. 
Nakagomi S, Suzuki Y, Namikawa K, Kiryu-Seo S, Kiyama H. 2003. Expression of the 
activating transcription factor 3 prevents c-Jun N-terminal kinase-induced 
neuronal death by promoting heat shock protein 27 expression and Akt activation. 
J Neurosci 23(12):5187-5196. 
Nakazawa T, Tamai M, Mori N. 2002. Brain-derived neurotrophic factor prevents 
axotomized retinal ganglion cell death through MAPK and PI3K signaling 
pathways. Invest Ophthalmol Vis Sci 43(10):3319-3326. 
Navarro X, Vivo M, Valero-Cabre A. 2007. Neural plasticity after peripheral nerve injury 
and regeneration. Prog Neurobiol 82(4):163-201. 
Neumann S, Bradke F, Tessier-Lavigne M, Basbaum AI. 2002. Regeneration of sensory 
axons within the injured spinal cord induced by intraganglionic cAMP elevation. 
Neuron 34(6):885-893. 
Neumann S, Woolf CJ. 1999. Regeneration of dorsal column fibers into and beyond the 
lesion site following adult spinal cord injury. Neuron 23(1):83-91. 
Newman JP, Verity AN, Hawatmeh S, Fee WE, Jr., Terris DJ. 1996. Ciliary neurotrophic 
factors enhances peripheral nerve regeneration. Arch Otolaryngol Head Neck 
Surg 122(4):399-403. 
Newton RA, Bingham S, Case PC, Sanger GJ, Lawson SN. 2001. Dorsal root ganglion 
neurons show increased expression of the calcium channel alpha2delta-1 subunit 
following partial sciatic nerve injury. Brain Res Mol Brain Res 95(1-2):1-8. 
Noguchi K, Senba E, Morita Y, Sato M, Tohyama M. 1989. Prepro-VIP and 
preprotachykinin mRNAs in the rat dorsal root ganglion cells following peripheral 
axotomy. Brain Res Mol Brain Res 6(4):327-330. 
204 
 
Obata K, Katsura H, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, Dai Y, 
Fukuoka T, Noguchi K. 2007. Roles of extracellular signal-regulated protein 
kinases 5 in spinal microglia and primary sensory neurons for neuropathic pain. J 
Neurochem 102(5):1569-1584. 
Obata K, Yamanaka H, Dai Y, Mizushima T, Fukuoka T, Tokunaga A, Noguchi K. 
2004a. Activation of extracellular signal-regulated protein kinase in the dorsal 
root ganglion following inflammation near the nerve cell body. Neuroscience 
126(4):1011-1021. 
Obata K, Yamanaka H, Dai Y, Mizushima T, Fukuoka T, Tokunaga A, Noguchi K. 
2004b. Differential activation of MAPK in injured and uninjured DRG neurons 
following chronic constriction injury of the sciatic nerve in rats. Eur J Neurosci 
20(11):2881-2895. 
Obata K, Yamanaka H, Dai Y, Tachibana T, Fukuoka T, Tokunaga A, Yoshikawa H, 
Noguchi K. 2003. Differential activation of extracellular signal-regulated protein 
kinase in primary afferent neurons regulates brain-derived neurotrophic factor 
expression after peripheral inflammation and nerve injury. J Neurosci 
23(10):4117-4126. 
Oblinger MM, Lasek RJ. 1984. A conditioning lesion of the peripheral axons of dorsal 
root ganglion cells accelerates regeneration of only their peripheral axons. J 
Neurosci 4(7):1736-1744. 
Oblinger MM, Szumlas RA, Wong J, Liuzzi FJ. 1989. Changes in cytoskeletal gene 
expression affect the composition of regenerating axonal sprouts elaborated by 
dorsal root ganglion neurons in vivo. J Neurosci 9(8):2645-2653. 
Oellig C, Pirvola U, Taylor L, Elde R, Hokfelt T, Pettersson RF. 1995. Acidic FGF and 
FGF receptors are specifically expressed in neurons of developing and adult rat 
dorsal root ganglia. Eur J Neurosci 7(5):863-874. 
Ohara S, Tantuwaya V, DiStefano PS, Schmidt RE. 1995. Exogenous NT-3 mitigates the 
transganglionic neuropeptide Y response to sciatic nerve injury. Brain Res 
699(1):143-148. 
Orie NN, Thomas AM, Perrino BA, Tinker A, Clapp L. 2009. Ca(2+)/calcineurin 
regulation of cloned vascular K(ATP) channels: crosstalk with the protein kinase 
A pathway. Br J Pharmacol. 
Ornitz DM, Itoh N. 2001. Fibroblast growth factors. Genome Biol 2(3):REVIEWS3005. 
Otto D, Unsicker K, Grothe C. 1987. Pharmacological effects of nerve growth factor and 
fibroblast growth factor applied to the transectioned sciatic nerve on neuron death 
in adult rat dorsal root ganglia. Neurosci Lett 83(1-2):156-160. 
Pannese E. 1974. The histogenesis of the spinal ganglia. Adv Anat Embryol Cell Biol 
47(5):7-97. 
Pannese E. 1978. The response of the satellite and other non-neuronal cells to the 
degeneration of neuroblasts in chick embryo spinal ganglia. Cell Tissue Res 
190(1):1-14. 
Pannese E. 1981. The satellite cells of the sensory ganglia. Adv Anat Embryol Cell Biol 
65:1-111. 
Pannese E. 2002. Perikaryal surface specializations of neurons in sensory ganglia. Int 
Rev Cytol 220:1-34. 
205 
 
Pannese E, Arcidiacono G, Frattola D, Rigamonti L, Procacci P, Ledda M. 1988a. 
Quantitative relationships between axoplasm and Schwann cell sheath in 
unmyelinated nerve fibres. An electron microscope study. J Anat 159:49-56. 
Pannese E, Ledda M, Arcidiacono G, Frattola D, Rigamonti L, Procacci P. 1988b. 
Qualitative and quantitative observations on the structure of the Schwann cells in 
myelinated fibres. Acta Anat (Basel) 131(4):314-326. 
Pannese E, Rigamonti L, Procacci P, Ledda M, Arcidiacono G, Frattola D. 1988c. The 
structure of Schwann cells in unmyelinated fibres. A qualitative and quantitative 
electron microscope study. J Submicrosc Cytol Pathol 20(2):325-333. 
Parada CA, Reichling DB, Levine JD. 2005. Chronic hyperalgesic priming in the rat 
involves a novel interaction between cAMP and PKCepsilon second messenger 
pathways. Pain 113(1-2):185-190. 
Park SY, Choi JY, Kim RU, Lee YS, Cho HJ, Kim DS. 2003. Downregulation of 
voltage-gated potassium channel alpha gene expression by axotomy and 
neurotrophins in rat dorsal root ganglia. Mol Cells 16(2):256-259. 
Pearce JM. 2000. Wallerian degeneration. J Neurol Neurosurg Psychiatry 69(6):791. 
Pearson AG, Gray CW, Pearson JF, Greenwood JM, During MJ, Dragunow M. 2003. 
ATF3 enhances c-Jun-mediated neurite sprouting. Brain Res Mol Brain Res 
120(1):38-45. 
Pei YY, Duan SB, Cai WJ, Yi XN, Zeng ZC, Zhang JW, Xu YZ, Zou QY, Wen XD. 
2005. [Effects of transforming growth factor-beta 1 on the peripheral nerve 
regeneration of rats]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 30(4):447-451. 
Pellitteri R, Russo A, Stanzani S. 2006. Schwann cell: a source of neurotrophic activity 
on cortical glutamatergic neurons in culture. Brain Res 1069(1):139-144. 
Perlson E, Hanz S, Ben-Yaakov K, Segal-Ruder Y, Seger R, Fainzilber M. 2005. 
Vimentin-dependent spatial translocation of an activated MAP kinase in injured 
nerve. Neuron 45(5):715-726. 
Perlson E, Hanz S, Medzihradszky KF, Burlingame AL, Fainzilber M. 2004. From snails 
to sciatic nerve: Retrograde injury signaling from axon to soma in lesioned 
neurons. J Neurobiol 58(2):287-294. 
Perry VH, Gordon S. 1988. Macrophages and microglia in the nervous system. Trends 
Neurosci 11(6):273-277. 
Peyronnard JM, Terry LC, Aguayo A. 1975. Schwann cell internuclear distances in 
developing rat unmyelinated nerve fibers. Arch Neurol 32(1):36-38. 
Pichichero M, Beer B, Clody DE. 1973. Effects of dibutyryl cyclic AMP on restoration of 
function of damaged sciatic nerve in rats. Science 182(113):724-725. 
Piehl F, Arvidsson U, Johnson H, Cullheim S, Dagerlind A, Ulfhake B, Cao Y, Elde R, 
Pettersson RF, Terenius L, et al. 1993. GAP-43, aFGF, CCK and alpha- and beta-
CGRP in rat spinal motoneurons subjected to axotomy and/or dorsal root 
severance. Eur J Neurosci 5(10):1321-1333. 
Pierau FK, Taylor DC, Abel W, Friedrich B. 1982. Dichotomizing peripheral fibres 
revealed by intracellular recording from rat sensory neurones. Neurosci Lett 
31(2):123-128. 
Poteryaev D, Titievsky A, Sun YF, Thomas-Crusells J, Lindahl M, Billaud M, Arumae 
U, Saarma M. 1999. GDNF triggers a novel ret-independent Src kinase family-
206 
 
coupled signaling via a GPI-linked GDNF receptor alpha1. FEBS Lett 463(1-
2):63-66. 
Price J. 1985. An immunohistochemical and quantitative examination of dorsal root 
ganglion neuronal subpopulations. J Neurosci 5(8):2051-2059. 
Qiu J, Cafferty WB, McMahon SB, Thompson SW. 2005. Conditioning injury-induced 
spinal axon regeneration requires signal transducer and activator of transcription 3 
activation. J Neurosci 25(7):1645-1653. 
Qiu J, Cai D, Dai H, McAtee M, Hoffman PN, Bregman BS, Filbin MT. 2002a. Spinal 
axon regeneration induced by elevation of cyclic AMP. Neuron 34(6):895-903. 
Qiu J, Cai D, Filbin MT. 2002b. A role for cAMP in regeneration during development 
and after injury. Prog Brain Res 137:381-387. 
Rabinovsky ED, Smith GM, Browder DP, Shine HD, McManaman JL. 1992. Peripheral 
nerve injury down-regulates CNTF expression in adult rat sciatic nerves. J 
Neurosci Res 31(1):188-192. 
Raivich G, Behrens A. 2006. Role of the AP-1 transcription factor c-Jun in developing, 
adult and injured brain. Prog Neurobiol 78(6):347-363. 
Raivich G, Bohatschek M, Da Costa C, Iwata O, Galiano M, Hristova M, Nateri AS, 
Makwana M, Riera-Sans L, Wolfer DP, Lipp HP, Aguzzi A, Wagner EF, Behrens 
A. 2004. The AP-1 transcription factor c-Jun is required for efficient axonal 
regeneration. Neuron 43(1):57-67. 
Raivich G, Hellweg R, Kreutzberg GW. 1991. NGF receptor-mediated reduction in 
axonal NGF uptake and retrograde transport following sciatic nerve injury and 
during regeneration. Neuron 7(1):151-164. 
Raivich G, Makwana M. 2007. The making of successful axonal regeneration: genes, 
molecules and signal transduction pathways. Brain Res Rev 53(2):287-311. 
Ransone LJ, Verma IM. 1989. Association of nuclear oncoproteins fos and jun. Curr 
Opin Cell Biol 1(3):536-540. 
Renganathan M, Cummins TR, Waxman SG. 2001. Contribution of Na(v)1.8 sodium 
channels to action potential electrogenesis in DRG neurons. J Neurophysiol 
86(2):629-640. 
Rich KM, Disch SP, Eichler ME. 1989. The influence of regeneration and nerve growth 
factor on the neuronal cell body reaction to injury. J Neurocytol 18(5):569-576. 
Richardson PM, Issa VM. 1984. Peripheral injury enhances central regeneration of 
primary sensory neurones. Nature 309(5971):791-793. 
Richardson PM, Lu X. 1994. Inflammation and axonal regeneration. J Neurol 242(1 
Suppl 1):S57-60. 
Richardson PM, Verge VM. 1986. The induction of a regenerative propensity in sensory 
neurons following peripheral axonal injury. J Neurocytol 15(5):585-594. 
Richardson PM, Verge VM. 1987. Axonal regeneration in dorsal spinal roots is 
accelerated by peripheral axonal transection. Brain Res 411(2):406-408. 
Ro LS, Chen ST, Tang LM. 1998. Extent of collateral sprouting of intact nerve fibers in 
rats depends on the local availability of nerve growth factor. J Formos Med Assoc 
97(4):247-251. 
Rusnak F, Mertz P. 2000. Calcineurin: form and function. Physiol Rev 80(4):1483-1521. 
207 
 
Ryoke K, Ochi M, Iwata A, Uchio Y, Yamamoto S, Yamaguchi H. 2000. A conditioning 
lesion promotes in vivo nerve regeneration in the contralateral sciatic nerve of 
rats. Biochem Biophys Res Commun 267(3):715-718. 
Saussede-Aim J, Matera EL, Herveau S, Rouault JP, Ferlini C, Dumontet C. 2009. 
Vinorelbine induces beta3-tubulin gene expression through an AP-1 Site. 
Anticancer Res 29(8):3003-3009. 
Scaravilli F, Giometto B, Chimelli L, Sinclair E. 1991. Macrophages in human sensory 
ganglia: an immunohistochemical and ultrastructural study. J Neurocytol 
20(7):609-624. 
Schaden H, Stuermer CA, Bahr M. 1994. GAP-43 immunoreactivity and axon 
regeneration in retinal ganglion cells of the rat. J Neurobiol 25(12):1570-1578. 
Schaefer TS, Sanders LK, Nathans D. 1995. Cooperative transcriptional activity of Jun 
and Stat3 beta, a short form of Stat3. Proc Natl Acad Sci U S A 92(20):9097-
9101. 
Schecterson LC, Bothwell M. 1992. Novel roles for neurotrophins are suggested by 
BDNF and NT-3 mRNA expression in developing neurons. Neuron 9(3):449-463. 
Scheibe RJ, Ginty DD, Wagner JA. 1991. Retinoic acid stimulates the differentiation of 
PC12 cells that are deficient in cAMP-dependent protein kinase. J Cell Biol 
113(5):1173-1182. 
Scherer SS, Kamholz J, Jakowlew SB. 1993. Axons modulate the expression of 
transforming growth factor-betas in Schwann cells. Glia 8(4):265-276. 
Schmalbruch H. 1986. Fiber composition of the rat sciatic nerve. Anat Rec 215(1):71-81. 
Schmalbruch H. 1987. Loss of sensory neurons after sciatic nerve section in the rat. Anat 
Rec 219(3):323-329. 
Schmitt AB, Breuer S, Liman J, Buss A, Schlangen C, Pech K, Hol EM, Brook GA, Noth 
J, Schwaiger FW. 2003. Identification of regeneration-associated genes after 
central and peripheral nerve injury in the adult rat. BMC Neurosci 4:8. 
Schoenen J, Delree P, Leprince P, Moonen G. 1989. Neurotransmitter phenotype 
plasticity in cultured dissociated adult rat dorsal root ganglia: an 
immunocytochemical study. J Neurosci Res 22(4):473-487. 
Schreyer DJ, Andersen PL, Williams K, Kosatka I, Truong TN. 1997. Quantitative 
analysis of GAP-43 expression by neurons in microcultures using cell-ELISA. J 
Neurosci Methods 72(2):137-145. 
Schreyer DJ, Hryciw, T. and Davies, G.F. . 2004. FGF-2 and cyclic AMP signaling cross-
talk and the regulation of GAP-43 expression in adult DRG cultures. Society for 
Neuroscience Abstracts 390.15. 
Schreyer DJ, Skene JH. 1991. Fate of GAP-43 in ascending spinal axons of DRG neurons 
after peripheral nerve injury: delayed accumulation and correlation with 
regenerative potential. J Neurosci 11(12):3738-3751. 
Schreyer DJ, Skene JH. 1993. Injury-associated induction of GAP-43 expression displays 
axon branch specificity in rat dorsal root ganglion neurons. J Neurobiol 
24(7):959-970. 
Schumacher M, Jung-Testas I, Robel P, Baulieu EE. 1993. Insulin-like growth factor I: a 
mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP. 
Glia 8(4):232-240. 
Schwab ME. 2004. Nogo and axon regeneration. Curr Opin Neurobiol 14(1):118-124. 
208 
 
Schwab ME, Thoenen H. 1977. Retrograde axonal and transsynaptic transport of 
macromolecules: physiological and pathophysiological importance. Agents 
Actions 7(3):361-368. 
Schwaiger FW, Hager G, Schmitt AB, Horvat A, Streif R, Spitzer C, Gamal S, Breuer S, 
Brook GA, Nacimiento W, Kreutzberg GW. 2000. Peripheral but not central 
axotomy induces changes in Janus kinases (JAK) and signal transducers and 
activators of transcription (STAT). Eur J Neurosci 12(4):1165-1176. 
Seijffers R, Allchorne AJ, Woolf CJ. 2006. The transcription factor ATF-3 promotes 
neurite outgrowth. Mol Cell Neurosci 32(1-2):143-154. 
Seijffers R, Mills CD, Woolf CJ. 2007. ATF3 increases the intrinsic growth state of DRG 
neurons to enhance peripheral nerve regeneration. J Neurosci 27(30):7911-7920. 
Seino S, Shibasaki T. 2005. PKA-dependent and PKA-independent pathways for cAMP-
regulated exocytosis. Physiol Rev 85(4):1303-1342. 
Seo TB, Oh MJ, You BG, Kwon KB, Chang IA, Yoon JH, Lee CY, Namgung U. 2009. 
ERK1/2-mediated Schwann cell proliferation in the regenerating sciatic nerve by 
treadmill training. J Neurotrauma 26(10):1733-1744. 
Sheng HZ, Lin PX, Nelson PG. 1995. Combinatorial expression of immediate early genes 
in single neurons. Brain Res Mol Brain Res 30(2):196-202. 
Shinder V, Govrin-Lippmann R, Cohen S, Belenky M, Ilin P, Fried K, Wilkinson HA, 
Devor M. 1999. Structural basis of sympathetic-sensory coupling in rat and 
human dorsal root ganglia following peripheral nerve injury. J Neurocytol 
28(9):743-761. 
Siconolfi LB, Seeds NW. 2001. Mice lacking tPA, uPA, or plasminogen genes showed 
delayed functional recovery after sciatic nerve crush. J Neurosci 21(12):4348-
4355. 
Sjoberg J, Kanje M. 1990. The initial period of peripheral nerve regeneration and the 
importance of the local environment for the conditioning lesion effect. Brain Res 
529(1-2):79-84. 
Skene JH. 1984. Growth-associated proteins and the curious dichotomies of nerve 
regeneration. Cell 37(3):697-700. 
Skene JH. 1989. Axonal growth-associated proteins. Annu Rev Neurosci 12:127-156. 
Skene JH. 1990. GAP-43 as a 'calmodulin sponge' and some implications for calcium 
signalling in axon terminals. Neurosci Res Suppl 13:S112-125. 
Skene JH, Virag I. 1989. Posttranslational membrane attachment and dynamic fatty 
acylation of a neuronal growth cone protein, GAP-43. J Cell Biol 108(2):613-624. 
Skene JH, Willard M. 1981. Axonally transported proteins associated with axon growth 
in rabbit central and peripheral nervous systems. J Cell Biol 89(1):96-103. 
Sleeper AA, Cummins TR, Dib-Hajj SD, Hormuzdiar W, Tyrrell L, Waxman SG, Black 
JA. 2000. Changes in expression of two tetrodotoxin-resistant sodium channels 
and their currents in dorsal root ganglion neurons after sciatic nerve injury but not 
rhizotomy. J Neurosci 20(19):7279-7289. 
Smith DS, Skene JH. 1997. A transcription-dependent switch controls competence of 
adult neurons for distinct modes of axon growth. J Neurosci 17(2):646-658. 
Snider WD, Zhou FQ, Zhong J, Markus A. 2002. Signaling the pathway to regeneration. 
Neuron 35(1):13-16. 
209 
 
Sommervaille T, Reynolds ML, Woolf CJ. 1991. Time-dependent differences in the 
increase in GAP-43 expression in dorsal root ganglion cells after peripheral 
axotomy. Neuroscience 45(1):213-220. 
Song H, Ming G, He Z, Lehmann M, McKerracher L, Tessier-Lavigne M, Poo M. 1998. 
Conversion of neuronal growth cone responses from repulsion to attraction by 
cyclic nucleotides. Science 281(5382):1515-1518. 
Song XY, Li F, Zhang FH, Zhong JH, Zhou XF. 2008. Peripherally-derived BDNF 
promotes regeneration of ascending sensory neurons after spinal cord injury. 
PLoS One 3(3):e1707. 
Soto I, Marie B, Baro DJ, Blanco RE. 2003. FGF-2 modulates expression and distribution 
of GAP-43 in frog retinal ganglion cells after optic nerve injury. J Neurosci Res 
73(4):507-517. 
Squinto SP, Stitt TN, Aldrich TH, Davis S, Bianco SM, Radziejewski C, Glass DJ, 
Masiakowski P, Furth ME, Valenzuela DM, et al. 1991. trkB encodes a functional 
receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve 
growth factor. Cell 65(5):885-893. 
Starkey ML, Davies M, Yip PK, Carter LM, Wong DJ, McMahon SB, Bradbury EJ. 
2009. Expression of the regeneration-associated protein SPRR1A in primary 
sensory neurons and spinal cord of the adult mouse following peripheral and 
central injury. J Comp Neurol 513(1):51-68. 
Sterne GD, Brown RA, Green CJ, Terenghi G. 1998. NT-3 modulates NPY expression in 
primary sensory neurons following peripheral nerve injury. J Anat 193 ( Pt 
2):273-281. 
Stevens A, Schabet M, Schott K, Wietholter H. 1989. Role of endoneural cells in 
experimental allergic neuritis and characterisation of a resident phagocytic cell. 
Acta Neuropathol 77(4):412-419. 
Stockli KA, Lillien LE, Naher-Noe M, Breitfeld G, Hughes RA, Raff MC, Thoenen H, 
Sendtner M. 1991. Regional distribution, developmental changes, and cellular 
localization of CNTF-mRNA and protein in the rat brain. J Cell Biol 115(2):447-
459. 
Stoll G, Muller HW. 1999. Nerve injury, axonal degeneration and neural regeneration: 
basic insights. Brain Pathol 9(2):313-325. 
Stoop R, Poo MM. 1996a. Synaptic modulation by neurotrophic factors. Prog Brain Res 
109:359-364. 
Stoop R, Poo MM. 1996b. Synaptic modulation by neurotrophic factors: differential and 
synergistic effects of brain-derived neurotrophic factor and ciliary neurotrophic 
factor. J Neurosci 16(10):3256-3264. 
Streit P. 1980. [Retrograde axonal transport and neurotransmitter specificity]. Bull 
Schweiz Akad Med Wiss 36(1-3):21-51. 
Streit P, Stella M, Cuenod M. 1980. Transneuronal labeling in the pigeon visual system. 
Neuroscience 5(4):763-777. 
Strittmatter SM, Fankhauser C, Huang PL, Mashimo H, Fishman MC. 1995. Neuronal 
pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-
43. Cell 80(3):445-452. 
Strittmatter SM, Fishman MC. 1991. The neuronal growth cone as a specialized 
transduction system. Bioessays 13(3):127-134. 
210 
 
Strittmatter SM, Valenzuela D, Vartanian T, Sudo Y, Zuber MX, Fishman MC. 1991. 
Growth cone transduction: Go and GAP-43. J Cell Sci Suppl 15:27-33. 
Stucky CL, Lewin GR. 1999. Isolectin B(4)-positive and -negative nociceptors are 
functionally distinct. J Neurosci 19(15):6497-6505. 
Sun Y, Landis SC, Zigmond RE. 1996. Signals triggering the induction of leukemia 
inhibitory factor in sympathetic superior cervical ganglia and their nerve trunks 
after axonal injury. Mol Cell Neurosci 7(2):152-163. 
Sun Y, Zigmond RE. 1996a. Involvement of leukemia inhibitory factor in the increases in 
galanin and vasoactive intestinal peptide mRNA and the decreases in 
neuropeptide Y and tyrosine hydroxylase mRNA in sympathetic neurons after 
axotomy. J Neurochem 67(4):1751-1760. 
Sun Y, Zigmond RE. 1996b. Leukaemia inhibitory factor induced in the sciatic nerve 
after axotomy is involved in the induction of galanin in sensory neurons. Eur J 
Neurosci 8(10):2213-2220. 
Swett JE, Torigoe Y, Elie VR, Bourassa CM, Miller PG. 1991. Sensory neurons of the rat 
sciatic nerve. Exp Neurol 114(1):82-103. 
Tamura S, Morikawa Y, Senba E. 2005. Up-regulated phosphorylation of signal 
transducer and activator of transcription 3 and cyclic AMP-responsive element 
binding protein by peripheral inflammation in primary afferent neurons possibly 
through oncostatin M receptor. Neuroscience 133(3):797-806. 
Tapia M, Inestrosa NC, Alvarez J. 1995. Early axonal regeneration: repression by 
Schwann cells and a protease? Exp Neurol 131(1):124-132. 
Tatagiba M, Brosamle C, Schwab ME. 1997. Regeneration of injured axons in the adult 
mammalian central nervous system. Neurosurgery 40(3):541-546; discussion 546-
547. 
Taylor DC, Pierau FK. 1982. Double fluorescence labelling supports electrophysiological 
evidence for dichotomizing peripheral sensory nerve fibres in rats. Neurosci Lett 
33(1):1-6. 
Tejero-Diez P, Rodriguez-Sanchez P, Martin-Cofreces NB, Diez-Guerra FJ. 2000. bFGF 
stimulates GAP-43 phosphorylation at ser41 and modifies its intracellular 
localization in cultured hippocampal neurons. Mol Cell Neurosci 16(6):766-780. 
Teng FY, Tang BL. 2006. Axonal regeneration in adult CNS neurons--signaling 
molecules and pathways. J Neurochem 96(6):1501-1508. 
Terenghi G. 1999. Peripheral nerve regeneration and neurotrophic factors. J Anat 194 ( Pt 
1):1-14. 
Tessler A, Himes BT, Krieger NR, Murray M, Goldberger ME. 1985. Sciatic nerve 
transection produces death of dorsal root ganglion cells and reversible loss of 
substance P in spinal cord. Brain Res 332(2):209-218. 
Thoenen H. 1991. The changing scene of neurotrophic factors. Trends Neurosci 
14(5):165-170. 
Thoenen H, Korsching S, Heumann R, Acheson A. 1985. Nerve growth factor. Ciba 
Found Symp 116:113-128. 
Thoenen H, Zafra F, Hengerer B, Lindholm D. 1991. The synthesis of nerve growth 
factor and brain-derived neurotrophic factor in hippocampal and cortical neurons 
is regulated by specific transmitter systems. Ann N Y Acad Sci 640:86-90. 
211 
 
Thompson SW, Vernallis AB, Heath JK, Priestley JV. 1997. Leukaemia inhibitory factor 
is retrogradely transported by a distinct population of adult rat sensory neurons: 
co-localization with trkA and other neurochemical markers. Eur J Neurosci 
9(6):1244-1251. 
Todd KJ, Auld DS, Robitaille R. 2007. Neurotrophins modulate neuron-glia interactions 
at a vertebrate synapse. Eur J Neurosci 25(5):1287-1296. 
Torigoe K, Hashimoto K, Lundborg G. 1999. A role of migratory Schwann cells in a 
conditioning effect of peripheral nerve regeneration. Exp Neurol 160(1):99-108. 
Torres-Aleman I, Naftolin F, Robbins RJ. 1990a. Trophic effects of basic fibroblast 
growth factor on fetal rat hypothalamic cells: interactions with insulin-like growth 
factor I. Brain Res Dev Brain Res 52(1-2):253-257. 
Torres-Aleman I, Naftolin F, Robbins RJ. 1990b. Trophic effects of insulin-like growth 
factor-I on fetal rat hypothalamic cells in culture. Neuroscience 35(3):601-608. 
Trupp M, Ryden M, Jornvall H, Funakoshi H, Timmusk T, Arenas E, Ibanez CF. 1995. 
Peripheral expression and biological activities of GDNF, a new neurotrophic 
factor for avian and mammalian peripheral neurons. J Cell Biol 130(1):137-148. 
Trupp M, Scott R, Whittemore SR, Ibanez CF. 1999. Ret-dependent and -independent 
mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal 
cells. J Biol Chem 274(30):20885-20894. 
Tsai SY, Yang LY, Wu CH, Chang SF, Hsu CY, Wei CP, Leu SJ, Liaw J, Lee YH, Tsai 
MD. 2007. Injury-induced Janus kinase/protein kinase C-dependent 
phosphorylation of growth-associated protein 43 and signal transducer and 
activator of transcription 3 for neurite growth in dorsal root ganglion. J Neurosci 
Res 85(2):321-331. 
Tsui-Pierchala BA, Milbrandt J, Johnson EM, Jr. 2002. NGF utilizes c-Ret via a novel 
GFL-independent, inter-RTK signaling mechanism to maintain the trophic status 
of mature sympathetic neurons. Neuron 33(2):261-273. 
Tsui-Pierchala BA, Putcha GV, Johnson EM, Jr. 2000. Phosphatidylinositol 3-kinase is 
required for the trophic, but not the survival-promoting, actions of NGF on 
sympathetic neurons. J Neurosci 20(19):7228-7237. 
Tsujino H, Kondo E, Fukuoka T, Dai Y, Tokunaga A, Miki K, Yonenobu K, Ochi T, 
Noguchi K. 2000. Activating transcription factor 3 (ATF3) induction by axotomy 
in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell 
Neurosci 15(2):170-182. 
Tsuzuki K, Noguchi K, Mohri D, Yasuno H, Umemoto M, Shimobayashi C, Fukazawa 
K, Sakagami M. 2002. Expression of activating transcription factor 3 and growth-
associated protein 43 in the rat geniculate ganglion neurons after chorda tympani 
injury. Acta Otolaryngol 122(2):161-167. 
Tucker BA, Mearow KM. 2008. Peripheral sensory axon growth: from receptor binding 
to cellular signaling. Can J Neurol Sci 35(5):551-566. 
Twiss JL, Smith DS, Chang B, Shooter EM. 2000. Translational control of ribosomal 
protein L4 mRNA is required for rapid neurite regeneration. Neurobiol Dis 
7(4):416-428. 
Twiss JL, van Minnen J. 2006. New insights into neuronal regeneration: the role of 
axonal protein synthesis in pathfinding and axonal extension. J Neurotrauma 
23(3-4):295-308. 
212 
 
Unsicker K, Grothe, C., Lodecke, G., Otto, D. and Westermann. R. 1993. Fibroblast 
growth factors: their roles in the central and peripheral nervous system. Fallon 
SELaJH, editor. New York: Academic Press. 
Utley DS, Lewin SL, Cheng ET, Verity AN, Sierra D, Terris DJ. 1996. Brain-derived 
neurotrophic factor and collagen tubulization enhance functional recovery after 
peripheral nerve transection and repair. Arch Otolaryngol Head Neck Surg 
122(4):407-413. 
Uysal CA, Mizuno H, Hyakusoku H. 2009. Sciatic nerve anatomy in rat re-visited: a 
more proximal intervention. J Plast Reconstr Aesthet Surg. 
Van Hooff CO, De Graan PN, Oestreicher AB, Gispen WH. 1988. B-50 phosphorylation 
and polyphosphoinositide metabolism in nerve growth cone membranes. J 
Neurosci 8(5):1789-1795. 
Varon S. 1968. Possible involvement of nerve growth factors in neuroblastoma 
pathology. J Pediatr Surg 3(1):165-166. 
Verge VM, Gratto KA, Karchewski LA, Richardson PM. 1996. Neurotrophins and nerve 
injury in the adult. Philos Trans R Soc Lond B Biol Sci 351(1338):423-430. 
Verge VM, Richardson PM, Wiesenfeld-Hallin Z, Hokfelt T. 1995. Differential influence 
of nerve growth factor on neuropeptide expression in vivo: a novel role in peptide 
suppression in adult sensory neurons. J Neurosci 15(3 Pt 1):2081-2096. 
Vogel KS. 1993. Development of trophic interactions in the vertebrate peripheral nervous 
system. Mol Neurobiol 7(3-4):363-382. 
Vogt PK, Bos TJ. 1989. The oncogene jun and nuclear signalling. Trends Biochem Sci 
14(5):172-175. 
Vogt PK, Morgan I. 1990. The genetics of jun. Semin Cancer Biol 1(1):27-36. 
Waetzig V, Zhao Y, Herdegen T. 2006. The bright side of JNKs-Multitalented mediators 
in neuronal sprouting, brain development and nerve fiber regeneration. Prog 
Neurobiol 80(2):84-97. 
Wakisaka S, Kajander KC, Bennett GJ. 1991. Increased neuropeptide Y (NPY)-like 
immunoreactivity in rat sensory neurons following peripheral axotomy. Neurosci 
Lett 124(2):200-203. 
Wall PD. 1984. The painful consequences of peripheral injury. J Hand Surg [Br] 9(1):37-
39. 
Wall PD, Devor M, Inbal R, Scadding JW, Schonfeld D, Seltzer Z, Tomkiewicz MM. 
1979. Autotomy following peripheral nerve lesions: experimental anaesthesia 
dolorosa. Pain 7(2):103-111. 
Wall PD, Gutnick M. 1974a. Ongoing activity in peripheral nerves: the physiology and 
pharmacology of impulses originating from a neuroma. Exp Neurol 43(3):580-
593. 
Wall PD, Gutnick M. 1974b. Properties of afferent nerve impulses originating from a 
neuroma. Nature 248(5451):740-743. 
Wall PD, Waxman S, Basbaum AI. 1974. Ongoing activity in peripheral nerve: injury 
discharge. Exp Neurol 45(3):576-589. 
Waller AV. 1850. Experiments on the section of the glossopharyngeal and hypoglossal 
nerves of the frog, and observations of the alterations produced thereby in the 
structure of their primitive fibers. Philosophical Transactions Royal Society of 
London B Biological Sciences 140:423-429. 
213 
 
Waltereit R, Weller M. 2003. Signaling from cAMP/PKA to MAPK and synaptic 
plasticity. Mol Neurobiol 27(1):99-106. 
Walton KM, Rehfuss RP. 1990. Molecular mechanisms of cAMP-regulated gene 
expression. Mol Neurobiol 4(3-4):197-210. 
Walton MR, Dragunow I. 2000. Is CREB a key to neuronal survival? Trends Neurosci 
23(2):48-53. 
Wang H, Sun H, Della Penna K, Benz RJ, Xu J, Gerhold DL, Holder DJ, Koblan KS. 
2002. Chronic neuropathic pain is accompanied by global changes in gene 
expression and shares pathobiology with neurodegenerative diseases. 
Neuroscience 114(3):529-546. 
Wang R, Guo W, Ossipov MH, Vanderah TW, Porreca F, Lai J. 2003. Glial cell line-
derived neurotrophic factor normalizes neurochemical changes in injured dorsal 
root ganglion neurons and prevents the expression of experimental neuropathic 
pain. Neuroscience 121(3):815-824. 
Wang TH, Meng QS, Qi JG, Zhang WM, Chen J, Wu LF. 2008. NT-3 expression in 
spared DRG and the associated spinal laminae as well as its anterograde transport 
in sensory neurons following removal of adjacent DRG in cats. Neurochem Res 
33(1):1-7. 
Wang W, van Niekerk E, Willis DE, Twiss JL. 2007. RNA transport and localized 
protein synthesis in neurological disorders and neural repair. Dev Neurobiol 
67(9):1166-1182. 
Watson FL, Heerssen HM, Bhattacharyya A, Klesse L, Lin MZ, Segal RA. 2001. 
Neurotrophins use the Erk5 pathway to mediate a retrograde survival response. 
Nat Neurosci 4(10):981-988. 
Watson FL, Heerssen HM, Moheban DB, Lin MZ, Sauvageot CM, Bhattacharyya A, 
Pomeroy SL, Segal RA. 1999. Rapid nuclear responses to target-derived 
neurotrophins require retrograde transport of ligand-receptor complex. J Neurosci 
19(18):7889-7900. 
Waxman SG, Cummins TR, Dib-Hajj SD, Black JA. 2000. Voltage-gated sodium 
channels and the molecular pathogenesis of pain: a review. J Rehabil Res Dev 
37(5):517-528. 
Waxman SG, Dib-Hajj S, Cummins TR, Black JA. 1999. Sodium channels and pain. Proc 
Natl Acad Sci U S A 96(14):7635-7639. 
Weber JR, Skene JH. 1998. The activity of a highly promiscuous AP-1 element can be 
confined to neurons by a tissue-selective repressive element. J Neurosci 
18(14):5264-5274. 
Weise B, Unsicker K, Grothe C. 1992. Localization of basic fibroblast growth factor in a 
subpopulation of rat sensory neurons. Cell Tissue Res 267(1):125-130. 
Whitmarsh AJ, Davis RJ. 2007. Role of mitogen-activated protein kinase kinase 4 in 
cancer. Oncogene 26(22):3172-3184. 
Wickenden AD, Maher MP, Chaplan SR. 2009. HCN pacemaker channels and pain: a 
drug discovery perspective. Curr Pharm Des 15(18):2149-2168. 
Wiegant VM. 1978. Cyclic nucleotides in nervous tissue. Brain Res Bull 3(6):611-622. 
Wiklund P, Ekstrom PA, Edstrom A. 2002. Mitogen-activated protein kinase inhibition 
reveals differences in signalling pathways activated by neurotrophin-3 and other 
214 
 
growth-stimulating conditions of adult mouse dorsal root ganglia neurons. J 
Neurosci Res 67(1):62-68. 
Willis D, Li KW, Zheng JQ, Chang JH, Smit A, Kelly T, Merianda TT, Sylvester J, van 
Minnen J, Twiss JL. 2005. Differential transport and local translation of 
cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons. J 
Neurosci 25(4):778-791. 
Wolfgang CD, Chen BP, Martindale JL, Holbrook NJ, Hai T. 1997. gadd153/Chop10, a 
potential target gene of the transcriptional repressor ATF3. Mol Cell Biol 
17(11):6700-6707. 
Wolfgang CD, Liang G, Okamoto Y, Allen AE, Hai T. 2000. Transcriptional 
autorepression of the stress-inducible gene ATF3. J Biol Chem 275(22):16865-
16870. 
Wong BJ, Mattox DE. 1991. Experimental nerve regeneration. A review. Otolaryngol 
Clin North Am 24(3):739-752. 
Wong J, Oblinger MM. 1990. A comparison of peripheral and central axotomy effects on 
neurofilament and tubulin gene expression in rat dorsal root ganglion neurons. J 
Neurosci 10(7):2215-2222. 
Woolf CJ, Reynolds ML, Molander C, O'Brien C, Lindsay RM, Benowitz LI. 1990. The 
growth-associated protein GAP-43 appears in dorsal root ganglion cells and in the 
dorsal horn of the rat spinal cord following peripheral nerve injury. Neuroscience 
34(2):465-478. 
Wright DE, Snider WD. 1995. Neurotrophin receptor mRNA expression defines distinct 
populations of neurons in rat dorsal root ganglia. J Comp Neurol 351(3):329-338. 
Wu C, Lai CF, Mobley WC. 2001. Nerve growth factor activates persistent Rap1 
signaling in endosomes. J Neurosci 21(15):5406-5416. 
Wu D, Zhang Y, Bo X, Huang W, Xiao F, Zhang X, Miao T, Magoulas C, Subang MC, 
Richardson PM. 2007. Actions of neuropoietic cytokines and cyclic AMP in 
regenerative conditioning of rat primary sensory neurons. Exp Neurol 204(1):66-
76. 
Xian CJ, Zhou XF. 1999. Neuronal-glial differential expression of TGF-alpha and its 
receptor in the dorsal root ganglia in response to sciatic nerve lesion. Exp Neurol 
157(2):317-326. 
Xie F, Zheng B. 2008. White matter inhibitors in CNS axon regeneration failure. Exp 
Neurol 209(2):302-312. 
Xing JL, Hu SJ. 1999. Relationship between calcium-dependent potassium channel and 
ectopic spontaneous discharges of injured dorsal root ganglion neurons in the rat. 
Brain Res 838(1-2):218-221. 
Xu XJ, Hao JX, Hokfelt T, Wiesenfeld-Hallin Z. 1994. The effects of intrathecal 
neuropeptide Y on the spinal nociceptive flexor reflex in rats with intact sciatic 
nerves and after peripheral axotomy. Neuroscience 63(3):817-826. 
Xu ZQ, Zhang X, Grillner S, Hokfelt T. 1997. Electrophysiological studies on rat dorsal 
root ganglion neurons after peripheral axotomy: changes in responses to 
neuropeptides. Proc Natl Acad Sci U S A 94(24):13262-13266. 
Yang H, Xia Y, Lu SQ, Soong TW, Feng ZW. 2008. Basic fibroblast growth factor-
induced neuronal differentiation of mouse bone marrow stromal cells requires 
215 
 
FGFR-1, MAPK/ERK, and transcription factor AP-1. J Biol Chem 283(9):5287-
5295. 
Ygge J. 1989. Neuronal loss in lumbar dorsal root ganglia after proximal compared to 
distal sciatic nerve resection: a quantitative study in the rat. Brain Res 478(1):193-
195. 
Yin Q, Kemp GJ, Frostick SP. 1998. Neurotrophins, neurones and peripheral nerve 
regeneration. J Hand Surg Br 23(4):433-437. 
Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, Hai T, Whelan J. 1997. 
Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and 
kidney. J Biol Chem 272(32):19943-19950. 
Yoo JY, Wang W, Desiderio S, Nathans D. 2001. Synergistic activity of STAT3 and c-
Jun at a specific array of DNA elements in the alpha 2-macroglobulin promoter. J 
Biol Chem 276(28):26421-26429. 
Yoo S, Nguyen MP, Fukuda M, Bittner GD, Fishman HM. 2003. Plasmalemmal sealing 
of transected mammalian neurites is a gradual process mediated by Ca(2+)-
regulated proteins. J Neurosci Res 74(4):541-551. 
Zhang JM, Donnelly DF, Song XJ, Lamotte RH. 1997. Axotomy increases the 
excitability of dorsal root ganglion cells with unmyelinated axons. J Neurophysiol 
78(5):2790-2794. 
Zhang X, Meister B, Elde R, Verge VM, Hokfelt T. 1993. Large calibre primary afferent 
neurons projecting to the gracile nucleus express neuropeptide Y after sciatic 
nerve lesions: an immunohistochemical and in situ hybridization study in rats. Eur 
J Neurosci 5(11):1510-1519. 
Zhang X, Wrzeszczynska MH, Horvath CM, Darnell JE, Jr. 1999. Interacting regions in 
Stat3 and c-Jun that participate in cooperative transcriptional activation. Mol Cell 
Biol 19(10):7138-7146. 
Zheng JQ, Kelly TK, Chang B, Ryazantsev S, Rajasekaran AK, Martin KC, Twiss JL. 
2001. A functional role for intra-axonal protein synthesis during axonal 
regeneration from adult sensory neurons. J Neurosci 21(23):9291-9303. 
Zhou XF, Deng YS, Chie E, Xue Q, Zhong JH, McLachlan EM, Rush RA, Xian CJ. 
1999. Satellite-cell-derived nerve growth factor and neurotrophin-3 are involved 
in noradrenergic sprouting in the dorsal root ganglia following peripheral nerve 
injury in the rat. Eur J Neurosci 11(5):1711-1722. 
Zhou XF, Rush RA. 1996. Endogenous brain-derived neurotrophic factor is 
anterogradely transported in primary sensory neurons. Neuroscience 74(4):945-
953. 
Zigmond RE, Hyatt-Sachs H, Mohney RP, Schreiber RC, Shadiack AM, Sun Y, 
Vaccariello SA. 1996. Changes in neuropeptide phenotype after axotomy of adult 
peripheral neurons and the role of leukemia inhibitory factor. Perspect Dev 
Neurobiol 4(1):75-90. 
Zochodne D. 2008. Neurobiology of peripheral nerve regeneration. Cambridge: 
Cambridge University Press. 
Zou T, Ling C, Xiao Y, Tao X, Ma D, Chen ZL, Strickland S, Song H. 2006. Exogenous 
tissue plasminogen activator enhances peripheral nerve regeneration and 
functional recovery after injury in mice. J Neuropathol Exp Neurol 65(1):78-86. 
  
216 
 
 
